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Chapter 1 
General Introduction 

General introduction 
'Fatigued? So what's the problem?' 
Chronic fatigue syndrome (CFS) is characterized by persistent severe disabling 
fatigue for which no somatic explanation can be offered Several accompanying 
symptoms may be present, such as myalgia, headache, sleep problems, and memory 
and concentration problems 
Chronic fatigue is a major problem for the patient as well as for the doctor The 
doctor is confronted with a patient with multiple nonspecific symptoms, for which 
no somatic explanation can be found, and for which a somatic treatment is also 
lacking Moreover, no scientifically sound diagnostic test is available to establish the 
diagnosis 'chronic fatigue syndrome' Due to these uncertainties physicians are 
reluctant in making this diagnosis The patient, on the other hand, is very persistent 
in receiving a diagnosis and a somatic explanation He experiences severe, disabling 
symptoms and is convinced that there is a physical cause for these symptoms 
Conclusions offered by the doctor that 'there is nothing wrong' or 'that complaints 
therefore must be psychological' are certainly not accepted The patient feels not to 
have been taken seriously The fact that a satisfactory explanation for the complaints 
has not been found leads to repeated costly diagnostic evaluations m the regular and 
alternative medical circuits, invanantly with disappointing results 
Commonly patients feel that their partner, family, friends, neighbours, or 
colleagues also do not appreciate their situation Statements such as 'everybody is 
tired now and then', or 'the doctor could not find anything, so what is the 
problem9 , or even reproaches of malingering are often noted by patients 
The complaints can have a significant deleterious impact on social, leisure, and 
occupational activities Because of problems in maintaining occupational activities, 
many patients are on sick leave or apply for invalidity benefits Recently, legislation 
with respect to awarding invalidity benefits in The Netherlands has been tightened 
The major criterion for awarding invalidity benefits is the presence of established 
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physical abnormalities. In chronic fatigue syndrome such abnormalities cannot be 
documented by definition. Consequently, patients are denied invalidity benefits and 
are sent back to work. Subsequently, these patients get involved in lengthy juridical 
procedures, in which doctors are called upon to provide the legally required medical 
explanation, with resulting expensive diagnostic evaluations. Eventually, considering 
present strict legislation, the patient is left at the short end of the stick. 
Thus, chronic fatigue syndrome is a serious problem: to the patient who 
experiences genuine disabling complaints for which no solution is offered; to the 
doctor who cannot provide a solution, although required so by the patient; and 
chronic fatigue is a problem to society, not in the least considering the repeated 
expensive diagnostic evaluations and juridical procedures. A recent survey among 
general practitioners in The Netherlands yielded a highly conservative estimated 
prevalence of 1.2 per 1000.' Considering a population of 15 million people this 
would mean a number of at least 17,000 patients with chronic fatigue syndrome in 
The Netherlands. 
History 
Complaints of nonspecific chronic fatigue have received much attention during the 
last decade in the scientific and popular media. It is, however, not a new condition. 
Complaints of chronic fatigue have been described as early as 1750 when Sir 
Richard Manningham described a condition with similar symptoms, called 
febrícula.2 Manningham noted similar descriptions in the writings of Hippocrates. In 
the 19th century the neurologist George Beard used the term Neurasthenia, referring 
to the lack of strength of the nerves that he believed to underlie this condition.3 
Shortly after Beard's account of chronic fatigue, Da Costa published an extensive 
study on battle-worn soldiers of the American Civil War.4 The main symptoms he 
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described were fatigue, breathlessness, dizziness, headache, gastrointestinal 
disturbances, and chestpain. This syndrome has been called Da Costa's syndrome, 
effort syndrome, neurocirculatory asthenia, and the autonomic imbalance syndrome. 
Da Costa attributed this syndrome to an 'irritable heart'. 
In the middle of this century (1934-1956) several epidemics of fatiguing illnesses 
have been described that attracted much publicity. The first recorded epidemic 
occurred among doctors and nurses of several hospitals in Los Angeles in 1934.56 In 
the winter of 1948-1949 an epidemic broke out in a town called Akureyri in 
Iceland.7 Many other outbreaks have been reported since, for example, outbreaks in 
Adelaide, Australia (1949),8 New York State, USA (1950),9 and during the summer 
of 1954 in the Royal Free Hospital in London, UK.10 In these same years 
descriptions of endemic cases have also been reported.11"13 
Various names have been used for these fatiguing illnesses. Some of these names 
refer to the geographical sites were an epidemic had occurred, such as Akureyri 
disease, Iceland disease, and Royal Free disease. Other names refer to presumed 
etiology, such as atypical poliomyelitis, myalgic encephalomyelitis (ME), 
neuromyasthenia, postviral fatigue syndrome, chronic Candidiasis, chronic 
Brucellosis, chronic fatigue and immune dysfunction syndrome (CFIDS). 
Present interest in chronic unexplained fatigue began in the early 1980's with the 
description of chronic Epstein-Barr virus syndrome (or chronic mononucleosis 
syndrome). It was reported that chronic fatigue can begin during acute infectious 
mononucleosis, and that patients with chronic fatigue had unusual levels of 
antibodies to Epstein-Barr virus antigens.14"17 The syndrome consisted of a 
combination of nonspecific symptoms, such as severe fatigue, weakness, malaise, 
sore throat, painful lymph nodes, problems with memory and concentration, 
confusion, and depression. Later studies have cast doubt on the relation between 
chronic fatigue and Epstein-Barr virus.18,19 
13 
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Diagnosis and assessment 
Because of unproven involvement of Epstein-Barr virus to the etiology of chronic 
Epstein-Barr syndrome, Holmes and collegues20 in 1988 coined the name 'Chronic 
Fatigue Syndrome' (CFS), as this name is strictly descriptive and free from 
unproven etiological assumptions They also proposed a case definition (CDC-1988 
criteria) to improve comparability and reproducibility of clinical and epidemiological 
research Patients have to experience persisting or relapsing debilitating fatigue, 
which does not resolve with bedrest, severe enough to reduce or impair average 
daily activity level below 50% of the patient's premorbid activity level for at least 
six months, and for which no explanation could be found after prior examinations 
Also, at least 6 out of a list 11 specified symptoms have to be present Patients with 
psychiatric diagnoses are excluded 
Less stringent criteria have been formulated in the United Kingdom21 and 
Australia 22 According to these criteria fatigue has to be disabling, of definite onset, 
and lasting for at least six months Other symptoms may be present, but are not 
required Psychiatric diagnoses such as depression and anxiety are no grounds for 
exclusion In 1994 the CDC criteria have been revised 23 There are three major 
differences with the original criteria First, the symptom criteria for CFS are less 
strict (4 out of 8 specified symptoms) Second, patients not fulfilling symptom 
criteria for CFS but have unexplained fatigue for at least six months fatigue are 
classified as cases of idiopathic chronic fatigue Third, psychiatric diagnosis, such as 
depression and anxiety are no reasons for exclusion 
There are major shortcomings to these criteria First, they reflect consensus 
rather than validated criteria Second, diagnosis is established more on exclusionary 
than on positive grounds And third, and most important, the positive criteria are 
based on a set of rather arbitrarily chosen nonspecific symptoms The latter 
objection in particular concerns the CDC-1988 and CDC-1994 criteria Fatigue is a 
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complaint difficult to define or measure, which is not in the least due to its 
nonspecific and subjective nature To date, no clear definition of fatigue exists24, 
resulting in problems in measurement Other symptoms commonly reported in CFS 
are also nonspecific Thus, symptoms appear to have little diagnostic value 
Etiology and treatment 
Many hypotheses have been proposed related to the causes of chronic fatigue 
syndrome In the early 1980 s research was primarily focussed on somatic factors A 
number of microorganisms, notably Epstein-Barr virus1315 and enteroviruses2526 have 
been suggested as possible causes for CFS Also, CFS has been attributed to 
lmmunotoxins released from yeast, especially Candida Albicans,27 pesticide and 
amalgam intoxications, hypoglycaemia, an abnormal immune response,28 
abnormalities in the muscle,2'30 and abnormalities of the central nervous system 3132 
These studies have provided conflicting results As yet, no somatic cause has been 
proven to be etiologically related to CFS 
Studies on psychological factors emerged somewhat later and initially were 
concerned with stressful life-events33 and personality factors3334 as predisposing 
factors for CFS The bulk of psychological studies focussed on psychiatric disorders 
Particular attention was payed to depression and somatisation disorder, to which 
complaints were attributed 35 36 Others have described a vicious circle of avoidance 
of physical activity, attributing complaints to a physical cause, and depression 
perpetuating complaints 37 But scientific evidence for these hypotheses still is 
lacking 
At present, no somatic treatment has been found effective in CFS 
Antidepressants are frequently described, fluoxetine (Prozac") being the most 
fashionable purported agent On the one hand based on the assumption that CFS in 
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fact is a depressive disorder, and on the other hand based on case reports and 
uncontrolled studies claiming beneficial effects of anti-depressants, not only on 
depressive symptoms, but also on fatigue Scientifically sound studies are awaited 
Positive results have been reported with cognitive-behavioural therapy, which is 
directed at changing cognitions and increasing physical activity 37 38 However, this 
therapy lacks empirical foundation in CFS 
Outline of this thesis 
What originally instigated symptoms in chronic fatigue syndrome is unknown The 
studies presented in this thesis are primarily concerned with processes that cause 
complaints to perpetuate 
Reviews of somatologie and psychological hypotheses regarding the cause of 
CFS are presented in Chapter 2 and Chapter 3 respectively 
Considering the above mentioned problems in assessment, one of the first goals 
we set out for was to develop an assessment method that allowed us to measure 
fatigue and related processes (Chapter 4) 
Chapter 5 describes a study on the usefulness of laboratory tests in CFS Patients 
with CFS are compared with well matched healthy controls and the relationships 
between laboratory data, clinical status, and psychological parameters are 
investigated 
In Chapter 6 a study on the natural course in CFS is presented Such studies are 
needed since they provide information, not only on prognosis, but also on factors 
associated with chronicity 
Antidepressants are frequently described in CFS (notably fluoxetine), but 
without scientific justification Therefore, we performed a double-blind placebo-
controlled study on the effect of fluoxetine (ProzacR) in CFS This is the first 
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controlled study on the effectiveness of antidepressant therapy in CFS (Chapter 7) 
Fatigue has been reported to be a frequent symptom in patients with multiple 
sclerosis (MS), but has been poorly studied in these patients Chapter 8 contains a 
multi-dimensional study in which a comprehensive characterisation of fatigue in 
multiple sclerosis is provided and an evaluation of the relationships between fatigue 
on the one hand and impairment in daily life, depression, level of physical activity, 
and cognitions and attributions, sleeping problems, and neuropsychological problems 
on the other 
In Chapter 9 a model on psychological factors that play a role in the perpetuation 
of fatigue is developed and tested This model is also tested in fatigued patients with 
MS 
An extensive measurement of physical activity in CFS and MS is presented in 
Chapter 10 
Chapter 11 evaluates the prevalence of neuropsychological impairment in CFS 
Prevalence rates based on self-report are related to prevalence rates based on 
standardized neuropsychological tests 
Finally, Chapter 12 entails a general discussion of the studies presented in this 
thesis and discusses implications for future research and for clinical practice 
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Somatologie hypotheses 
Introduction 
In the past few years, publications about the chronic fatigue syndrome (CFS) have 
appeared with increasing frequency in international literature The syndrome is 
characterized by longstanding unexplained fatigue which has led to a serious 
decrease in the level of achievement The majority of patients are females between 
20 and 50 years old, often women from the higher social classes The prevalence of 
CFS is estimated to be 0 1-1 0% ' 3 In many countries patient organizations have 
already been established The Dutch society (the Myalgie Encephalomyelitis or ME 
Foundation) now (1991) has 3600 members 
The cause and the pathogenesis of this syndrome are as yet still unknown In 
addition to sporadic cases, outbreaks or epidemic manifestations have also been 
described, although it is not known whether they are of the same etiology and 
pathogenesis Since it is not clear whether one syndrome or multiple syndromes are 
involved, it would be better to refer to 'chronic fatigue e causa ignota For 
simplicity's sake, however, we shall use the term chronic fatigue syndrome' in this 
article In the literature one can find a wide variety of other terms Akureyn disease, 
chronic fatigue and immune dysfunction syndrome (CFIDS), chronic Epstein Barr 
virus syndrome, chronic mononucleosis, Iceland Disease, myalgic 
encephalomyelitis, neuromyasthenia, postviral fatigue syndrome, 'Royal Free' 
disease and yuppie flu 
For the history of CFS, the reader is referred to the literature 45 Various 
publications have also appeared in Dutch medical journals 6 9 Dutch studies are, 
however, lacking Various definitions of the term 'chronic fatigue' were used by the 
different authors, which affects the comparability of these studies Many 
investigators used the definition of Holmes et al , 'persistent or relapsing debilitating 
fatigue, severe enough to reduce or impair daily activity below 50% of the 
premorbid activity level for a period of least 6 months, and for which no explanation 
could be found after prior examinations 10 The diagnosis CFS is established by 
means ot exclusion (Table 1) 
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Table 1: Criteria for the diagnosis of the chronic fatigue syndrome, acceding to Holmes et 
Major criteria 
1. New onset of persistent or relapsing, debilitating fatigue or easy fatigability that does 
not resolve with bed rest and is severe enough to reduce average daily activity by at 
least 50% of the premorbid activity level for a period of at least 6 months. 
2. Other clinical conditions that may cause similar symptoms must be excluded. These 
conditions include: malignancy, autoimmune disease, infection (occult abscess, 
endocarditis, Lyme disease, tuberculosis, fungal infections, helminthic infestation, 
toxoplasmosis, amebiasis, giardiasis, HIV infection), chronic inflammatory diseases 
(sarcoidosis, Wegener granulomatosis, chronic hepatitis), endocrine diseases 
(diabetes, hypothyroidism, Addison disease, Cushing syndrome), psychiatric diseases 
(endogenous depression, hysteria, anxiety neurosis, schizophrenia, etc.), alcoholism, 
drug dependency or abuse, intoxication (chemical solvents, pesticides, heavy metals), 
chronic cardiac, pulmonary, hepatic, gastrointestinal, renal or hematologic disease. 
Minor symptom criteria 
I Mild fever (37 5° - 38.6°C orally) or chills 
2. Sore throat 
3. Painful posterior cervical, anterior cervical, or axillary lymph nodes 
4. Unexplained generalized muscle weakness 
5. Muscle discomfort or myalgia 
6 Prolonged (at least 24 hours) generalized fatigue following previously well-tolerated 
exercise 
7 New generalized headaches (different from headaches in the premorbid phase) 
8. Migratory arthralgia without joint swelling or redness 
9 Neuropsychologic symptoms (photophobia, transient visual scotoma, forgetfulness, 
excessive irritability, confusion, difficulty thinking, inability to concentrate, 
depression) 
10. Sleep disturbance (insomnia or hypersomnia) 
II Acute or subacute onset of the symptoms (within several hours to days). 
Physical examination criteria 
1. Low-grade fever (37.6° - 38.6°C orally or 37.8° - 38.8 °C rectally) 
2. Nonexudative pharyngitis 
3. Palpable or tender anterior cervical, posterior cervical, or axillary lymph nodes 
( < 2 cm m diameter). 
Somatologie hypotheses 
This condition represents a difficult medical problem which - due to the lack of a 
solution - is commonly considered to be of little importance by the medical 
profession Many physicians are sceptical about the existence of such a syndrome, 
especially because examination does not reveal any abnormalities 6 " The conclusion 
that the doctor found 'nothing' is, however, not accepted by the patient and certainly 
is not considered to be a solution for the problem of fatigue The patient is 
convinced that the cause of his complaints is somatic The fact that a satisfactory 
physical explanation of these complaints cannot be found is frustrating for both the 
patient and the examining physician It leads to expensive, repetitive and 
unsuccessful diagnostics performed by the physician, for the patient it leads to 
repeated and continuously disappointing consultations with physicians from the 
regular as well as the alternative medical circuits In this respect, a major problem is 
the fact that fatigue in itself is so difficult to measure Furthermore, the prolonged 
presence of the complaints causes severe problems as far as daily functioning is 
concerned In this article, the pattern of complaints, hypotheses on somatic causes, 
pathogenesis, and therapeutic aspects are described The psychological aspects are 
discussed by Vercoulen et al elsewhere in this journal 
The pattern of complaints 
Definition of this syndrome is exceedingly difficult because of the lack of an 
objective instrument which can measure chronic fatigue The same also applies for 
the frequently recorded accompanying phenomena American clinical investigators 
of the Centers for Disease Control have drawn up a number of criteria (see Table 
l)10 For establishment of the diagnosis, two of the major and 6-8 of the minor 
criteria are required These criteria are of necessity somewhat arbitrary in nature In 
addition, the required number of criteria is so large that we have found that a fairly 
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sizeable proportion of the patients with severe chronic fatigue in our practice do not 
meet the criteria On the other hand, these entena do improve the comparability ot 
the patient groups to be investigated In addition, the criteria give a good impression 
of the various manifestations of CFS It is clear that these can vary markedly 
Depending on these manifestations, the patient will be referred to an internist, a 
neurologist, a reumatologist or a psychiatrist 
CFS exhibits a striking number of similarities with a disease known in 
rheumatology as fibromyalgia 12 M Fibromyalgia or fibrositis is a form of non-
articular rheumatism, which is characterized by diffuse muscular and joint pain and 
is often accompanied by general fatigue, chronic headaches, depression, 
paraesthesia, and sleep disturbances Painful pressure points are also characteristic 
Like CFS, this condition affects predominantly women between 20 and 50 years of 
age Laboratory studies reveal as a rule only mild abnormalities or none at all 
Single fibre electromyography demonstrates abnormalities which are also found in 
patients with CFS 
Hypotheses on the cause and pathogenesis 
The factors which play a role in the development of the complaints are to a large 
extent still unknown In the literature a number of hypotheses have been proposed 
on somatic as well as psychologic factors which could play a role in the development 
and the perpetuation of CFS In a large number of cases the complaints appear to 
have started subsequent to an acute infectious disease, this applies for the sporadic 
cases as well as the outbreaks This has resulted in the hypothesis that there is a 
persistent infection together with an abnormal reaction of the immune system In 
addition, for a group of selected patients abnormalities of the muscles were 
described This could mean that these complaints indeed have an organic substrate 
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Table 2 Possible causative agents of the chronic fatigue syndrome 
Micro organisms 
Epstein-Barr virus 6 7 15 22 
varicella zoster virus 212> 
cytomegalovirus '8 20 2124 
human herpesvirus type 6 22 25 
Borrelia burgdorferi u 30 
Toxoplasma gondii 17 
Candida albicans 3133 
POSSIBLE CAUSE 
A number of micro-organisms has been indicated as the possible causative agent of 
the syndrome (Table 2) 6 715 " The references given in this table refer to studies of 
varying quality with conflicting results The patient groups studied are as a rule 
poorly defined and are not mutually comparable 
Attention has focused in particular on two viruses the Epstein-Barr virus (EBV) 
and enteroviruses EBV, a virus which infects more than 90% of the population, 
persists after the primary infection mainly in B-lymphocytes and the salivary 
glands The fact that antibodies against the 'early antigen' (EA) of this virus are 
continuously demonstrated in patients with CFS, eventually together with a lack of 
antibodies against the nuclear antigen (EBNA), is considered proof of active viral 
multiplication in these patients " 15 '6 
Similar publications have also appeared in this journal79 In later studies, 
however, the presence of this serological pattern could not be confirmed, it could 
only be demonstrated in a small number of cases, but also healthy patients exhibited 
high anti-EA titers n 18) 
Enteroviruses are also universal micro-organisms but they do not as a rule cause 
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persistent infections British investigators contended that enterovirus persists in 
patients with CFS, they believed that they had identified the somatic component of 
the disease26 This finding first encountered considerable scepticism since 
enteroviruses were actually not considered to be persistent viruses until several years 
ago (see also the article of Galama et al elsewhere in this journal) Investigators 
have since demonstrated enterovirus RNA in muscle biopsies by means of 
hybridization techniques In 24% of a group of patients with CFS selected on the 
basis of myalgia and muscle weakness, persistent enteroviruses were found in faeces 
and in muscle biopsies 2627 In addition, viral antigens of enterovirus (VP-1) were 
demonstrated in serum in about 60% of the patients, moreover, a high percentage 
also exhibited IgM antibodies against enteroviruses Epstein-Barr virus DNA was 
found in the muscle biopsies of more than 10% of this same group but not in the 
muscle biopsies of controls The two viruses were never demonstrated in one and the 
same patient21 These results were reported by one group of investigators whereby 
the inclusion criteria for the patient group is poorly defined and the controls are not 
satisfactorily described These observations therefore are in urgent need of 
confirmation 
The significance of the other persistent micro-organisms listed in Table 2 is not 
yet clear A clear-cut association with CFS has not been demonstrated for any of 
them In orthomolecular medicine (a form of alternative medicine) the hypothesis, 
based on Crook's book, that colonizing Candida species are the causative agent has 
caused quite a commotion,31 the line of thought behind this theory, however, does 
not hold Treatment with nystatin and complicated diets are prescribed Scientific 
evidence of the efficacy of this approach is, however, lacking (see also the article of 
Berkhof et al elsewhere in this journal) 32 n 
As tar as non-microbiological causes are concerned, significance has been 
attributed - especially by lay journalists - to the influence of intoxication by for 
example pesticides and amalgam There is, however, no proof that the removal of 
amalgam from the teeth has a therapeutic effect M 
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On the grounds of information which is circulated among patients with CFS, 
many believe that they suffer from hypoglycaemia Recently, a study was described 
of CFS patients who believed that they suffered from postprandial hypoglycaemia 
However, during symptomatic periods normal blood glucose values were 
demonstrated " We too have found that the blood glucose values for patierts with 
CFS are consistently normal 
ABNORMAL IMMUNE RESPONSE 
Although there is no proof, the available data point in the direction of an abnormal 
host reaction to certain persisting micro-organisms as a factor for the development of 
CFS The immunological findings for CFS reported in the literature are, however, 
fairly contradictory 36 IgG subclass deficiencies as well as normal IgG levels,3739 
increased as well as normal concentrations of circulating interleukin-2,40 41 and 
normal serum concentrations of interferon but an increased level of 2'-5'-
ohgoadenylate synthetase (a cellular enzyme that is induced specifically by 
interferon) have been described "2 "5 Decreased and normal numbers of CD4 cells 
(helper/inducer Τ cells) and CD8 cells (cytotoxic/suppresser Τ cells) have been 
reported ^ 4 9 The most consistent finding was probably the decreased cytotoxic 
capacity of natural killer (NK cells, lymphocytic cells with large granules which are 
able to lyse tumour cells and cells infected with viruses without prior 
sensibilization) The number of NK cells in patients with CFS can be normal or even 
increased but their function is clearly depressed 50 There is, however, no clear 
relationship between the immunological abnormalities found and the seventy of the 
clinical pattern 
An elevated cytokine production could possibly explain the fatigue and general 
malaise 4 0 These phenomena are also encountered in patients who have been treated 
with interferon The immunological abnormalities which are related in the literature 
to chronic fatigue cannot be demonstrated with any consistency 
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ABNORMALITIES IN THE MUSCLES 
In a considerable percentage of patients with CFS, Epstein-Barr virus DNA or 
enterovirus RNA has been demonstrated in muscle biopsies In addition, single fibre 
electromyography has revealed abnormalities which are consistent with disturbed 
conduction across the muscle membrane 51 " Decreased use of the muscles can, 
however, also lead to retarded conduction through the muscle fibres 31 
By means of nuclear magnetic resonance (NMR) spectroscopy early excessive 
acidosis was demonstrated in one patient with CFS " According to some 
investigators patients with CFS have a decreased tolerance for exercise 54 55 At 
present, it is not known whether the cause is central (lack of psychological 
motivation) or peripheral (in muscle) 
Histologically one study showed a relative increase in type-2 fibres with atrophy 
of these fibres,56 which according to sceptics can be explained by inactivity At the 
ultrastructural level, abnormal mitochondria and fat inclusions have been observed 56 
Confirmation of these observations is, however, lacking 
It is not clear how frequent the abnormalities described above occur, nor 
whether the abnormalities found are a cause or a consequence of the complaints 
ABNORMALITIES OF THE CENTRAL NERVOUS SYSTEM 
Recently, studies of a group of patients with CFS investigated with single photon 
emission computerized tomography (SPECT) revealed abnormalities in more than 
70% of cases, these abnormalities were suggestive of cortical hypoperfusion, 
especially in the temporal region 57 This finding obviously needs confirmation Other 
investigators have reported subtle abnormalities along the hypothalamus-pituitary-
adrenal axis 56 They could be related to the depression and sleep disturbances 
experienced by a number of patients with CFS 
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Therapeutical aspects 
There is as yet no specific therapy for CFS Acyclovir, which is active against 
chronic EBV infections, was found to be ineffective in a controlled study 58 In a 
placebo-controlled study treatment with high doses of intramuscular immunoglobulin 
was effective in some cases 59 In two recent studies the effect of high doses of 
intravenously administered IgG was assessed,606' although the immunological values 
improved in both studies, clinical improvement was seen only in one study in a 
small number of patients In the other study no clinical improvement was observed 
The group treated with Immunglobulin also suffered obvious side-effects For the 
time being it appears that such an expensive therapy cannot be justified 
It has also been reported that fish oil yields favourable results Controlled studies 
with other medications (transfer factor, ampligen, calcium blockers) are still in 
progress 
The possibilities of psychological treatment and therapy with antidepressant 
agents are discussed in the article by Vercoulen et al 
Discussion 
The diagnosis of CFS can only be established by excluding a number of accepted 
causes of fatigue For this purpose Homes et al established a number of criteria 10 
There is, however, a lack of agreement about some of the exclusion entena In 
addition, the criteria for accompanying characteristics have not yet been validated 
We must conclude that a good definition of CFS is not yet available As a result, 
studies of CFS suffer a disadvantage because the definitions of patient groups vary, 
the results of the studies cannot be compared mutually This could explain the many 
conflicting findings 
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Among the various possible causes of CFS, a special role is attributed to the 
infectious diseases The arguments for this are 
- the complaints often begin after a flu-like disease, 
- the occurrence of outbreaks of CFS, 
- the symptoms of night sweating, mild fever, and lymphadenopathy 
Since most infections are considered to be accepted causes of fatigue, CFS must be 
attributable to special forms of infection For instance, it might be an as yet 
unknown manifestation of the common infections Whether EBV can play a causal 
role within the framework of this hypothesis is not yet clear Serological studies at 
present do not provide the answer Studies of the degree of viral multiplication 
performed by means of culture and in situ hybridization on muscle tissue can 
provide better insight Few such studies have as yet been performed 
The role of enteroviruses should also be investigated Persistence is not a general 
characteristic of enteroviruses and could be indicative of a special form of the 
infection It is striking that a high percentage of patients exhibit viral antigens (VP-
1) in the circulation, according to reports from English investigators It is not known 
how specific this VP-1 test is In addition, these scientists studied a group of patients 
selected on the basis of muscle complaints This means that these results probably do 
not apply for the total group of CFS patients 
On the one hand, subtle immunological abnormalities can form the basis for 
persistence of the virus On the other hand, the continuous defence against a 
persisting infection can lead to an increased activity of the immune system, 
accompanied by the production of cytokines which in themselves could form the 
explanation for the fatigue The central position of the immune system becomes even 
more apparent when one realizes that there is a close relationship between the 
immune apparatus, the central nervous system and the neuro-endocnne system 
Lymphocytes are able to produce adrenocorticotropic hormone-like (ACTH-like) 
substances after a viral infection In addition, lymphocytes have receptors for a 
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number of neuropeptides and the mitogenic reaction of lymphocytes is inhibited by 
stress 62 M Depression too can give rise to a number of immunological and 
endocrinological changes65 They could represent the connection with the 
psychological hypotheses An integrated investigation of the psychological and 
somatological findings therefore appears to be essential The fact that immunological 
studies have as yet yielded few consistent results is presumably a question of 
methodology It is therefore also recommended that the immunological studies be 
repeated under standard conditions Studies of the muscles revealed subtle 
abnormalities It is not clear how frequently these abnormalities occur nor whether 
they are a cause or a consequence of the complaints It is striking that according to 
Stokes et al the muscular strength and the fatigability of the muscles are normal in 
CFS 55 We too have found that patients with CFS do not exhibit muscular atrophy 
despite the prolonged inactivity This is indicative of a central (1 e motivation) 
rather than a peripheral (in the muscles) cause 
A specific therapy is at present not available In his approach to the patient the 
physician must exhibit a positive attitude and understanding of the patient Attempts 
to soothe the patient ('luckily we found nothing') are counterproductive At 
Nijmegen University Hospital an investigation has been started to gain more insight 
into the pathogenesis of CFS Both the somatological and the psychological aspects 
will be taken into consideration 
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Psychosocial hypotheses 
Introduction 
In the article of Swanink et al. elsewhere in this journal the somatic aspects of the 
chronic fatigue syndrome (CFS) are described. Patients with CFS report not only 
various somatic complaints but also psychological complaints. Most of these patients 
experience memory and concentration disturbances. Often, they also feel depressed. 
As a rule, these complaints have a marked influence on their daily life: many can 
only work on a part-time basis or not at all and they often also suffer various social 
and physical limitations. 
Specific studies of the role of psychological factors in chronic fatigue have only 
been undertaken in the past few years. Earlier studies were orientated almost entirely 
toward somatic aspects. Of the studies which focus specifically on psychological 
factors, more than half have been published in the recent past. From these 
investigations, it is clear that in one way or another there is an important relationship 
between psychological factors and chronic fatigue. In this article a survey of these 
factors is presented. For this purpose we shall first consider studies which focused 
on general functioning, the role of personality factors and the significance of 
psychological diagnoses. Subsequently, several psychological hypotheses on 
etiological factors and factors which cause the complaints to persist will be 
presented. Finally possible approaches to treatment are discussed. 
Consequences of the complaints for daily functioning 
Fatigue is a complaint which is difficult to quantify. Partly for this reason, it is very 
difficult to assess the magnitude of the influence of the complaint on daily 
functioning. In only one investigation, the influence of the complaint on daily 
functioning was investigated in a standardized manner.1 This study consisted of 1159 
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patients who had visited the general practitioner because of physically unexplained 
fatigue of more than 1 month duration From the scores of the 'sickness impact 
profile',2 an instrument which measures the influence of disease in 12 areas of 
psychosocial and physical functioning, it appeared that these patients experienced 
many more problems in the fields of household work, occupation, social contacts, 
and recreation than people without complaints ' We have found that many of our 
patients with chronic fatigue are declared partially or totally disabled and draw 
sickness benefits, moreover their social contacts become less frequent, recreational 
activities such as sports and hobbies decrease and jobs in and around the home are 
scarsely done Many patients report that colleagues, friends and (to a lesser extent) 
family do not take their complaints seriously, especially if a somatic explanation 
cannot be found The patient often has the feeling that he has to defend himself 
against the belief that he is shamming 
Other complaints experienced by patients with CFS are of a neuropsychological 
nature This type of complaint involves the cognitive processes such as language, 
memory, concentration and the capacity to abstract The majority of the patients 
complain of forgetfulness and concentration problems,3 " they cannot follow the news 
on television, cannot remember why they went into a particular room, find it 
difficult to reach a decision and cannot pay attention to a conversation, especially if 
several people are taking part Still, it is not easy to reproduce these complaints in 
the laboratory situation with the help of standardized neuropsychological tests Some 
investigators report indeed demonstrable concentration and memory disturbances 
among their patients4 7 but their results have not always been confirmed 8 9 The 
explanation for these contradictions lies presumably in the diversity of the 
measurement methods used and the differences in inclusion criteria 
Another unanswered question is what causes the eventual neuropsychological 
disorders are they the direct result of, for example, a viral disease or are they only 
the consequences of the fatigue9 
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Despite the discrepancies in the neuropsychologic investigations it remains a fact 
that the complaints of patients with CFS can have severe consequences for their 
daily functioning It continues to be worthwhile to collect new data in this field 
Personality factors 
Is it possible to distinguish a specific personality profile for patients with CFS which 
might predispose to the development of CFS9 Stncklin et al found the following 
personality profile for patients with CFS Socially withdrawn, depression, tension, 
stress, physical discomfort, low self-esteem and feeling of helplessness 10 In another 
study, the patients were characterized as being more sensitive, less sociable, more 
pessimistic and more inhibited than individuals without complaints ' Both of these 
studies were however retrospective in nature It is therefore likely that the 
characteristics mentioned are not in fact premorbid personality characteristics but are 
instead a consequence of the prolonged complaints There are therefore insufficient 
indications for personality characteristics which can be called typical of or 
predisposing to CFS 
Psychiatric diagnoses 
A relatively large number of investigations has focused on psychiatric diagnoses in 
patients with CFS The percentage patients for whom a psychiatric diagnosis has 
been established vanes between 60 and 80%'3 I 1 1 4 The diagnoses include 
somatization disorder, anxiety disorders, and mood disorders, in particular 
depression Can the complaints of patients with CFS be considered as a 
manifestation of a psychiatric disorder9 
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Somatization disorder, which also includes 'hysteria', although this term is no 
longer in use, is defined in DSM-III-R as 'prolonged presence of multiple somatic 
symptoms for which a physical basis cannot be demonstrated' For this diagnosis, at 
least 13 out of a list of 35 symptoms, varying from gastrointestinal complaints, 
complaints of pain and cardiopulmonary complaints to conversion or 
pseudoneurological complaints, must be present Fatigue is not one of the criteria 
This means that the diagnosis of a somatization disorder can only be established for 
patients with CFS with a large number of accompanying complaints 
The prevalence of the diagnosis somatization disorder among patients with CFS 
is about 15% 1 4 1 6 Although this percentage is considerably higher than that reported 
for the healthy population (the prevalence for the latter lies between 0 2 and 
2 0%),15 it is comparable to the prevalence found for somatization disorder for other 
patient groups, such as women who have undergone a hysterectomy, patients with 
the irritable bowel syndrome and patients with chronic pain " Both the low 
percentage and the fairly arbitrary manner in which it is diagnosed indicate that 
somatization disorder cannot explain CFS 
The anxiety disorders experienced by patients with CFS are mainly social phobia 
(2%) and panic disorder (7-8%) 3 и 16 It has been reported that 36% of patients with 
CFS have at some time experienced an episode which can be diagnosed as an anxiety 
disorder 18 This percentage did not differ significantly from that found for a group of 
healthy controls (25%) 
Some investigators believe that in a number of cases the complaints of patients 
with CFS are a manifestation of depression 1 9 2 0 This is based on the following 
arguments and findings in more than half of the cases of CFS, depression -
according to the strict definition - has been diagnosed,3 " 13 и 18 the symptoms of the 
patients with CFS are to a large extent identical to the symptoms of depression," 
fatigue or a lack of energy is even one of the DSM-III-R criteria for depression 15 
Among patients with CFS who also have been found to suffer from depression, there 
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is a marked relationship between the onset of the complaints of fatigue and the onset 
of the depression 21 In another investigation, the premorbid prevalence of depression 
was reported to be higher than that found for the normal population (50% versus 
12 5%) 22 There are, however, also arguments which make it less likely that CFS is 
a manifestation of depression Firstly, agreement in symptoms between the two 
disorders does not automatically imply that the two disorders are identical 
Depression and dementia, for example, also exhibit a marked similarity in 
symptoms n Moreover, the higher premorbid prevalence of depression could not be 
confirmed in another study 3 
Finally, differences have been found between patients with CFS and a control 
group of depressed patients the degree of neurosis as well as the severity of the 
depression was considerably lower among patients with CFS than the depressed 
controls 3 With respect to the severity, it was noted that in CFS there is an elevated 
depression score rather than a clinical depression 8 
The conclusion for the time being is that psychiatric diagnoses do not sufficiently 
explain the complaints of chronic fatigue In view of the fact that a certain degree of 
depression is encountered among many patients with CFS, it is likely that depression 
plays a role in CFS m one way or another 
Psychological hypotheses 
In the literature presently available there are indications that psychological factors 
play a role in the development as well as - and probably predominantly - in the 
perpetuation of the complaints Here a complex interaction with physical factors is 
involved 
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THE ROLE OF STRESS IN THE DEVELOPMENT OF CFS 
At the time of the development of CFS stressful 'life events' can play a role It has 
been reported that patients with CFS experience more stressful life events or 
subjective stress before the development of the complaints than healthy controls 81021 
Stress and depression could have a negative influence on the immunological 
capacities of an organism,2325 and in this way the defence against infections could be 
diminished 26 " A subsequent infection could be the start of CFS The problem with 
this explanation is that it is so nonspecific with respect to the development of CFS 
For other physical complaints too it has been reported that the patients had 
experienced more stressful life events before the development of the disease than 
healthy controls 
As far as perpetuation of the CFS complaints is concerned, there are 3 
hypotheses In the first, physical inactivity is central, in the second depression and in 
the third the role of attributions 
THE INACTIVITY HYPOTHESIS 
This cognitive-behavioural hypothesis assigns the key role to the avoidance of 
physical activity which ensures that the complaints of fatigue are maintained 28 29 It is 
assumed that the patient is inactive during an acute infection, as a result his physical 
condition deteriorates Complaints such as fatigue and myalgia subsequently occur at 
lower levels of exertion The patient can 'learn' that physical exercise will produce 
complaints of fatigue and myalgia, thus, he will try to prevent these complaints by 
avoiding physical exercise As a result his physical condition deteriorates further and 
a vicious circle is established 
A relationship between inactivity and fatigue has indeed been demonstrated '21 
The question now is does inactivity lead to the persistence of complaints or does 
persistence of the complaints lead to inactivity Support for the first possibility (and 
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therefore for the inactivity hypothesis) is a study which demonstrated that physical 
training of patients with CFS led to an increase in the exercise capacity and a 
decrease in complaints 30 Others have also reported an acquired response of 
avoidance,31 they found no abnormalities of the muscular system but suspect that 
there is a decreased tolerance for the consequences of exercise. In other 
investigations abnormalities of the muscular system were seen but the question 
remains whether the abnormalities are a consequence of being inactive or the 
inactivity is a consequence of the abnormalities (see also the article by Swanink et 
al elsewhere in this journal) It is clear that the last word has not yet been spoken in 
this respect 
THE INFLUENCE OF DEPRESSION 
As mentioned above there are too many differences between patients with CFS and 
patients with a clinical depression to be able to state that chronic complaints of 
fatigue must be considered a manifestation of depression. Nevertheless patients with 
CFS often have elevated scores on depression questionnaires, as do other patients 
with physical complaints 32 The presence of a depression or, more accurately, the 
fact that the depression score is elevated must probably be considered a consequence 
of CFS which is directly related to a viral infection33 or a psychologic reaction to the 
chronic complaints 3 33 In a number of publications it has been reported that many 
patients were very active before the development of the complaints and that they set 
very high standards for themselves 27 34 The feeling that they are now capable of 
little or nothing could be very frustrating and might lead to a reaction of depression 
Depression as a result of chronic fatigue could also play a role in the 
perpetuation of the complaints The symptoms of depression closely resemble the 
symptoms of an acute infection Depression is as a rule often not recognized as such 
and the complaints accompanying the depression are easily attributed to physical 
causes 8 " This process can be facilitated by the tendency of the patient to look for 
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physical causes to explain his complaints The depression is then not treated and 
functions as a complicating factor Already in 1961 Imboden et al established that 
patients with an elevated depression score recover from an infection more slowly 
than others " The mechanism is not clear but it is conceivable that the effect of a 
depression can be exerted via somatic and psychological mechanisms Depression 
can in fact lead to immunological and endocrinological changes,2325 but it is also 
known that depressed individuals are less active which would add an extra 
component to the avoidance of physical activity 
Depression appears therefore to be related to CFS in a complex manner whereby 
both psychological and somatic factors can play a role 
ATTRIBUTIONS 
Attributions are the ideas which someone has about the causal relationships between 
events In CFS, attributions concerning the cause of the complaints are of specific 
interest Patients with CFS attribute the complaints to somatic causes they are 
convinced that the complaints have a physical cause and they exhibit a strong 
resistance to psychological interpretations of the complaints 3 8 " 19 
Among patients with CFS there has as yet not been a specific investigation of the 
background of this somatic attribution Possibly it is a result of the fact that - within 
the framework of the experience of the patient - the complaints of fatigue arose after 
the flu or some other physically orientated event such as the delivery of a child or 
surgery Talking about ME (myalgic encephalomyelitis) might confirm such 
attributions because this term implies an organic disease 
Attributions and the way the patient thinks about his complaints have received 
little attention in the literature but there are indications that attribution to a physical 
cause can have a direct influence on perpetuation of the CFS complaints Thus, it 
appeared that among patients with chronic gastric complaints, attribution of the 
complaints to somatic factors was related to an unfavourable course 36 Moreover, 
48 
Psychosocial hypotheses 
attributions can reinforce the avoidance of activity Attributing the complaints to a 
somatic cause which cannot be found enhances the feeling of helplessness and thus 
the reaction of depression These feelings can be accompanied by complaints of 
fatigue so that a vicious circle is established 
Attribution of the complaints to physical factors can also lead to the denial of the 
influence of psychologic factors The patient's own capacity to combat the 
complaints of fatigue and to leam how to cope with them is as a result hampered 
Treatment 
At the present time there is no effective treatment of CFS The preceding 
considerations suggest, however, several methods of approach Treatment could be 
directed toward increasing physical activity, decreasing the feelings of depression 
and influencing attributions 
In general, one should realize that patients with CFS will receive a psychological 
interpretation of their complaints with scepticism This is probably partly due to the 
fact that they have been told by professionals and by those in their immediate circle 
that there is 'nothing wrong', that their complaints are 'only psychologic' or that 
they 'just' have ME None of these attributions will satisfy the patient The patient 
believes he is not being taken seriously A serious attitude toward the patient and his 
complaints is therefore exceedingly important Understanding the enormous 
influence which these complaints can have on daily life can help in this respect It 
should be explained that the complaints are the consequence of an interaction 
between physical and psychological factors, although the nature of this interaction 
often can no longer be ascertained No matter how the complaints developed, the 
patient must learn to cope with them Within this framework, influencing the 
attribution to physical causes would seem to be an important first step since these 
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attributions often have an inhibitory effect on every non-somatic treatment 
Attention can subsequently be directed toward the degree to which physical 
activity is avoided If necessary a training programme can be initiated in order to 
gradually increase the physical activity The crux of this treatment is to interrupt the 
above-mentioned vicious circle by making sure that the occurrence of symptoms no 
longer functions as a signal that rest is needed 28 Positive results with increased 
activity have already been reported,30 but controlled studies have not yet been 
performed 
An eventual depression can be treated by means of psychological as well as 
medical intervention Positive results with antidepressants have been reported,1937 
but here too controlled studies have not been performed 29 
Conclusion 
From the above, it is clear that psychological factors play a role, presumably in the 
development but definitely in the perpetuation of chronic fatigue As far as is known 
at present, the nature of the attributions, avoidance of physical activity, and 
depression can play a role The patient group is, however, heterogeneous and it is 
therefore feasible that the various somatological (see article by Swanink et al ) and 
psychological hypotheses do not apply to the group of patients with CFS as a whole 
but only to certain categories 
Our observation that CFS is insufficiently explained by psychiatric disorders is 
important for application of the criteria of Holmes 38 The presence of a psychiatric 
diagnosis is used here as an exclusion criterion it is presumed that the presence of a 
psychiatric diagnosis would in itself be sufficient to explain the complaints of 
chronic fatigue Such a premise would appear to us to be at the very least premature, 
partly in view of the hypothesis described in this article that depression can be a 
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consequence of the complaints and (or) can play a role in the perpetuation of these 
complaints 
At present, there are still multiple aspects of chronic fatigue to be investigated 
As yet most of the studies have focused on either somatic or psychological factors 
This dualism does not appear to be justified In CFS there appears to be a complex 
interaction between somatic and psychologic factors The study which our research 
team has just started in Nijmegen is focused on the influence of and the relationships 
between the two types of factors 
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Dimensional assessment of chronic fatigue syndrome 
Abstract 
The absence of laboratory tests and clear criteria to identify homogeneous 
(sub)groups in patients presenting with unexplained fatigue, and to assess clinical 
status and disability in these patients, calls for other assessment methods In the 
present study, a multi-dimensional approach to the assessment of chronic fatigue 
syndrome (CFS) is evaluated Two-hundred and ninety-eight patients with CFS 
completed a postal set of questionnaires that assessed behavioural, emotional, social, 
and cognitive aspects of CFS By means of statistical analyses nine relatively 
independent dimensions of CFS were identified along which CFS-assessment and 
CFS-research can be directed These dimensions were named psychological well-
being, functional impairment in daily life, sleep disturbances, avoidance of physical 
activity, neuropsychological impairment, causal attributions related to the 
complaints, social functioning, self-efficacy expectations, and subjective experience 
of the personal situation A description of the study sample on these dimensions is 
presented 
Introduction 
The chronic fatigue syndrome (CFS) is characterised by severe disabling fatigue of 
unknown origin Several operational definitions12 have proved to be unsatisfactory 
in identifying cases of CFS 34 A major problem of these criteria is, that they are 
mainly based on symptoms Fatigue, the main symptom in CFS, is a nonspecific 
complaint, as it is reported in the population as such5 and in a substantial number of 
patients seen in primary care settings 6 7 Moreover, fatigue is a prominent symptom 
in a variety of physical and psychiatric illnesses Fatigue is not only nonspecific, but 
as a phenomenon is difficult to understand Kennedy8, reviewing the literature on 
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fatigue, concluded that 'the status of fatigue as a physiological response, 
psychological perception, or symptom of physical and psychiatric diseases remains 
unclear'. To date, no clear definition of fatigue exists, resulting in problems in 
measurement.9 
Not only is fatigue highly nonspecific, but so are other symptoms commonly 
observed in CFS. Patients with CFS show considerable overlap in symptoms with 
patients with a clinical depression and those with chronic neuromuscular diseases10 
and chronic pain." Symptoms alone thus seem to have little diagnostic value. 
Neither do laboratory tests contribute to the assessment of CFS.12"15 
The absence of laboratory tests and clear criteria to identify homogeneous 
(sub)groups in patients presenting with unexplained chronic fatigue and assessing 
clinical status and disability in these patients calls for other assessment methods.3 In 
the present study, a multi-dimensional approach to the assessment of CFS will be 
used. Behavioural, emotional, social, and cognitive aspects of CFS are measured. 
The main aims of this study are to identify dimensions of CFS and to provide a 
description of patients presenting with unexplained chronic fatigue using these 
dimensions. 
Subjects and method 
SUBJECTS 
In the present study the following inclusion and exclusion criteria have been 
applied:4 patients had to experience severe disabling fatigue, of definite onset, 
lasting for more than 1 year; other symptoms may be present. Patients with 
established medical conditions known to produce chronic fatigue, and patients with a 
diagnosis of schizophrenia, bipolar-disorder, psychotic depression, substance use 
disorder, eating disorder, or proven organic brain disease were excluded. Three-
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hundred and ninety-five self-referred patients were sent a postal questionnaire. 
Ninety per cent completed and returned the questionnaire (N=357). Detailed 
information on present illness, specialist visits, and treatment was obtained. Based of 
this information, respondents with definite or suspected illnesses that could provide 
an explanation for the complaints were excluded (e.g. patients taking medication for 
heart problems). Patients who had not been examined for their complaints by at least 
one specialist (10 patients) also were excluded from analyses. These inclusion and 
exclusion procedures resulted in a study sample of 298 subjects. 
INSTRUMENTS 
Fatigue questionnaire. We participated in the development of the Checklist 
Individual Strength (CIS) by the University Hospital of Amsterdam and the 
University Hospital of Rotterdam. This 24-item questionnaire was designed to 
measure several aspects of fatigue. Each item is scored on a 7-point Likert scale. 
Principal components analyses yielded a four-factor solution. Four items that had a 
low loading on their primary factor or that loaded substantially on more than one 
factor were deleted. The factors were easy to interpret and were named: (1) 
subjective experience of fatigue (8 items); (2) concentration (5 items); (3) motivation 
(4 items); (4) physical activity level (3 items). The final subscales accounted for 
67.7% of the variance. Psychometric properties were excellent: Cronbach's alpha 
reliability coefficient for the entire CIS was .90. Gutman split-half reliability 
coefficient was .92. Cronbach's alpha's for the subscales were .88, .92, .83, and 
.87 respectively. Data from two comparison groups were available. The first group 
consisted of healthy subjects (/V=60; mean age=32). The second group were 
patients with functional bowel disorder (FBD) (N=61; mean age=41). 
Self-reported complaints. Symptom assessment was based on spontaneous reports 
by the patient. Patients were asked to write down their complaints. Information 
concerning the course and duration of the complaints was also obtained. 
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Psychological well-being The Beck Depression Inventory (BDI)16 is a 
standardized self-report questionnaire used to measure depression Four diagnostic 
categories are based on the total score 0-9 = nondepressed, 10-15 = mildly 
depressed, 16-23= moderately depressed, 24 or more = severely depressed A score 
of 16 or more is indicative of a clinical depression The Symptom Checklist (SCL-
90)17 is a 90-item indicator of psychopathology and screens for anxiety (SCL-ANX), 
agoraphobia (SCL-AGO), depression (SCL-DEP), somatization (SCL-SOM), 
cognitive difficulties (SCL-COG), interpersonal sensitivity (SCL-SEN), hostility 
(SCL-HOS), and sleep disturbances (SCL-SLP) A total score called the 
psychoneuroticism score (SCL-PSN) can be obtained Comparison data were 
available for normal subjects (N=1009, mean age=43), for a mixed psychiatric 
outpatient group (N=2118, mean age = 36) [17], and for a group of patients with 
functional bowel disorder (FBD) (N=103, mean age=44) 
Daily functioning The effect of the complaints on daily functioning was assessed 
by the Sickness Impact Profile (SIP),1819 using the following eight subscales home 
management (SIP-HM), mobility (SIP-MOB), alertness behaviour (SIP-AB), 
sleep/rest (SIP-SR), ambulation (SIP-A), social interactions (SIP-SI), work (SIP-W), 
and recreation and pastimes (SIP-RP) Comparison data were available for two 
groups of patients registered at five family practices situated in urban, suburban, and 
rural areas 19 The first group (N=450, mean age = 47) reported physical complaints 
of minor severity or no physical complaints at all The second group (N= 144, mean 
age = 49) reported moderate to severe physical complaints (gastrointestinal, back 
pain, arthralgia, and cardiovascular complaints) 
In addition to the SIP, general questions regarding daily functioning were 
included the patient's opinion concerning (a) the extent to which their complaints 
interfered with daily activities (4-point scale), (b) problems in housekeeping 
activities and work (5-point scale), (c) satisfaction in housekeeping activities and 
work (5-point scale) 
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Avoidance behaviour Avoidance of physical activity is thought to play a role in 
the perpetuation of the complaints in CFS 20 21 Therefore, four questions were asked 
with respect to avoidance of physical activity as a way of coping with complaints 
(e g 'avoiding complaints by nonactivity') The level of physical activity is assessed 
by the CIS-Activity subscale (see section Fatigue questionnaire) 
Cognitions and attributions Cognitions were assessed by (a) a specific 3-point 
scale question concerning self-efficacy expectations ('do you think you can influence 
your complaints9'), (b) causal attributions, patients were asked to write down their 
opinion regarding the causes of the complaints These responses were coded into the 
dichotomous variables 'physical causes' and 'non-physical causes', (c) the Multi-
dimensional Health Locus of Control questionnaire (MHLC)2223 which measures 
control beliefs with respect to health in general The MHLC contains three 
subscales internal attributions (MHLC-I health is determined by own 
behaviour/capacities), external attributions (MHLC-E health is determined by 
fate/chance), and powerful others (MHLC-P health is determined by 
partner/friends/doctors) MHLC-data of a comparison group of patients with FBD 
are available (N= 103, mean age = 44) 
Social interactions General questions were asked concerning (a) satisfaction in 
social life (5 point scale), (b) problems in social relations (4-pomt scale), (c) the SIP 
contains a subscale assessing the effect of the complaints on social life (SIP-SI see 
section Daily functioning) 
Sleep disturbances (a) A general sleep disturbances-question, which is coded 
'yes' or 'no', (b) a question with respect to the type of the sleep disturbance 
(problems falling asleep, restless sleep, and early awakening in the morning), (c) 
duration of sleep at night and during the day, (d) the SCL-90 contains a subscale on 
sleeping problems (SCL-SLP see section Psychological well-being) 
In addition to the above mentioned instruments information on age, sex, marital 
status, occupation, and education was obtained 
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STATISTICAL ANALYSES 
Testing differences between groups has been performed by analyses of variance 
(ANOVA). When appropriate, covariates were included in the ANOVA. The 
identification of the dimensions of CFS was a four-step procedure: (I) Principal 
components analyses on all subscales and the general questions. Variables that had 
low factor loadings or that loaded substantially on more than one factor were 
excluded; (II) Per factor the included variables were weighted in order to achieve 
approximately equal standard deviations; (III) Per factor reliability procedures were 
performed on the weighted variables (Cronbach's a). Variables that suppressed 
alpha were excluded. For each dimension a score is obtained by summing the scores 
of the variables belonging to the dimension. (IV) Stepwise multiple regression 
analyses were performed on the dimension scores in order to evaluate interrelations. 
In analyses in which more than 5 % of cases were excluded because of missing 
values, these values were replaced by means of the linear trend at point method, 
which is available in SPSS (release 6.0). For each variable, the existing series is 
regressed on an index variable, scaled 1 to n. Missing values are replaced with their 
predicted value. 
Results 
DESCRIPTIVE 
Biographical. Mean age was 39 yr (range 18-73). There were 75 males and 223 
females. Fifty-five per cent of patients were married or cohabited, 34% were single, 
8% were divorced, and 3% were widowed. Only 31% of patients reported being still 
at work, whereas 58% worked before onset of the complaints. Of the patients 
presently working, 80% worked part-time because of the complaints. All patients 
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Table 1. Spontaneously reported complaints by 298 CFS-patients 
Complaint 
myalgia 
difficulty concentrating 
gastrointestinal complaints 
headache 
dizzyness 
sleepdisturbances 
memory problems 
muscle weakness 
recurrent infections 
irritabillity 
depression 
changes in body temperature 
speech disturbances 
visual disturbances 
arthralgia 
polyuria 
excessive transpiration 
coordination disturbances 
emotional lability 
sore throat 
allergies 
% 
71 
51 
49 
46 
43 
43 
36 
35 
26 
24 
22 
21 
20 
19 
17 
16 
16 
15 
15 
13 
12 
(N) 
(210) 
(151) 
(145) 
(136) 
(127) 
(122) 
(106) 
(103) 
(77) 
(72) 
(66) 
(63) 
(59) 
(57) 
(52) 
(48) 
(48) 
(45) 
(44) 
(39) 
(36) 
had visited at least one specialist for their complaints (internist 81%, neurologist 
59%, psychologist 35%, psychiatrist 32%, rheumatologist 19%) 
Spontaneously reported complaints are presented in Table 1 Only complaints 
reported by at least 10% of patients are included in the table The average number of 
complaints reported is 8 (sd=3 8) Median duration of the complaints was 5 у г 
Subjective feeling of fatigue (CIS-Subjective Fatigue) Data are presented in 
Table 2 Overall analyses of variance revealed group differences on CIS-Subjective 
63 
Chapter 4 
Fatigue subscale (ρ < 001 age and sex were entered as covanates in the analyses) 
Patients with CFS reported more fatigue than healthy subjects and patients with 
FBD, FBD-patients reported more fatigue than healthy subjects 
Psychological well-being SCL-90 data of CFS-patients, psychiatric outpatients, 
FBD-patients, and healthy subjects are depicted in Table 3 As sex is related to SCL-
90 scores,17 this variable was entered as a covanate in analyses of variance Overall 
analyses revealed group differences on all subscales (p< 001) Significant 
differences between groups are displayed m Table 3 On the BDI, 32% of patients 
did not have depressed feelings at all Using a score of 16 or more, 36% of patients 
could be considered as having a clinical depression 
Daily functioning Ninety-three per cent of patients reported that they 
experienced severe impairment in daily life because of their complaints, 7% reported 
moderate impairment Sixty-two percent reported marked problems in activities at 
home or at work and 70% reported not to be satisfied with respect to daily 
functioning Data on the SIP are presented in Table 4 Overall analyses of variance 
showed group differences on all subscales (p< 001) 
Avoidance behaviour Only 4% of patients did not score on any of the four items 
measuring avoidance of physical activity, 11% scored on one item, 17% scored on 
two items, 26% scored on three items, and 43% scored on four items Overall 
analyses of variance revealed group differences on CIS-Activity (p<0 001) Age 
and sex were entered as covanates in the analyses See Table 2 for mean scores, 
standard deviations, and group differences 
Cognitions Eighty-six per cent of patients reported a physical explanation 
for their complaints (predominantly viral infection), whereas only 7% reported a 
psychological explanation Thirty-nine per cent of the patients believed that they 
could influence their complaints (positive self-efficacy), 27% did not know, and 
35 % believed that this would not be possible (negative self-efficacy) Compared to 
FBD-patients, CFS-patients showed less internal attributions regarding health in 
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Table 2: Mean CIS scores (standard deviations in brackets) of 298 patients with chronic 
fatigue syndrome (CFS), 61 patients with functional bowel disorder (FBD), and 60 
healthy subjects. High scores indicate a high level of fatigue, a high level of 
concentration problems, low motivation, and a low level of physical activity. 
Subscales 
subjective fatigue 
concentration 
motivation 
activity 
CFS 
6.1 (1.0) 
4.8(1.8) 
4.0(1.7) 
5.0(1 7) 
FBD 
4.4(1.8) 
3.6(1.7) 
3.4(1.6) 
3.3(1.9) 
Healthy 
2.4(1.4) 
2.2(1.2) 
2.0(1.0) 
2.0(1.3) 
On all subscales, CFS-patients scored significantly higher than FBD-patients 
and healthy controls and FBD-patients scored significantly higher than 
healthy controls (p< .001). 
Table 3: Mean SCL-90 scores (standard deviation in brackets) of 290 patients with chronic 
fatigue syndrome (CFS), 103 patients with functional bowel disorder (FBD), 1009 healthy 
subjects, and 2118 psychiatric outpatients. 
ANG 
AGO 
DEP 
SOM 
IN 
SEN 
HOS 
SLP 
PSN 
Healthy 
13 9 ( 5 . 2 ) " 
8.4 ( 2.9)" 
22.5 ( 7.9)" 
17.8(6.6)" 
13.7(4.9)" 
25.6 ( 8.0)" 
7.6 ( 2.4)" 
4.9 ( 2.7)" 
123.9(33.3)" 
FBD 
17.0(7.1) 
9.3(4.3) 
26.9 (10.2)" 
23.7 ( 9.4)" 
17.1 (6 .5)" 
27 2 ( 9.0) 
8.2 ( 2.4) 
6.5(3.4) 
147.8 (45.2)" 
CFS 
17.9(6.9) 
9.7 ( 4.4) 
31.2(11 3) 
30.6 ( 8.7) 
23.0(7.3) 
27.9 (10.2) 
8.7 ( 3.4) 
7.5(6.5) 
167.8 (48.7) 
Psychiatric 
26.0 ( 9.9)" 
13.9(7.3)" 
42.2 (15.0)" 
26.6 (10.0)" 
21.7(8.2) ' 
39.1 (15.5)" 
11.6(5.3)" 
7.8(3.7) 
206.0 (65.6)" 
significantly different from CFS: p< .05 
" significantly different from CFS: p< .001 
ANX = anxiety; AGO = agoraphobia; DEP = depression; SOM = somatization; IN = 
cognitive difficulties; SEN = interpersonal sensitivity; HOS = hostility; SLP = sleep; 
PSN= psychoneuroticism. 
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Table 4· Mean SIP scores (standard deviations m brackets) of 296 patients with 
CFS comparison group I (450 family practice patients with physical complaints 
of minor severity or no physical complaints at all), and comparison group 2 (144 
family practice patients with moderate to severe physical complaints) 
SR 
HM 
MOB 
SI 
A 
AB 
W 
RP 
Comparison group 1 
2 8 ( 6 2 ) · 
2 1 ( 8 4 ) ' 
1 2 ( 5 8 ) * 
2 3 ( 6 3 ) ' 
1 4 ( 5 2 ) · 
2 5 ( 9 0 ) " 
4 5 (15 0)' 
4 3 (10 3)· 
Comparison group 2 
10 7(10 7)" 
134(16 1) 
6 2 (10 8)" 
9 2(11 4)' 
8 0(11 5) 
11 1 (18 2)" 
16 1 (28 4)" 
18 0(18 5) 
CFS 
16 6(11 7) 
15 7(10 1) 
9 5 ( 9 5 ) 
14 9(10 4) 
7 8 ( 8 1) 
30 7 (20 6) 
25 2(16 9) 
20 0(10 1) 
* significantly different from CFS p< 001 
SR = sleep and rest, HM= activities at home, MOB = mobility, SI = social 
interactions, A = ambulation,AB=alertness behaviour, W = work, RP = recreation 
and pastimes 
general (MHLC I, p< 001) and had less confidence in powerful others (MHLC-P, 
p< 001) There was no significant difference between these two groups with respect 
to external attributions (MHLC-E) 
Social interactions Twenty-seven per cent of patients reported difficulties in 
social relations and 29% reported not to be satisfied with social interactions On the 
SIP-social functioning (SIP-SI) subscale, CFS-patients showed more problems in 
social interactions than patients with moderate to severe physical complaints (see 
Table 4) 
Sleep disturbances Although 43% of patients reported to have sleep 
disturbances spontaneously (see Table 1), 61% of patients reported sleep 
disturbances when specifically asked for (of those patients, 56% had problems 
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tailing asleep, 67% had restless sleep, and 27% woke up early in the morning) 
Average duration of sleep at night was 8 h (range 3-14) and during the day 2 h 
(range 1-11) For SCL-SLP results, see Table 3 
Neuropsychological complaints A total of 59% reported memory and/or 
concentration problems (see also Table 1) Neuropsychological problems are also 
expressed in high scores on CIS-Concentration (Table 2) and SIP-alertness behaviour 
(S1P-AB Table 4) Overall analyses of variance revealed group differences on CIS-
Concentration {p< 001) and SIP-AB (p< 001) For significant differences between 
groups for CIS-concentration see Table 2 and for SIP-AB see Table 4 
DIMENSIONS 
Principal components analysis yielded a 9-factor solution (see Table 5) The 
tirst eight factors were easily interpreted and were named psychological well-being, 
functional impairment in daily life, sleep disturbances, avoidance behaviour, 
concentration problems, causal attributions related to the complaints, social 
functioning, and self-efficacy expectations The ninth factor was somewhat more 
difficult to interpret It contains variables would have been expected to be included 
in other dimensions The general question 'problems in housekeeping/work', for 
example, would have been expected to be included in the dimension functional 
impairment What the variables in this factor have m common, in contrast with 
variables that are included in the other eight dimensions, is that they represent highly 
subjective general interpretations of the personal situation On the SIP, for example, 
respondents mark a list of specific situations as either present or absent Hence, less 
subjective interpretation is required than is the case in evaluating the extent to which 
complaints interfere with daily functioning in general The variables in this 
dimension tap another mode of responding This dimension could be named 
'subjective experience' 
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Table 5: Dimensions of CFS, composing variables, and Cronbach alpha 
reliability coefficients of the dimensions 
Dimension 
Psychological Well-being 
Functional Impairment 
Sleep Disturbances 
Avoidance Physical 
Activity 
Neuropsychological 
Functioning 
Social Functioning 
Variables 
SCL-ANX, SCL-AGO, 
SCL-DEP, SCL-SEN, 
SCL-IN, SCL-SOM, BDI, 
SIP-HH, SIP-Α, SIP MOB 
sleep disturbances, SCL-SLP 
avoidance of physical 
activity items 
SIP-AB, CIS-Concentration 
problems relations, 
Cronbach's 
alpha 
91 
80 
78 
63 
84 
Causal Attributions 
Self-Efficacy 
Expectations 
Subjective Experience 
satisfaction social life, 62 
SIP-SI 
physical attributions, 71 
non-physical attributions 
self-efficacy expectations, 
MHLC-Intemal 77 
problems in housekeepmg/ 
work, CIS-Activity, 75 
satisfaction in daily life, 
CIS-Subjective Fatigue 
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Reliability analyses resulted in Cronbach's alpha's varying from 62 to 91 (see 
Table 5 for detailed information on variables finally included in each dimensions and 
dimension reliability coefficients Variables are ordered according to the magnitude 
of their primary factor loading) 
Stepwise multiple regression analyses were performed to evaluate interrelations 
between ímensions Each of the nine dimensions served as the dependent variable 
consequetively with the remaining dimensions as the independent variables As the 
Subjective Experience dimension represents another mode of responding, this 
dimension was excluded as independent variable from all regression analyses In 
these analyses the number of excluded cases exceeded 5% Therefore, for all 
regression analyses missing values were replaced using the linear trend at point 
method Results are displayed in Table 6 (variables are ordered according to the step 
number they were entered into the model) The analyses show that, although the 
dimensions are interrelated, the combined effect of related dimensions can explain 
only a minor to moderate part of the variance Also, regression analyses were 
performed with fatigue severity (CIS-Subjective Fatigue subscale), being the 
principal complaint in CFS, as the dependent variable Fatigue severity was 
predicted by the dimensions Psychological Well-being, Functional Impairment, and 
Self-efficacy Expectations (R2= 51, variance explained 27%) 
Discussion 
In the present study a multi-dimensional approach to the assessment of CFS was 
developed This study identified nine dimensions, measuring emotional, behavioural, 
cognitive, and social functioning Multiple regression analyses showed that, although 
interrelations between dimensions exist, the combined effect of related dimensions 
explained only a minor to moderate part of variance Hence, each dimension 
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Table 6: Stepwise multiple regression analyses with dimensions and fatigue severity 
Dependent variable 
Psychological 
Well-being 
Functional Impairment 
Sleep Disturbances 
Avoidance Physical 
Activity 
Concentration 
Social Functioning 
Self-Efficacy 
Causal Attributions 
Subjective Experience 
Fatigue severity 
(CIS subscale 
subjective fatigue) 
Independent 
Dimensions in model 
Concentration 
Sleep disturbances 
Social Functioning 
Causal Attributions 
Functional Impairment 
Social Functioning 
Avoidance Physical Activity 
Psychological Well-being 
Psychological Well being 
Functional Impairment 
Psychological Well-being 
Social Functioning 
Functional Impairment 
Causal Attributions 
Concentration 
Psychological Well-being 
Functional Impairment 
Psychological Well-being 
Psychological Well-being 
Concentration 
Functional Impairment 
Concentration 
Self-Efficacy 
Social Functioning 
Psychological Well being 
Psychological Well being 
Functional Impairment 
Self-efficacy 
variables 
R2 (% variance 
explained) 
69 (47%) 
46 (22%) 
45 (20%) 
29 ( 8%) 
61 (38%) 
57(33%) 
13(2%) 
19(3%) 
62 (39%) 
53 (28%) 
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provides a unique contribution to the assessment of CFS Comprehensive assessment 
ot CFS then implies measurement of different dimensions simultaneously 
A recently developed multi-dimensional questionnaire is the Profile of Fatigue-
Related Symptoms (PFRS),2"25 which has four subscales emotional distress, 
cognitive difficulty, fatigue and somatic symptoms The PFRS was developed to 
provide in a measure of seventy and pattern of illness The PFRS resembles the CIS 
used in this study, although the former only gives information on symptoms whereas 
the CIS also provides data on behaviour The PFRS may be a suitable instrument to 
assess symptoms, but comprehensive assessment of CFS goes further than 
symptoms 
Eifert and Wilson26 cautioned for methodological pitfalls in multi-dimensional 
assessment Studies on the relationships between different dimensions can be 
confounded by the use of different methods of assessment across these dimensions 
The surfacing of a set of variables that requires a higher degree of subjective 
interpretation as a separate dimension (subjective experience), in contrast to the 
standardized psychological instruments measuring the same concept, supports this 
notion Since different modes of assessment may yield different results, it is 
appropriate to measure every dimension by different methods We are currently 
carrying out studies in which, apart from selr-report, other modes of assessment are 
also being used These include standardized neuropsychological laboratory tests, the 
actometer (an apparatus to measure the level of physical activity), and self-
momtoring 
The use of multiple measures increases the complexity of the method, and results 
in a rather vast package of instruments This is clearly a disadvantage in clinical 
practice In research settings, on the other hand, multi-dimensional assessment in 
CFS has many advantages This method provides in a comprehensive assessment of 
patients with CFS Clinical status, disability, and other relevant processes are 
measured Multi-dimensional assessment may fill the void that exists in methods to 
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identify homogeneous (sub)groups in patients with unexplained chronic fatigue. 
Studies that evaluate the effects of therapeutic interventions should not only 
concentrate on a possible reduction in fatigue severity or other symptoms, but also 
on the effects of treatment on other aspects of the patients' functioning should be 
evaluated. Also, multi-dimensional assessment might be useful in tailoring therapy to 
the individual patient. 
Some critical remarks with respect to the present study have to be made. The 
sample was self-referred. Generalizing results to other cohorts of patients with CFS 
might then be difficult. To test generalizability, the present study sample was 
compared with a recently tested group of 68 patients, who were referred for 
unexplained fatigue by their family doctor or a specialist to the General Internal 
Medicine out-patient clinic of our hospital. There were no differences between both 
groups with respect to socio-demographic data or any other measure we used, except 
that self-referred patients reported more complaints and had a longer duration of 
complaints. 
Information on physical abnormalities and treatment relied on self-report. This 
made the exclusion of patients with a medical condition known to produce fatigue 
difficult. To overcome this problem as far as possible, complaints had to habe been 
present for more than 1 year. This minimalized the risk of including patients with 
delayed convalescence of a viral infection. Moreover, we excluded all patients who 
had not been investigated by at least one specialist. 
The dimensions we have found should not be considered as exhaustive in 
measuring all relevant aspects of CFS, nor is it said that the identified dimensions 
should be measured by the instruments used in the present study. But the main theme 
here is that, to get a comprehensive picture of CFS, a multi-dimensional approach 
should be applied. 
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A Clinical and laboratory study 
Abstract 
Objective To investigate the relation between severity of complaints, laboratory data 
and psychological parameters in patients with chronic fatigue syndrome (CFS) 
Subjects Eighty eight patients with CFS and 77 healthy controls matched for age, 
gender and geographical area 
Methods Patients and controls visited our outpatient clinic for a detailed medical 
history, physical examination and psychological tests Checklist Individual Strength 
(CIS), Beck Depression Inventory (BDI) and Sickness Impact Profile (SIP) Venous 
blood was drawn for a complete blood cell count, serum chemistry panel, C-reactive 
protein and serological tests on a panel of infectious agents 
Results All patients fulfilled the criteria for CFS as described by Sharpe et al (J R Soc 
Med 1991,84 118-21), only 18 patients (20 5%) fulfilled the CDC criteria The outcome 
ot serum chemistry tests and haematological tests were within the normal range No 
significant differences were found m the outcome of serological tests Compared to 
controls, significant differences were found in the results on the CIS, the BDI, and the 
SIP These results varied with the number of complaints (CDC criteria) When the 
number of complaints was included as the covanate in the analysis, there were no 
significant differences on fatigue severity, depression, and functional impairment 
between patients who fulfilled the CDC criteria and patients who did not 
Conclusion It is concluded that the psychological parameters of fatigue seventy, 
depression and functional impairment are related to the clinical severity of the illness 
Because the extensive panel of laboratory tests applied in this study did not discriminate 
between patients and controls, it was not possible to investigate a relation between the 
outcomes of psychological and laboratory testing 
Introduction 
Chronic Fatigue Syndrome (CFS) is characterized by severe disabling fatigue of 
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definite onset (not lifelong), lasting for more than 1 year, and for which no 
explanation can be found The fatigue is often accompanied by a variety of non-
specific symptoms and signs The aetiology of CFS is not known For research 
purposes, the Centers for Disease Control described a working case definition, 
which represented a consensus opinion rather than validated criteria ' Similar but 
less stringent case definitions were subsequently proposed in the United Kingdom2 
and in Australia 3 In these case definitions, the fatigue has to be disabling, of 
definite onset, and lasting for at least 6 months Other symptoms, such as myalgia 
and neuropsychological problems, may be present but are not required 
A number of somatic and psychological hypotheses have been proposed as 
possible explanations for the cause of CFS *5 One of these hypotheses is that a 
persistent viral infection leads to continuous immune activation with production of 
proinflammatory cytokines, which could explain a number of symptoms6 7 8 
According to another hypothesis the primary defect is an immune dysfunction, that 
includes inadequate killing of virus-infected cells, thereby resulting in persistent 
infection 9 '° " Some researchers have proposed that CFS is an atypical manifestation 
of a depression,1213 whilst others think that the perpetuation of the complaints is the 
result of prolonged physical inactivity '* Recently, impaired activation of the 
hypothalamic-pituitary-adrenal axis has been found in patients with CFS '5 Altered 
reactivity of the hypothalamic-pituitary-adrenal axis has also been described for 
patients with the primary fibromyalgia syndrome, which is thought to be closely 
related to CFS 16 
Abnormalities observed in serological and immunological studies on patients 
with CFS are diverse, sometimes conflicting, and often minimal In some studies, 
patients were selected on postviral fatigue, severe myalgia and muscle weakness,17 " 
whereas in other studies, CFS patients were selected on increased antibody titres to 
EBV u 2 ° As a consequence, these data cannot be extrapolated to CFS patients in 
general The impact of the abnormalities in laboratory studies is not clear, because 
80 
A Clinical and laboratory study 
usually a correlation with clinical seventy of the illness is not made 
In the present study, laboratory data of patients with severe disabling fatigue 
lasting for more than 1 year have been compared with those of a well matched 
control group Our leading question was to investigate whether there would be a 
relation between seventy of the complaints, laboratory data and the psychological 
parameters fatigue severity, depression and functional impairment Furthermore, we 
investigated whether patients who fulfill the CDC entena differ from patients who 
do not, clinically, in laboratory tests or in psychological tests The study was 
approved by the ethical committee of our hospital 
Material and methods 
SUBJECTS 
One-hundred patients were randomly chosen from a database of 298 patients with 
CFS The latter patient group, which was self-referred, was desenbed in detail by 
Vercoulen et al21 In brief, all patients experienced severe disabling fatigue, of 
definite onset, lasting for more than 1 year, other symptoms may be present but are 
not required Patients with established medical conditions known to produce chronic 
fatigue, and patients with a diagnosis of schizophrenia, bipolar disorder, psychotic 
depression, substance use disorder, eating disorder, or proven organic brain disease 
were excluded The selected patients were invited to visit our outpatient clinic for a 
detailed medical history as well as a physical examination All patients gave their 
informed consent 
Blood samples were taken for complete blood cell counts, a serum chemistry 
panel which included sodium, potassium, calcium, bicarbonate, glucose, creatinine, 
creatinine Phosphokinase, liver function tests (lactic dehydrogenase, alkaline 
phosphatase, alanine aminotransferase, gamma-glutamyl transferase), and red blood 
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cell magnesium (RBC-Mg) Three patients dropped out during these investigations 
In nine patients, medical history and physical examination revealed other 
diagnoses that might contribute to their complaints (chronic pancreatitis, diabetes 
mellitus, severe chronic obstructive pulmonary disease (COPD), cardiac arrhythmia, 
anorexia, colon carcinoma, cocaine abuse, manic depressive disorder, paranoia) 
These patients were excluded from the analyses The remaining 88 patients were 
asked to visit our clinic again after 3 months and to bring a healthy, non-fatigued 
control subject with them, matched for gender, age and geographical area The use 
of healthy neighbourhood controls is necessary to control for recent local epidemics 
Seventy-seven patients were able to find such a control None of the controls were 
receiving medical treatment, and they all stated that they were not feeling fatigued 
CLINICAL EXAMINATION 
Questionnaire Patients and controls were asked to complete a questionnaire With 
this questionnaire, information was obtained on age, sex, marital status, education, 
occupation, duration of the symptoms, medication and treatment Information on the 
number and presence of the complaints was obtained in two ways One way was to 
ask both patients and controls to write down their complaints with a maximum of 16 
(spontaneously reported) The other way was to ask them whether they had a 
specific complaint or not (standardized questionnaire), and how often it was present 
using a 4-point scale 1 = never, 2 = several times per month, 3 = several limes 
per week, 4 = every day Because a score below 3 did not discriminate between 
patients and controls, a specific complaint was scored as being present when the 
score was 3 or 4 
Physical examination All patients had an extensive physical examination with 
special attention for swollen lymph nodes, pharyngitis, muscle atrophy, muscle 
strength, and tendon reflexes Unless indicated by medical history, a physical 
examination of controls was not done 
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LABORATORY TESTS 
Blood samples were taken for a complete blood cell count, differential count, C-
reactive protein and serological tests on a panel of infectious agents Antibodies to 
viral capsid antigen and to early antigen of Epstein-Barr virus were detected by 
indirect immunofluorescence on HH514 cells These cells are a subclone of P3HR1 
and were kindly provided by Dr G Miller (Yale University School of Medicine, 
New Haven, CT, USA) Raji cells were used for the detection of antibodies against 
Epstein-Barr virus nuclear antigen HSB-2/HHV-6GS cells (obtained from the AIDS 
Research and Reference Reagents Program of the NIH) were used for the detection 
of immunoglobulin G (IgG) and IgM against human herpesvirus type 6 Before IgM 
was tested, serum samples were incubated with GullSORB (Gull Laboratories, UT, 
USA), to remove IgG and rheumatoid factor ELIS As for antibodies against 
cytomegalovirus (CMV) and Toxoplasma gondii were performed as described by 
van Loon et al n Toxoplasma IgG was expressed in international units (IU) and 
CMV-IgG antibodies in arbitrary units (AU) using a standard curve of reference 
serum samples Antibody capture ELISAs were used for the detection of IgM and 
IgA antibodies For the detection of enteroviral IgG, IgM and IgA, antibody-capture 
ELISAs were used as recently described 23 For all ELISAs except Toxoplasma IgG 
and CMVIgG a ratio was computed as follows the extinction of each serum was 
divided by the extinction of a cut-off serum When the ratio was > 1 2 a serum was 
considered positive, when the ratio was < 1 a serum was considered negative When 
the ratio was in between, this was considered indeterminate 
PSYCHOLOGICAL TESTS 
Different aspects of fatigue, depression, and functional impairment were measured 
as described before 2l The following tests were used 
Fatigue questionnaire The Checklist Individual Strength (CIS) is a reliable and 
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validated questionnaire designed to measure four aspects of fatigue, namely 
subjective experience of fatigue (eight items), concentration (five items), motivation 
(four items), and physical activity (three items)21 Each subscale has a maximum 
score of 7 High scores indicate a high level of fatigue, a high level of concentration 
problems, low motivation, and a low level of physical activity 
Depression Depression was assessed by the Beck Depression Inventory (BDI)24 
A score of 16 or more is indicative of a clinical depression 
Functional impairment The effect of the complaints on daily functioning was 
assessed by the Dutch version of the Sickness Impact Profile (SIP), which is 
psychometncally similar to the English version 25 26 Because of the virtual absence of 
sickness in the healthy control group, we used normative data, which are available 
of patients who reported to have complaints of minor seventy or no physical 
complaints at all (iV=450, mean age= 47 years), and of patients who reported to 
have moderate to severe physical complaints (N=144, mean age, 49 years) 26 
STATISTICAL ANALYSES 
Differences between patients and controls were tested using Student's /-test for 
normal distributed variables Non-parametric tests such as Mann-Whitney's U-test 
and chi2 test were used when appropriate Testing differences between three groups 
or more was performed by analysis of variance (ANOVA) When appropriate, 
covanates were included in ANOVA. 
Results 
CLINICAL DATA 
Questionnaire The mean age of the 88 patients was 40 (SD 10 7, range 20-66) 
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years The male female ratio was 1 3 (23 males and 65 females) Sixty-seven per 
cent were married or cohabited, 26% were single, 2% were divorced, and 5% 
widowed Seventy-seven patients were able to find a healthy control matched for age 
(mean age 41 years, SD 11 3), sex (male female ratio, 1 3), and geographical area 
There were no differences of socioeconomic and marital status between patients and 
controls Thirty-one patients (35%) were on sick leave, and an additional 30 (34%) 
were not working at the time of our study Only 25 patients (29%) reported to be at 
work, compared to 54 (71%) of the controls (chi2 test, Ρ = 0 003) Sixty-seven per 
cent of the patients worked before the onset of the complaints Of the patients still 
working, 12 (48%) worked part-time as a result of their complaints 
All patients had visited one or more specialists for their complaints 
(predominantly internist, neurologist, psychologist, psychiatrist, rheumatologist) 
Sixty-five per cent of the patients were taking medication (mainly analgesics, 
vitamins, and homeopathic drugs) versus 16% of controls (mainly incidental use of 
analgesics) Sixty-six per cent of the patients reported an acute onset of symptoms 
after an infectious illness This is different from the studies in the UK on post-viral 
fatigue syndrome, in which attribution to an acute viral illness is a criterion, but 
similar to studies from the USA and Australia In 23% of the patients the onset of 
symptoms was gradual, 11% of the patients did not know how the symptoms had 
begun The average duration of symptoms was 11 years, (median 7 years, range 2-
45 years) Complaints that were repeatedly present (more than once a week) during 
the past 3 months are presented in Table 1 It should be noted that the number of 
complaints was higher when specifically asked for, compared to spontaneously 
reported When specifically asked for, the median number of complaints for patients 
was eight (range three to sixteen), for controls zero (range zero to four) Based on 
the standardized questionnaire, 18 patients (20 5%) fulfilled the CDC criteria For 
all patients, the median number of minor CDC criteria was six All patients fulfilled 
the criteria for CFS as described by Sharpe et al2 
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Table 1. Complaints of 88 patients with chronic fatigue 
Complaint 
Fatigue 
Myalgia 
Gastrointestinal complaints 
Concentration problems 
Allergies 
Muscle weakness 
Sleeping problems 
Memory problems 
Arthralgia 
Headache 
Irritability 
Dizziness 
Sore throat 
Polyuria 
Depressive feelings 
Recurrent infections 
Blurred vision 
Lymphadenopathy 
Slightly elevated body temperature 
Number (%) 
standardized* 
88 (100) 
66 (75) 
59 (67) 
57 (65) 
57 (65) 
53 (60) 
42 (48) 
42 (48) 
39(44) 
34 (39) 
29 (33) 
27 (31) 
19 (22) 
15(17) 
14(16) 
14(16) 
-
12(14) 
7(8) 
Number (%) 
spontaneous* 
88 (100) 
46 (55) 
42 (48) 
30 (34) 
-
24 (29) 
24 (29) 
17(19) 
28 (32) 
41 (47) 
12(14) 
21 (24) 
11(13) 
-
10(11) 
13(15) 
12(14) 
4(5) 
9(11) 
* Obtained by standardized questionnaire 
tt Spontaneously reported complaints 
Physical examination. Physical examination revealed no abnormalities, 
especially no swollen lymph nodes, no pharyngitis, no muscle atrophy and normal 
tendon reflexes. 
LABORATORY RESULTS 
The outcome of laboratory tests was similar for patients and controls Serum 
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Table 2. Results of serological tests 
Serological test 
Treponema pallidum MHT 
Brucella abortus agglutination 
Brucella abortus CFT 
EB viral capsid antigen IgG 
EB viral capsid antigen IgM 
EB viral capsid antigen IgA 
EB early antigen IgG 
EB early antigen IgA 
EB nuclear antigen 
Herpesvirus 6 IgG 
Herpesvirus 6 IgM 
Borrelia IgG 
Borrelia IgM 
Enterovirus CFT 
Enterovirus IgG (ratio) 
Enterovirus IgM (ratio) 
Enterovirus IgA (ratio) 
Toxoplasma IgG (I.U.) 
Toxoplasma IgM (ratio) 
Cytomegalovirus IgG (AU) 
Cytomegalovirus IgM (ratio) 
Cytomegalovirus IgA (ratio) 
Geometric mean titer (median titer) 
Patients 
(n = 88) 
negative 
<10 
< 4 
39 5 (32) 
<10 
< 8 
10.3 (8) 
< 8 
32.1 (16) 
15.5(10) 
<10 
5 positive* 
< 8 
36.3 (32) 
0.43 
0.68 
0.25 
175.6 
1 1 
23 4 
0 71 
1 0 
Controls 
(л = 77) 
negative 
<10 
< 4 
38.0 (32) 
<10 
< 8 
7.4 (8) 
< 8 
40.2 (32) 
16.8(10) 
<10 
4 positive" 
< 8 
35 7 (32) 
0.51 
0.61 
0.37 
130.8 
0.97 
34.7 
0.61 
1.0 
* Number of positives. 
P, not significant for all serological tests. 
AU, arbitrary units; CFT, complement fixation test; EB, Epstein-Barr; IU, 
international units; MHT, micro haemagglutination test. 
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Table 3. Mean CIS scores of 88 patients and 77 controls 
Mean value (±SD) 
Subscales P-value 
Patients Controls 
Subjective fatigue 5.8(1.1) 1.8(0.9) <0.001 
Concentration 4.4(1.6) 2.3(1.2) <0.001 
Motivation 3.2(1.7) 1.9(1.0) <0.001 
Activity 4.3(1.7) 1.9(12) <0.001 
chemistry tests and haematological tests were within the normal range (data not 
shown). Red blood cell magnesium was 143.7 μ% Mg/g RBC (SD 15.8) (normal 152 
μg Mg/g RBC, SD 30.0). Results of serological tests are presented in Table 2. 
Again no significant differences were found between patients and controls. C-
reactive protein, which is usually high in case of an infection, was low (< 10 mg 
L ') in both patients and controls. 
RESULTS OF PSYCHOLOGICAL TESTS 
Subjective feeling of fatigue. Scores of the fatigue questionnaire (CIS) are presented 
in Table 3. Patients were significantly more fatigued than controls as measured by 
the subscale subjective fatigue. Patients with CFS experienced significantly more 
concentration problems, had lower motivation, and showed less physical activity 
than healthy controls. 
Depression. Patients had significantly higher scores on the Beck Depression 
Inventory than controls. By using a score of 16 as the cut-off point, 18.3% of 
patients could be considered depressed versus 1.3% of controls (p<0.001). 
Functional impairment. Data on the inventory for functional impairment (SIP) 
are depicted in Figure 1. Patients with CFS scored significantly higher when 
compared to reference group 1 (no physical complaints or physical complaints of 
minor severity) (p<0.001 for all subscales). When patients with CFS were 
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SR HM 
• CFS patients 
MOB SI WLK 
¡ ^ Reference group 1 Reference group 2 
Figure 1. SIP-scores of 88 CFS patients compared to reference group 1 (physical 
complaints of minor severity or no physical complaints at all) and reference group 2 
(moderate to severe physical complaints). (SR=sleep/rest; HM= problems with activities 
at home; Μ'OB=mobility; SI=social interactions; WLK=walking; CON=cognitive 
difficulties; W=work; RP=recreation and pastimes). 
Compared to reference group 2 (patients with moderate to severe physical 
complaints), patients with CFS scored significantly higher on alertness behaviour 
(P< 0.001) and work (P< 0.001). There were no significant differences on other 
subscales. 
FULFILLMENT OF CDC-CRITERIA 
There were no differences in fatigue severity (CIS-subjective fatigue) between 
patients who fulfilled the CDC criteria (CDC-CFS patients) and patients who did not 
(non CDC-CFS patients). No differences on any of the laboratory tests could be 
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found when CDC-CFS patients were compared with non-CDC-CFS patients. When 
CDC-CFS patients were compared with non-CDC-CFS patients, there was a 
significant difference in CIS concentration (p<0.05), CIS activity (p<0.01), SIP 
sleep and rest (p<0.05), SIP ambulation (p<0.05), SIP alertness behaviour 
(p<0.05) and SIP recreation and pastimes (p<0.01), which means that patients who 
have more complaints are significantly more impaired in daily functioning. When 
the number of complaints was included as covariate in the analysis, only a 
significant difference in recreation and pastimes remained (p<0.05). 
Discussion 
In this paper, clinical, laboratory and psychological findings of a cohort of patients 
with CFS are compared to those of a well matched control group. Most studies on 
CFS described in the literature have secondary or tertiary referred patients. To avoid 
this selection bias, we chose to include self-referred patients, which by nature could 
be expected to be more representative of the general problem. That these patients 
were severely fatigued and were considerably impaired by their complaints, is clear 
from our data on the fatigue questionnaire (CIS) and inventory for functional 
impairment (SIP). There was a remarkable discrepancy between spontaneously 
reported complaints and those acquired by a standardized questionnaire as is shown 
in Table 1. Using the standardized questionnaire, in which it is specifically asked 
whether a complaint is present, complaints were more frequently reported. This 
implies that the number of criteria that are scored depends on how data are 
collected. In this study, the number of CDC symptom criteria was based on the data 
from the standardized questionnaire. Although, only 18 patients of our study 
population (20.5%) fulfilled the CDC criteria, there were no differences in fatigue 
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severity (CIS subjective fatigue) between patients who fulfilled the CDC criteria and 
patients who did not When the number of complaints was included as covanate in 
the analysis, there were also no significant differences on depression and functional 
impairment As there was no difference in any of the laboratory parameters, the sole 
effect of applying the CDC symptom criteria on our study group is separating 
patients with few symptoms from patients with many symptoms For the group as a 
whole, the median number of minor CDC-cntena was six It should be noted that 
the minor criteria that are obtained by physical examination, all focus on 
inflammation (or even infection), whilst an infectious aetiology forms only one of 
the possible explanations for CFS Although 66% of the patients reported an acute 
onset of their complaints after an infectious illness, we did not find abnormalities on 
physical examination, and symptom criteria that focus on inflammation, such as sore 
throat, lymphadenopathy, and mild fever, scored relatively low (22, 14, and 8%, 
respectively) This might be related to the long duration of symptoms Many patients 
reported that such symptoms had been present during the first few months of their 
illness However, this was not documented by a physician and may just reflect 
attribution to a 'viral' cause 
With regard to laboratory findings, low magnesium concentrations in red blood 
cells (RBC-Mg) has been described by some researchers 27 In our study, RBC-Mg 
was normal in CFS patients, and this is in accordance with the findings of others 28 29 
We could not detect differences on the serological parameters when patients 
were compared with matched controls By testing of paired sera, evidence was found 
for a recent Toxoplasma gondii infection in one patient, but there was no relation to 
the duration of the fatigue Despite the fact that no differences were found between 
patients and controls in laboratory tests, we did find significant differences on the 
latigue scale, the inventory for depression and functional impairment, when CFS 
patients were compared to controls However, this does not imply that CFS is a 
psychiatric disease Although depression scores were higher amongst patients than 
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amongst controls, only 18% of the patients could be considered depressed, whereas 
59% of the patients did not have depressive feelings at all 
Results on the inventory for functional impairment (SIP) indicate that CFS 
patients are considerably impaired by their complaints Compared to patients with 
moderate to severe physical complaints (reference group 2), CFS patients stopped 
working more often (SIP work, p<0 001), and are significantly more impaired by 
neuropsychological problems (expressed by SIP alertness behaviour, p<0 001) The 
measurement of these neuropsychological problems deserves more attention and is a 
subject for future research We need to get a better idea of exactly how CFS patients 
and non-symptomatic, normal subjects differ in terms of attention and concentration, 
cognitive functioning, memory, various dimensions of mood and emotional 
functioning, in addition to quality of everyday-life functioning Neuropsychological 
problems may also be a symptom of dysregulation of the hypothalamic-
hypopituitary-adrenal axis, which has been recently described by Demitrack et al '5 
As the laboratory parameters that were used in this study were within the normal 
range, they could not be correlated with the seventy of the illness, or to the CDC 
criteria Therefore, it was not possible to investigate a relation between the outcome 
of psychological and laboratory testing The fatigue questionnaire (CIS), the 
depression inventory (BDI), and the inventory for functional impairment (SIP) 
correlated with clinical severity of the complaints and are valuable tools in the 
assessment of patients with CFS Serological tests, however, are not helpful in 
assessing the presence or absence of CFS, because these tests did not discriminate 
between patients and controls 
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Prognosis in chronic fatigue syndrome 
Abstract 
Objective To determine spontaneous improvement after a follow up interval of 18 
months in patients with chronic fatigue syndrome (CFS) and to identify factors that 
predict improvement 
Methods A longitudinal study was used Of 298 initially assessed self referred 
patients fulfilling criteria for chronic fatigue syndrome, 246 patients completed self 
report questionnaires at follow up (response rate 83%) A multi dimensional 
assessment method was used, measuring behavioural, emotional, cognitive, and 
social functioning Comparison data from 53 healthy subjects matched for age, sex, 
and educational level were available 
Results Three per cent of patients reported complete recovery and 17% reported 
improvement At follow up, there were marked problems in occupational situation 
and consumption of medication was high Subjective improvement was confirmed by 
dimensional change at follow up recovered patients had similar scores to healthy 
subjects and improved patients showed significant improvement on four out of seven 
outcome measures, but still had higher scores than healthy subjects on all 
dimensions Sociodemographic variables or treatment by specialists and alternative 
practitioners did not predict improvement Predictors of improvement were 
subjective sense of control over symptoms, less fatigue, shorter duration of 
complaints, and a relative absence of physical attributions 
Conclusion The improvement rate in patients with a relatively long duration of 
complaints is small Psychological factors are related to improvement, especially 
cognitive factors 
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Introduction 
Although studies on chronic fatigue syndrome have increased dramatically the past 
years, little research has been done on the course of the complaint and on factors 
associated with its persistence There are four follow up studies of patients with 
chronic fatigue syndrome All patients m the study of Wilson et al ' and most 
patients in that of Bonner et al2 had been in specific CFS treatment programmes for 
chronic fatigue syndrome and therefore these studies did not investigate the natural 
course The study of Sharpe et al3 assessed variables associated with functional 
impairment at follow up only In a study by Clark et al " patients were referred to a 
chronic fatigue clinic It is not clear whether this was a study on the natural course 
of the disease or that these patients had been treated during the follow up interval 
Also, this study did not investigate cognitive factors as possible predictors of 
improvement 
Detailed prospective studies on the natural course m chronic fatigue syndrome 
are needed since they provide information, not only on prognosis, but also on factors 
associated with chronicity Identification of these factors is important to the 
development of therapeutic interventions 
In a previous study, we developed and tested a multidimensional assessment 
method for chronic fatigue syndrome, assessing behavioural, cognitive, emotional, 
and social functioning 5 The dimensions proved to be relatively independent each 
dimension provided a unique contribution to the description of the patient This 
means that comprehensive assessment of chronic fatigue syndrome entails 
measurement on all dimensions simultaneously Evaluating prognosis, therefore, 
also should be based on multidimensional assessment 
In the present study, we repeated the multi-dimensional assessment in the same 
group of patients 18 months later The main questions were Has improvement 
occurred 18 months later and what factors predict improvement9 
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Subjects and methods 
SUBJECTS 
At initial assessment, 357 self-referred patients completed postal questionnaires 
assessing the dimensions of chronic fatigue syndrome Of those patients, 298 
fulfilled criteria for the disease6 and were included in the study All patients were 
seen by at least one specialist A detailed description of this sample and of initial 
assessments has been reported previously 5 
These patients received the same postal questionnaires 18 months later Non-
responders were send reminders first, and in a second stage were contacted by 
telephone Two hundred and forty six patients finally completed and returned the 
questionnaires (response rate 83%) Nearly all non-responders had moved during the 
follow up interval without reporting their new address, one patient died, and the 
remaining patients were not interested in participating anymore Mean age in the 
follow up sample was 39 (95% confidence interval (95% CI) 37 1-40 0) years, there 
were 59 men and 187 women Mean duration of complaints at initial assessment was 
8 4 years (95% CI 7 3-9 6, median 4 5) Comparison data of fifty-three healthy 
subjects matched for age, sex, and education were available These subjects, selected 
through a regional newspaper advertisement, were included to provide a standard to 
evaluate whether patients who reported improvement or recovery actually had 
dimension scores similar to healthy subjects 
INSTRUMENTS 
The following dimensions were measured (Details about the construction of 
dimension scores and the instruments used are described elsewhere5) 
Subjective experience of the personal situation This dimension reflects the 
subjective experience of fatigue and disability and includes general questions with 
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respect to problems in housekeeping activities and work (5 point scale) and 
satisfaction in housekeeping activities and work (5 point scale), and the subjective 
fatigue subscale and the physical activity subscale of the fatigue questionnaire 
checklist individual strength (CIS) 
Psychological wellbeing The Beck depression inventory (BDI)7 is a standardised 
self report questionnaire to measure depression The following subscales were used 
from the symptom checklist (SCL-90)8, which is a 90-item indicator of 
psychopathology anxiety, agoraphobia, depression, somatisation, cognitive 
difficulties, interpersonal sensitivity 
Functional impairment The following subscales of the sickness impact profile 
(SIP) were included 9 '° activities at home, mobility, and ambulation 
Sleep disturbances These were measured by a sleep disturbances question, 
which was coded "yes" or "no" and the subscale on sleeping problems of the SCL-
90 
Avoidance behaviour Four questions were asked with respect to avoidance of 
physical activity as a way of coping with complaints (e g "avoiding complaints by 
nonactivity") At initial assessment patients had to indicate whether they did or did 
not engage in these behaviours, and a total score was derived In the present study 
these items were scored on a 4 point scale (seldom - now and then - often - very 
often) These items were summed into a total score 
Neuropsychological functioning This dimension was measured by the self report 
questionnaires CIS subscale concentration and the SIP subscale concentration 
Social interactions General questions were asked concerning a) satisfaction in 
social life (5 point scale), and b) problems in social relations (4 point scale) Also, 
the subscale social interactions of the SIP is included 
Sense of control over symptoms (self-efficacy expectations) This dimension 
contains a specific 3 point scale question measuring the subjective sense of control 
over symptoms ("Do you think you can influence your complaints9") and the 
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subscale internal attributions of the multi-dimensional health locus of control 
questionnaire (health is determined by own behaviour/capacities).1112 
Causal attributions. At initial assessment, patients were asked to write down 
their opinion regarding the cause of their complaints. The responses were coded into 
a variable with categories "physical" and "non-physical". In the present study eight 
possible causes were presented. Patients could indicate on a 5 point scale if they 
agreed or disagreed with each cause. Factor analyses yielded two subscales: 
"physical" and "non-physical". Per subscale item scores were summed and divided 
by the number of items in the scale. 
The following questions were asked with respect to the follow up interval of 18 
months: the patient's opinion with respect to self reported change (completely 
recovered - improved - unchanged - complaints got worse); changes in marital status 
and occupational situation; visits and treatment by specialists and alternative 
practitioners for CFS complaints; medication use for CFS complaints. 
Severity of fatigue and the non-cognitive dimensions (avoidance of physical 
activity being measured differently at initial and follow up assessment was excluded) 
were considered as the seven outcome measures of clinical status and disability. 
STATISTICS 
Patients who had missing values in more than one dimension were not included. 
Missing values were replaced for the variable "causal attributions" at initial 
assessment, because this variable had missing values in more than 5% of cases. The 
linear trend at point method was used. The existing series is regressed on an index 
variable scaled 1 to n. Missing values are replaced with their predicted value. 
Evaluating relations between variables is performed by Chi2-test in the case of 
dichotomous or nominal variables. Spearman rank correlation coefficient and Mann-
Whitney test were used for other variables. To evaluate whether there were 
significant differences between recovered, improved, or non-improved patients in 
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the degree of improvement on the outcome measures of clinical status and disability 
Mann-Whitney U tests were performed on the difference between scores at initial 
and follow up assessment. 
Bonferroni correction was used for multiple comparisons to control type I error. 
Prediction of outcome measures was done by stepwise multiple regression analyses. 
To detect the causal direction of variables at initial assessment that predicted fatigue 
severity at follow up, cross lagged panel analyses were performed.13 The direction of 
causation between two variables χ and y can be inferred by comparing the 
correlation between variable χ on initial assessment and variable y on follow up 
assessment (г х^у2) with the correlation between variable y on initial assessment and 
variable χ on follow up assessment (r y,,x2)· The principal direction of causation is 
said to go from χ to у if correlation r x
u
y2 is significantly greater than correlation r 
Results 
CHANGES IN PERSONAL SITUATION DURING FOLLOW UP INTERVAL 
There were no major changes in marital status (unchanged in 93% of cases). 
Occupational situation remained unchanged in 197 (80%) patients. Before onset of 
complaints, 141 (57%) patients worked. At initial assessment 30 (12%) patients 
were unemployed, 69 (28%) worked, 105 (43%) were on sick leave or received 
disablement insurance benefits. The remaining 42 (17%) patients were housewives, 
were retired, or went to school. At follow up assessment, 29 (12%) patients were 
unemployed, 71 (29%) worked, 103 (42%) were on sick leave or received 
disablement insurance benefits. The remaining 43 (17%) patients were housewives, 
were retired, or went to school. 
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SELF REPORTED CHANGE 
Eight (3%) patients indicated that they had completely recovered, 42 (17%) reported 
that they were feeling much better, 147 (60%) reported that complaints had 
remained the same, and 49 (20%) reported that complaints had become worse 
Unless stated otherwise, the groups "completely recovered" and "feeling much 
better" will be combined into one group ("improved" n=50, 20%) m further 
analyses, because of the small sample size of the former There were no differences 
in any of the dimensions at initial assessment between patients who reported that 
complaints had remained the same and patients who reported that they had become 
worse At follow up assessment, there were only differences between these two 
groups on the dimensions of functional impairment and sense of control over 
symptoms As both groups seemed similar, they were combined into one group 
("non-improved" n = 196, 80%) 
TREATMENT DURING FOLLOW UP INTERVAL 
During the follow up interval of 18 months, 143 (58%) patients had visited a 
specialist and 110 (45%) had visited an alternative practitioner One hundred and 
seventy one (70%) patients had visited either of them Of the 110 patients that had 
visited a specialist, 78 were treated by that specialist (32% of the total sample) All 
patients that had visited an alternative practitioner received treatment One-hundred 
and forty six (59%) patients had been treated by either a specialist or an alternative 
practitioner during the follow up interval 
At initial assessment, 87% of patients used medication, mainly homeopathic 
drugs (38%), vitamins (26%), analgesics (24%), antidepressants (17%), antibiotics 
(14%), and sleep medication (7%) At follow up, 75% used medication 
(homeopathic drugs 21%, vitamins 20%, analgesics 28%, anti-depressants 9%, 
antibiotics 1%, sleep medication 9%) At initial assessment, there was no 
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Table 1: Mean scores and standard deviations of dimensions and fatigue seventy at initial 
assessment (Al) and follow up (FU) for 8 recovered patients, 42 improved patients, 197 non-
improved patients, and 53 healthy subjects High scores indicate abnormal functioning 
Fatigue severity 
(CIS) 
Psychological 
well being 
Functional 
impairment 
Social functioning 
Sleep disturbances 
Concentration 
problems 
Subjective 
experience 
Depression (BDI) 
AI 
FU 
Al 
FU 
AI 
FU 
Al 
FU 
Al 
FU 
Al 
FU 
Al 
FU 
Al 
FU 
Recovered 
Mean (sd) 
5 4 ( 18) 
1 8 ( 1 0)" 
69 6 (37 9) 
24 4 (21 7)" 
7 3 ( 8 5) 
0 6 ( 10)" 
23 6 (22 2) 
10 9(12 7) 
5 8 ( 4 2) 
3 4 ( 3 5) 
182(11 5) 
2 9 ( 2 5)" 
35 9(17 2) 
4 9 ( 4 9)" 
9 3 ( 5 0) 
2 1 ( 3 3)" 
Improved 
Mean (sd) 
5 6 ( 1 1) 
4 5 ( 1 3)" 
83 4 (44 2) 
60 8(38 2)" 
7 9 ( 5 6) 
6 3 ( 5 5) 
46 3 (24 8) 
39 3 (22 3) 
5 2 ( 4 1) 
4 6 ( 3 8) 
35 7 (18 0) 
26 0(17 1)* 
41 6(12 4) 
29 4(13 4)" 
13 2 ( 6 8) 
9 0 ( 6 0)" 
Nonimproved 
Mean (sd) 
6 2 ( 0 9) 
6 2 ( 0 8) 
86 7 (45 5) 
77 4 (44 4)· 
11 4 ( 7 9) 
11 8 ( 7 7) 
42 0 (21 1) 
42 2 (23 9) 
5 9 ( 3 7) 
5 9 ( 3 5) 
34 1 (16 3) 
34 1 (16 1) 
46 8(10 8) 
44 8(10 6) 
14 1 ( 7 3) 
12 8 ( 7 0) 
Healthy 
Mean (sd) 
2 2(1 3) 
21 9(19 9) 
0 2 (0 7) 
21 5(15 2) 
2 9 ( 2 8 ) 
5 6 ( 5 0 ) 
11 8(10 4) 
2 7 (3 7) 
' p<0 05, Al versus FU 
" p<0 01, Al versus FU 
At initial assessment all patient groups scored significantly higher than healthy controls on 
all variables (p<0 008), except patients recovered at follow up who scored equal to 
healthy subjects on social functioning and sleep disturbances At follow up recovered 
patients scored equal to healthy subjects on all variables Improved and non-improved 
patients scored significanly higher than healthy controls on all variables (p<0 008) 
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significant difference between improved and non-improved patients in the proportion 
of patients using medication (82% versus 88%) At follow up, the proportion of 
patients using medication was significantly smaller in improved patients than in non-
improved patients (61% versus 78% p<0 01) 
SELF REPORTED CHANGE COMPARED WITH DIMENSIONAL CHANGE 
AND CHANGE IN FATIGUE SEVERITY 
Table 1 shows data on the seven outcome measures and depression at initial 
assessment and follow up assessment These data are presented for recovered, 
improved and non-improved patients and healthy subjects separately At initial 
assessment all patient groups had higher fatigue seventy scores than healthy 
subjects Recovered and improved patients showed significant improvement in 
fatigue severity At follow up, recovered patients similar scores to healthy subjects, 
whereas improved patients still had higher scores than healthy subjects 
For the other outcome measures each patient group had significantly higher 
scores than healthy subjects at initial assessment, except for patients recovered at 
follow up, whose scores were similar to healthy subjects on social functioning and 
sleep disturbances 
The recovered patients showed significant improvement on the outcome 
measures and at follow up had scores similar to healthy subjects on all dimensions 
Improved patients showed significant improvement on psychological wellbeing, 
concentration problems, and subjective experience However, at follow up these 
patients still had higher scores on these outcome measures than healthy subjects 
Non-improved patients only significantly improved on psychological wellbeing At 
follow up this group scored higher than healthy subjects on all outcome measures 
Analyses on difference scores showed that recovered and improved patients 
showed significantly greater improvement than non-improved patients on all 
outcome measures (p<0 017) Recovered patients had greater improvement on all 
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Table 2: Relations between variables at initial assessment and self reported improvement fl-
iest) and fatigue seventy (Pearson's r) at follow up 
Outcome measures at follow up 
Self reported improvement Fatigue seventy 
Variables at initial assessment Mann-Whitney p-value 
Z-statistic 
Spearman rank p-value 
correlation 
Age 
Duration of complaints 
Fatigue severity 
Psychological wellbeing 
Functional impairment 
Social functioning 
Sleep problems 
Concentration problems 
Subjective experience 
Avoidance of physical activity 
Physical attributions 
Sense of control over symptoms 
-2 51 
-4 17 
-3 77 
-0 65 
-2 95 
-0 14 
-1 08 
-0 57 
-2 96 
-0 34 
-2 54 
-5 03 
00119 
0 0001 
0 0002 
NS 
0 0031 
NS 
NS 
NS 
0 003 
NS 
0 0112 
0 0001 
0 14 
0 19 
0 55 
0 26 
0 35 
0 24 
0 13 
0 22 
0 48 
0 10 
0 10 
0 36 
0 036 
0 002 
0 0001 
0 0001 
0 0001 
0 0001 
0 048 
0 001 
0 0001 
NS 
NS 
0 0001 
outcome measures, but this was only significant in fatigue seventy and the subjective 
experience dimension (p<0 017) For depression, at initial assessment there were 
no significant differences between recovered improved, and non-improved patients 
on the BDI All groups had significant higher scores than healthy subjects 
At follow up, recovered and improved patients showed significant improvement 
Compared with healthy subjects, at follow-up, non-improved and improved patients 
still had higher BDI scores, but recovered patients had similar scores 
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Table 3: Multiple regression analyses predicting self reported improvement and fatigue 
severity (CIS Subjective fatigue) at follow up by variables at initial assessment Predictor 
variables are presented according to step number they entered the model 
Predictors 
Improvement Multiple R = 0 42, F= 12 37, p=0 0001 
Sense of control over symptoms 
Fatigue seventy 
Duration complaints 
Physical attributions 
Τ 
3 83 
3 12 
2 21 
2 0 0 
Significance 
0 0001 
0 002 
0 03 
0 05 
Fatigue seventy Multiple R=0 54, F=30 05, p=0 0001 
Fatigue seventy 5 86 0 0001 
Sense of control over symptoms 3 24 0 01 
Functional Impairment 2 29 0 02 
PREDICTION OF SELF REPORTED CHANGE BY VARIABLES AT INITIAL ASSESSMENT 
Self reported change was not related to sociodemographic variables, medication, or 
being treated by a specialist or alternative practitioner Self reported improvement 
was related to younger age, shorter duration of complaints, lower fatigue severity, 
and less abnormal scores in the dimensions sense of control over symptoms, 
functional impairment, physical attributions, and subjective experience (Table 2) 
Entering these variables in stepwise multiple regression analyses, self reported 
improvement was predicted by sense of control over symptoms, lower fatigue 
severity, shorter duration of complaints, and relative absence of physical attributions 
(Table 3) Median duration of complaints at initial assessment for the improved 
group was 2 years and for the non-improved group 6 years 
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PREDICTION OF FATIGUE SEVERTTY AT FOLLOW UP BY VARIABLES AT 
INITIAL ASSESSMENT 
High fatigue seventy at follow up was related to the following variables at initial 
assessment older age, high fatigue seventy, and higher scores on the dimensions 
psychological wellbeing, functional impairment, social functioning, sleep problems, 
concentration problems, sense of control over symptoms, and subjective experience 
(Table 2) Treating these as independent variables in stepwise multiple regression 
analyses, high fatigue seventy at follow up was predicted by three variables at initial 
assessment high fatigue seventy, lack of control over symptoms and functional 
impairment (Table 3) To evaluate the causal direction between fatigue seventy and 
predictors, cross lagged panel analyses were performed (Table 4) The correlation 
between sense of control over symptoms at initial assessment and fatigue severity at 
follow up was significantly stronger than the correlation between fatigue seventy at 
initial assessment and sense of control over symptoms at follow up, which implies 
that the direction of causation goes from sense of control over symptoms to fatigue 
seventy The cross lagged panel analyses between fatigue seventy and functional 
impairment was not significant 
Discussion 
As far as we know, this is the first prospective study on the natural course in chronic 
fatigue syndrome in which a comprehensive assessment of cognitive, emotional, 
behavioural and social functioning took place at initial assessment and follow up In 
the present sample only a few patients recovered or improved and problems in 
occupational situation were marked Medical consumption was also high All 
patients had visited specialists at some time before initial asessment During the 
follow up interval, nearly all patients continued visiting specialists and alternative 
practitioners, and used medication 
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Table 4: Cross-Lagged Panel analysis between fatigue seventy and the subjective sense of 
control over symptoms and functional impairment 
INITIAL ASSESSMENT FOLLOW-UP t-value p-value 
Sense of control r=0 32 Sense of control 
-2 88 0 001 
Fatigue severity r=0 21 Fatigue seventy 
Functional impairment r=0 30 Functional impairment 
-0 87 NS 
Fatigue seventy r=0 33 Fatigue seventy 
Self reported improvement was in accordance with improvement on the seven 
outcome measures of clinical status and disability Patients who recovered at tollow 
up showed significant improvement in five out of seven outcome measures At 
follow up, their scores were similar to healthy subjects on all outcome measures On 
the dimensions social functioning and sleep disturbances there was no significant 
improvement in recovered patients At initial assessment, however, on these 
dimensions recovered patients already had scores similar to healthy subjects 
Improved patients showed significant improvement on four out of seven outcome 
measures However, they still had higher scores than healthy subjects on all outcome 
measures at follow up, indicating that recovery was not complete The observation 
that on three out of seven outcome measures these patients did not show 
improvement underlines the importance of multidimensional assessment in studies on 
prognosis Recovered and improved patients showed significantly greater 
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improvement than non-improved patients Although for all outcome measures 
improvement was greater in recovered patients than in improved patients, these 
ditferences were only significant for fatigue seventy and the subjective experience 
dimension The small number of recovered patients may have prevented differences 
in the other five outcome measures from reaching significance 
Demographic variables were not predictive for self reported improvement, nor 
were receiving treatment by a specialist or an alternative practitioner Improvement 
could be predicted by sense of control over symptoms, lower fatigue, shorter 
duration of complaints, and relative absence of physical attributions 
Psychological wellbeing (including depression) did not predict improvement m 
this study, although others have suggested that this factor plays a part in the 
perpetuation of complaints 1516 " Sharpe et al ' found a relation between depression 
and improvement, but they measured depression retrospectively In the study of 
Clark et al " diagnosis of depression at initial assessment was not a predictor for the 
course of the condition 
Avoidance of physical activity is also thought to play a part in the perpetuation 
of complaints,1516 " but the present study is not conclusive on this issue The method 
of measuring avoidance of physical activity at initial assessment was crude, 
providing information on whether or not a patient avoided physical activity, rather 
than how much or how often At follow up assessment, avoidance of physical 
activity was scored on a 4 point scale (ranging from "seldom" to "almost all of the 
time") to increase discriminative power This variable correlated with self reported 
improvement (r= 0 13) and fatigue seventy at follow up (r=0 21) However, being 
assessed at follow-up only, the causal direction of the relationship with improvement 
and fatigue severity is unclear a reduction in avoidance of physical activity may 
merely reflect improvement rather than causing it Moreover, indicating how 
frequently one avoids physical activity does not give direct information on the actual 
level of physical activity, and that is what really is of interest We are currently 
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performing studies in which physical activity (besides self report questionnaires) is 
assessed by a combination of self observation lists and a motion sensing device (the 
Actometer) during two week observation periods 
Patients with a short duration of complaints were more likely to improve than 
patients with a long duration Because duration of complaints was long in the present 
sample (median 4 5 years), it might be speculated that most patients had already 
developed a chronic state In that case improvement is less likely Thus it is unclear 
whether present findings concerning improvement rate and predictors for 
improvement also apply to patients with a relatively short duration of complaints A 
prospective study with a larger subset of patients with a short duration of complaints 
(6 months to 1 year) seems warranted 
Attributing complaints to physical causes is one of the most distinctive features 
of CFS patients514 and a high score on this dimension predicted poor prognosis This 
accords with Sharpe et al ' who found that belief m a viral cause was related to 
functional impairment, but they assessed this variable at follow up only, thus leaving 
the question of causal direction unanswered Like us, Wilson et al2 found that the 
belief that a physical process explained all symptoms predicted poor outcome 
Bonner et al3 only found a trend for physical attributions to be associated with poor 
outcome However, this study was small and really concerned the outcome of treated 
patients Unfortunately, the study by Clark et al4 did not investigate cognitive 
factors 
The role of the subjective sense of control over symptoms (self efficacy 
expectations) has not been investigated in a prospective study before In the present 
study, sense of control over symptoms was a predictor of fatigue seventy and was 
the strongest predictor of improvement It might be speculated that a lack of 
subjective sense of control over symptoms is the result of severe fatigue However 
cross lagged panel analyses suggested that subjective sense of control over symptoms 
caused fatigue severity and not fatigue caused lack of sense of control The present 
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findings underline the role of attributions and cognitions in the perpetuation of the 
complaints 
The study of Clark et al4 is probably the only other study on the natural course 
in which predictors were assessed prospectively Like the present study they found 
3% of patients reporting full recovery, but the improvement rate in this study (38%) 
was higher than in the present study (17%) There may be several reasons for this 
discrepancy in improvement rate Firstly, the follow up interval in the study by 
Clark et al4 was substantially longer (mean 2 5 years) which may increase the 
chance of improvement Secondly, on a subjective change scale ranging from -7 
(significant worsening) to +7 (complete recovery) the authors used an arbitrary cut 
off point for improvement of more than +3 No validation of this cut off for 
improvement had been performed by comparing improved patients with healthy 
subjects as has been done in the present study 
There are methodological issues which should be addressed Some non-
responders at initial assessment were more likely to go to school, but were less 
likely to work, and had more problematic scores on social functioning However, on 
all other variables, notably all factors predicting improvement and fatigue severity, 
there were no differences between responders and non-responders Therefore, we 
feel that it is very unlikely that the follow up sample is biased 
The present findings have therapeutic and theoretical implications Several 
authors have proposed cognitive-behavioural therapy, which in general is directed at 
increasing physical activity and reducing depression to prevent chronicity '5161819 
Our findings stress the role of cognitive processess in the perpetuation of 
complaints We feel that in therapeutic trials more attention should be paid on 
breaking down physical attributions and increasing the subjective sense of control 
over symptoms 
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Fluoxetine in chronic fatigue syndrome 
Summary 
Background No somatic treatment has been found to be effective for chronic fatigue 
syndrome (CFS) Antidepressant therapy is commonly used Fluoxetine is 
recommended in preference to tricyclic agents because it has fewer sedative and 
autonomic nervous system effects However, there have been no randomised, 
placebo-controlled, double-blind studies showing the effectiveness of antidepressant 
therapy in CFS We have carried out such a study to assess the effect of fluoxetine 
in depressed and non-depressed CFS patients 
Methods In this randomised, double-blind study we recruited 44 patients to the 
depressed CFS group, and 52 to the non-depressed group In each group participants 
were randomly assigned to receive either fluoxetine (20 mg once a day) or placebo 
for 8 weeks The effect of fluoxetine was assessed by questionnaires, self-
observation lists, standard neuropsychological tests, and a motion-sensing device 
(Actometer), which were applied on the day treatment started and on the last day 
Findings The two groups were well matched in terms of age, sex distribution, 
employment and marital status, and duration of CFS There were no significant 
differences between the placebo and fluoxetine-treated groups m the change during 
the 8-week treatment period for any dimension of CFS There was no change in 
subjective assessments of fatigue, severity of depression, functional impairment, 
sleep disturbances, neuropsychological function, cognitions, or physical activity in 
the depressed or the non-depressed subgroup 
Interpretation Fluoxetine in a 20 mg daily dose does not have a beneficial effect on 
any characteristic of CFS The lack of effect of fluoxetine on depressive symptoms 
in CFS suggests that processes underlying the presentation of depressive symptoms 
in CFS may differ from those in patients with major depressive disorder 
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Introduction 
Chronic fatigue syndrome (CFS) is characterised by persisting, disabling fatigue that 
does not subside with rest in bed and for which no medical explanation can be 
offered. As yet, no effective somatic treatment for CFS is offered. Various drugs 
have been proposed for treatment of CFS1"4 and antidepressants (notable fluoxetine) 
are commonly prescribed. CFS patients may tolerate first-generation tricyclic 
antidepressants poorly because side-effects include sedation and exacerbation of 
fatigue symptoms.5 Lynch and colleagues6 suggested the use of fluoxetine since this 
drug has fewer sedative and autonomic nervous system effects. Case-reports and 
uncontrolled studies suggested that fluoxetine is beneficial in CFS.2 Lynch et α/.6 
reported that after 8 weeks of treatment a third of the mild to moderately depressed 
CFS-patients treated with fluoxetine showed reduction of at least 50% in severity of 
depressive symptoms, and another third showed between 25% and 50% reduction in 
symptom severity. However, the effectiveness of fluoxetine (or any other 
antidepressant) in the treatment of CFS has not been established in controlled 
studies. 
In a previous study,7 we developed and tested a multidimensional assessment 
method for CFS, which assessed the behavioural, cognitive, emotional and social 
features of CFS. These dimensions proved to be independent of each other and 
contributed to the description of the patient. Therefore, in an intervention study both 
the effect of treatment on fatigue severity and other dimensions are of interest. We 
have assessed the effectiveness of fluoxetine on the dimensions of CFS in a 
randomised, placebo-controlled, double-blind study. Fluoxetine is effective in 
treating depressive symptoms; since a proportion of CFS patients have depression, 
two groups of patients were included - a depressed CFS group and a non-depressed 
CFS group. This design allowed us to separate any indirect effect of fluoxetine on 
fatigue and other dimensions through improvement in depression from a direct effect 
of fluoxetine. 
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Patients and methods 
PATIENTS 
Patients had to fulfill the entena for chronic fatigue syndrome8 and give informed 
written consent Patients were randomly selected from our CFS-database, acquired 
through self-referral or referral by family doctors, to the outpatient clinic of the 
department of General Internal Medicine, University Hospital Nijmegen Patients 
had to have had fatigue for more than one year with substantial impairment in their 
daily life, which means a score of 35 or more on the subjective fatigue subscale of 
the checklist individual strength 7 Depressed patients had to have a diagnosis of 
major depressive disorder9 and a score on the Beck depression inventory of 16 or 
more (moderately to severely depressed) Non-depressed patients had to have a score 
on the Beck depression inventory of 10 or less (no depressive feelings at all) 
Psychiatric examination (SGSV supervised by FGZ) used a structured psychiatric 
interview Fatigue and loss of energy were not counted as symptoms either in 
making the diagnosis of major depressive disorder or in calculating Beck depression 
inventory score 
Exclusion criteria were any physical illness that could explain the complaints, 
any psychiatric diagnosis besides major depressive disorder in depressed patients, 
any psychiatric diagnosis in non-depressed patients, pregnancy or lactation, lack of 
contraception in women of childbeanng age, previous exposure to fluoxetine in a 
formal clinical trial, previous lack of satisfactory course of fluoxetine treatment, 
participation in recent clinical trials, use of any prescribed medication except 
incidental analgetics that could not be stopped, and current psychotherapy 
DESIGN 
In each group patients were randomly assigned, in a double-blinded manner, either 
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fluoxetine or placebo by kitnumber (provided by Lilly Research Centre CT Supply 
Group, Windlesham, UK) per block of ten Fluoxetine capsules (20 mg) were taken 
once a day Duration of treatment with fluoxetine or placebo was 8 weeks 
Compliance and side-effects were evaluated after 1 week, 2 weeks, and 6 weeks of 
treatment (figure 1) Blood samples were taken after 2 weeks of treatment for 
measurement of fluoxetine concentrations by a high-performance liquid 
chromatography system with spectrophotometnc detection at 230 nm To assess 
changes in CFS features, the tests were done on the day treatment started 
(pretreatment) and on the last day of treatment (post-treatment) Follow-up testing 
took place 2 months after treatment had stopped to assess the stability of possible 
effects of fluoxetine The study was approved by the ethics committee of the 
hospital 
PSYCHOLOGICAL TESTS 
The subjective feeling of fatigue was measured by the subjective fatigue subscale of 
the checklist individual strength 7 On the self-observation list, fatigue was measured 
4 times a day on a 4-point scale (daily observed fatigue score) Patients completed 
the self-observation list during the 12 days before the start of treatment, during the 
last 12 days of treatment, and during the 12 days before follow-up testing Both 
scores were combined as one primary outcome measure 
The Beck depression inventory10" was used to measure severity of depression 
The symptom checklist is an indicator of psychological well-being 12 The total score 
was used as the primary outcome measure 
The sickness impact profile1314 measures the influence of symptoms in different 
areas of daily functioning The total score was used as the primary outcome 
measure 
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The physical activities subscale of the checklist individual strength measures the 
extent of physical activity On the 12-day self-observation list, physical activity is 
rated daily on a 7-point scale (daily observed activity score) Patients wore a motion-
sensing device (the Actometer), day and night, during this 12-day period The 
Actometer is the size of a matchbox and is attached to the ankle, it measures the 
number of movements in 5-mmute periods Data are read by a personal computer 
and the mean is calculated as the primary outcome measure 
The subscale on sleep problems of the symptom checklist12 was used On the 12-
day self-observation list, quality of sleep (slept well, difficulty falling asleep, restless 
sleep, early awakening in the morning) is recorded daily (daily observed quality of 
sleep scores) Each score is expressed as a percentage of occurrence A special sleep 
pattern observation list was completed in combination with the 12-day self-
observation list and Actometer readings The patient recorded daily, every 30 
minutes, whether they were resting, asleep, or awake The following parameters 
were calculated over the 12 day-period hours asleep at night, hours asleep during 
the day, hours awake before falling asleep, hours awake during the night, hours 
staying in bed after waking up in the morning, hours resting during the day (daily 
observed sleep pattern scores) The daily observed sleep quality score was used as 
the primary outcome measure 
Neuropsychological functioning was measured by the concentration subscales of 
the checklist individual strength and the sickness impact profile Memory and 
concentration complaints were rated daily on the 12-day self-observation list This 
feature was also assessed by standard neuropsychological tests Speed of information 
processing was measured by the computerized complex reaction-time, which 
consisted of three consecutive tasks of increasing complexity, reaction time and 
motor speed were separately registered Baseline reaction time was the primary 
outcome measure for this dimension 
General questions were asked about satisfaction in social life and difficulties in 
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social relationships The Social Interactions subscale of the SIP was used as the 
primary outcome measure 
Sense of control over symptoms (self-efficacy expectations) were measured by a 
specific question (5-point scale) and the internal attributions subscale of the multi-
dimensional health locus of control questionnaire 1516 The modified pain cognition 
list" measures fatigue-related cognitions, it contained five subscales suffering, 
catastrophizing, confidence in medical care, resignment, and positive expectations 
The primary outcome meausure was self-efficacy expectations 
Known side-effects of fluoxetine (nausea, headache, nervousness, sleep 
disturbances, gastrointestinal disorders, dry mouth, anxiety, dizziness, tremor, 
perspiration, and weight loss) resemble symptoms commonly seen m CFS 
Therefore, these complaints were assessed with a special side effects probing list 
before treatment had started, after 2 weeks, after 6 six weeks, and at the end of 
treatment Each item was rated as never, a few times a month, a few times a week, 
or every day Information on sociodemographic data and duration of complaints was 
collected At post-treatment and at follow-up, self reported change compared with 
pretreatment was assessed (completely recovered, improved, no change, 
deteriorated) 
ANALYSIS 
Since the characteristics of CFS are independent, the effect of treatment can be 
assessed individually for each To prevent type I error because to multiple testing, 
the number of measures was reduced by selecting one primary outcome measure per 
characteristic to be used in the analyses Only patients who completed the trial were 
included into the analyses Skewed variables were log-transformed to produce 
approximately normal distributions The effect of fluoxetine was assessed by 
ANOVA of the difference in scores between pretreatment testing and post-treatment 
testing of each primary outcome measure Two main effects were calculated 
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Table 1: Patients entering trial and reasons for dropout 
Placebo Fluoxetine 
(n = 53) (n=54) 
Trial completed 51(96%) 45(83%) 
Skin reactions 1(2%) 3 ( 6 % ) 
Haematoma 1 ( 2%) 
Nausea .. 2 ( 4 % ) 
Headache 1(2%) 2 ( 4%) 
Personal reason .. 1(2%) 
DRUG-effect (fluoxetine versus placebo) and CONDITION-effect (depressed versus 
nondepressed). The INTERACTION-effect DRUG*CONDITION was also 
calculated. If ANOVA showed a significant effect of a certain characteristic, 
explorative analysis was done on the other variables of that characteristic. The 
stability of possible treatment effects was assessed ANOVA of the difference in 
scores between pretreatment and follow-up testing. Sociodemographic variables were 
compared by the χ2 test or the Kruskal-Wallis test when appropriate. Because there 
were nine comparisons ρ value was set at 0.01 for a two-tailed test to prevent type I 
error. Analyses were completed before the code was broken. 
Results 
48 depressed patients (9 men and 39 women) and 59 non-depressed patients (18 men 
and 41 women) entered the trial. Of the 107 patients, 96 patients completed the 
trial. 15% of patients in the fluoxetine group stopped treatment because of side-
effects versus 4% of placebo-treated patients (Table 1). There were no significant 
differences between the groups in employment or marital status, sex, age, or 
duration of complaints (Table 2). 
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Table 2: Demographic data 
Age 
Sex (M/F) 
Median (range) duration 
of complaints years 
Marital status 
Married/cohabiting 
Divorced 
Widowed 
Single 
Employment status 
Working 
Housewife 
Unemployed 
Disablement benefits/ 
sick leave 
Other 
Placebo 
depressed 
(n=23) 
38.5(10.1) 
5/18 
6 (2-20) 
19(83%) 
1 (4%) 
0 
3(13%) 
2 (9%) 
7 (30%) 
2 (9%) 
11 (48%) 
1 (4%) 
Fluoxetine 
depressed 
(n=21) 
39.9(8.6) 
3/18 
5 (1-30) 
14(67%) 
2 (9%) 
1 (5%) 
4(19%) 
2 (10%) 
3 (14%) 
1 (5%) 
15(71%) 
0 
Placebo 
non-depressed 
(n=28) 
37.8(11.9) 
9/19 
6 (2-30) 
16(57%) 
1 (4%) 
1 (4%) 
10(35%) 
9 (32%) 
3(11%) 
0 
13 (46%) 
3(11%) 
Fluoxetine 
non-depressed 
(n=24) 
39.8 (7.4) 
6/18 
5 (1-20) 
19 (79%) 
2 (8%) 
0 
3 (13%) 
4(17%) 
4(17%) 
0 
16 (66%) 
0 
There was no difference between the fluoxetine-treated group and the placebo-
treated group in the change from pretreatment to post-treatment for any primary 
outcome measure assessing subjective fatigue (Figure 2), depression (Figure 2), 
psychological well-being, functional impairment, physical activity, sleep 
disturbances, neuropsychological functioning, social interactions, or cognitions. 
The mean differences between fluoxetine and placebo in improvement in fatigue 
severity and depression severity were -0.164 (95% CI -0.64 to 0.31) and -0.186 
(95% CI -0.35 to -0.02), respectively. Thus, in the most extreme case fluoxetine 
would yield an improvement of 0.31 (3%) in fatigue and 2% in depression severity. 
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Pretreatment Post-treatment Follow-up 
Beck depression inventory score 
Pretreatment Post-treatment 
эЦ Placebo-depressed t i Fluoxetine-depressed 
• Placebo-nondepressedH Fluoxetine-nondepressed 
Follow-up 
Figure 2: Subjective fatigue scores and Beck depression inventory scores in four 
study groups (Data are group means with 95% CI). 
Fluoxetine in chronic fatigue syndrome 
Table 3: Self-reported change reported at posttreatment and follow-up testing 
recovered improved unchanged worse 
PL-D 
FL-D 
PL-ND 
FL-ND 
PL-D 
FL-D 
PL-ND 
FL-ND 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0(0%) 
0 (0%) 
0 (0%) 
0 (0%) 
3 (13%) 
1(5%) 
3(11%) 
2 ( 8%) 
3(13%) 
3 (14%) 
2 ( 7%) 
5(21%) 
14(61%) 
12 (57%) 
21 (78%) 
13(57%) 
12 (52%) 
13 (62%) 
22 (79%) 
17(71%) 
6 (26%) 
8 (38%) 
3(11%) 
8(35%) 
8(35%) 
5 (24%) 
4 (14%) 
2 ( 8%) 
PL-D=placebo-depressed, FL-D = fiuoxetine-depressed, PL-ND =placebo 
nondepressed, FL-ND=fluoxetine-nondepressed Percentages are row 
percentages 
In both cases the improvement is not clinically meaningful This study therefore has 
sufficient power 
At follow-up, there were no differences between the fluoxetine-treated and 
placebo groups for any variable assessing the characteristics of subjective fatigue 
(Figure 2) and depression (Figure 2) 
No patient reported complete recovery (Table 3) There was a trend for a 
DRUG-effect on self-reported change reported at post-treatment (DRUG-effect 
ρ = 0 052), when patients from the fluoxetine group were more likely to report 
deterioration There were no effects on self-reported change at follow-up testing 
After 2 and 6 weeks of treatment, there were no differences between the actively 
treated and placebo groups in the frequency of any of the possible fluoxetine side-
effects At the end of treatment, more fluoxetine-treated than placebo-treated 
patients complained of tremor (DRUG-effect p=0 006) and perspiration (DRUG-
effect p = 0 008) For complaints that occured at least a few times a week, 10 (22%) 
of fluoxetine-treated patients complained of tremor and 23 (51%) complained of 
Posttreatment 
Follow-up 
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perspiration at the start of treatment (placebo group, 12 [24%] and 17 [33%], 
respectively) At post-treatment, 18 (40%) of fluoxetine-treated patients complained 
of tremor, and 67% of transpiration (placebo group, 30 [26%] and 20 [40%], 
respectively) 
Fluoxetine was detected in plasma in all patients of the fluoxetine group 
(median = 40 ^g/l, range= 13-134), but in no patients of the placebo group 
Discussion 
This is the first randomised, placebo-controlled, double-blind study of the effect of 
antidepressant therapy in CFS We assessed the effect of fluoxetine not only on 
fatigue or depression, but also on other characteristics of CFS 
Despite previous promising results we found that fluoxetine does not have a 
beneficial effect on any characteristic of CFS (fatigue seventy, depression severity, 
functional impairment, sleep disturbances, neuropsychological functioning, 
cognitions, or physical activity) Fluoxetine was not superior to placebo for any 
feature of CFS There have been anecdotal reports that fluoxetine is poorly tolerated 
by patients with CFS In our trial, 15% of fluoxetine-treated patients withdrew 
because of side-effects, a higher withdrawal rate than in fluoxetine trials in 
depressed patients on the same regimen 18 20 Side-effect assessments showed that 
there was a significantly greater increase in the frequency of tremor and perspiration 
during the treatment period, compared with pretreatment, in the fluoxetine group 
We found that, in patients with several complaints, the frequencies of side-effects 
before treatment must be taken into account Many patients reported side-effects at 
the end of treatment, but most of them had reported these complaints before 
treatment had started 
We do not know whether a dose higher than the 20 mg daily we used may yield 
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a better effect A dose-effect relation in fluoxetine has not been established, and a 
dose of 5 mg daily is effective in major depressive disorder 21 In depressed patients, 
an increase of the dose to 60 mg daily in those who did not respond to 20 mg daily 
was no more effective than continuation22 24 In our study 20 mg daily was 
ineffective for CFS, and side-effects caused 15% of patients to withdraw Higher 
doses of fluoxetine may yield higher drop-out rates because of side-effects 21 The 
lack of effect of fluoxetine on depressive symptoms is surprising Gram's review of 
the effectiveness of fluoxetine in depressed patients concluded that fluoxetine is an 
effective antidepressant2I However, in our study fluoxetine was no better than 
placebo in treating depression This finding can not be explained by differences in 
pretreatment depression severity or by non-compliance At intake, patients were 
diagnosed as depressed according to DSM-III-R criteria, which include affective, 
somatic, and cognitive symptoms 9 Somatic symptoms and cognitive symptoms are 
commonly reported by patients with CFS, irrespective of whether they are 
depressed, and therefore these symptoms may not be related to disturbed mood in 
CFS Beck depression inventory score also is based on these three symptom groups, 
and an effect of fluoxetine on affective symptoms might then be masked by the 
absence of an effect in cognitive and somatic symptoms To test this hypothesis we 
did additional analyses on three subsets of Beck depression inventory items, divided 
into affective, cognitive, and somatic items In the fluoxetine group there were no 
significant changes in any of these subscores 
Our results have theoretical implications on the role of depression in CFS There 
may be differences in underlying processes of depressive symptoms between CFS 
patients with depressive comorbidity and patients with major depressive disorder 
Even the presentation of affective symptoms may not imply disturbed mood m CFS 
as it does in major depressive disorder Fluoxetine is a selective serotonin reuptake 
inhibitor We found that in depressed CFS patients disturbed serotonin processes are 
unlikely to be involved in the presentation of depression-like symptoms This 
131 
Chapter 7 
conclusion is supported by a study of serotonin processes in CFS 2i These authors 
found no differences in fenfluramine-induced prolactin and Cortisol responses 
between CFS patients and healthy controls 
We conclude that prescription of 20 mg fluoxetine in CFS is unwarranted, 
irrespective whether depressive symptoms are present; it does not lead to 
improvement in any area of the patient's functioning 
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The measurement of fatigue in multiple sclerosis 
Abstract 
Objective: To provide a multidimensional characterization of fatigue in patients with 
multiple sclerosis (MS) 
Design: Cross-sectional design Fifty patients with clinically definite MS were 
compared on the dimensions of fatigue with 51 patients with chronic fatigue syndrome 
(CFS) and 53 healthy subjects 
Results: Eighty-five percent of the patients with MS reported fatigue to be present at 
least once a week Patients with MS and patients with CFS had significantly higher 
subjective fatigue seventy scores than healthy subjects Patients with MS had similar 
psychological well-being scores than patients with CFS, except that patients with CFS 
had significantly higher somatization scores High somatization scores reflect strong 
focusing on bodily sensations Both groups of patients were significantly less active than 
the healthy subjects The Kurtzke Expanded Disability Status Scale (EDSS) score and 
Beck Depression Inventory were not related to subjective fatigue seventy In patients 
with MS and in patients with CFS subjective fatigue seventy was related to impairment 
in daily life, low sense of control over symptoms, and strong focusing on bodily 
sensations In CFS evidence was found for a relation between low levels of physical 
activity and attributing symptoms to a physical cause and between subjective fatigue 
severity and physical activity, but not in MS 
Conclusions: Patients with MS experienced significant fatigue, which had a significant 
impact on daily functioning and was not related to depression or EDSS Psychological 
factors, such as focusing on bodily sensations and low sense of control, play a role in 
the experience of fatigue in MS 
Introduction 
Fatigue is frequently reported by patients with multiple sclerosis (MS) Subjective 
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fatigue in a patients with MS is perceived as different from the fatigue experienced 
when the patient was still healthy ' 3 In one study, 87% of patients with MS reported 
fatigue to be a problem, fatigue was the presenting symptom in 33% of the patients, 
and a similar percentage of the patients indicated that fatigue was the most troubling 
symptom * In view of the fact that fatigue is a frequent symptom in MS, it is 
surprising that it has received little attention in research Multiple sclerosis is an 
inflammatory disease of the central nervous system It is therefore reasonable to 
assume that fatigue in MS is related to somatic processes, but evidence for this 
hypothesis is lacking The role of psychological factors with respect to fatigue in MS 
is also unclear 
This lack of clarity may be attributable in part to the fact that fatigue has been 
notoriously difficult to define or measure 5 In a study of patients with chronic fatigue 
syndrome (CFS), we found that different dimensions of fatigue could be discerned 
subjective feeling of fatigue, psychological well-being, functional impairment, level 
of physical activity, sleep problems, social functioning, neuropsychological 
functioning, attributions with respect to the causes of complaints, and sense of 
control over symptoms (self-efficacy expectations) 5 These dimensions were shown 
to be relatively independent Thus, each dimension provides a unique contribution to 
the description of the patient Comprehensive assessment of fatigue should therefore 
entail multidimensional assessment Studies using only questionnaires such as the 
Fatigue Seventy Scale do not provide a comprehensive assessment of fatigue, as the 
dimension subjective feeling of fatigue is the only dimension measured 
In understanding fatigue in MS, patients with CFS may serve as a useful 
comparison group for 2 major reasons (1) fatigue is the key symptom in CFS and 
(2) there are indications that avoidance of physical activity, depression, and 
cognitions and attributions can perpetuate fatigue in CFS 6 7 Patients with CFS avoid 
physical activity5 because in their view activity causes symptoms This avoidant 
behavior in tum leads to more symptoms through physical deconditioning Patients 
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with CFS attribute their symptoms to an organic cause and show a resistance to 
psychosocial interpretations of the complaints 5 810 Attributing complaints to an 
organic cause may reinforce the idea that physical activity is harmful Depression 
may develop as a result of prolonged disability and feelings of helplessness with 
respect to controlling complaints 6 7 Since depressed patients have low levels of 
physical activity, depression may contribute to the establishment of low levels of 
physical activity Depression may also directly produce fatigue In a longitudinal 
study, we found that cognitions concerning subjective sense of control over 
symptoms are a powerful predictor of fatigue and chronicity in CFS " It would be 
most valuable to investigate whether these psychological factors are involved in 
fatigue in MS as well 
In the present study, patients with MS were compared with patients with CFS 
and healthy subjects to evaluate the status of the dimensions in MS and to evaluate 
the relationships between the dimension of subjective fatigue and the other 
dimensions 
Method 
PATIENTS 
Fifty patients with clinically definite MS12 participated in this study (chronic 
progressive, n=19, relapsing remitting, n = 31) All patients were mobile The mean 
Kurtzke Expanded Disability Status Scale (EDSS)13 score was 2 8 (range, 1-6) 
Seventy-five percent of the patients had EDSS scores between 2 and 3 5 
Fifty-one patients with chronic subjective fatigue were randomly selected from 
our CFS database, acquired by referral to the General Internal Medicine outpatient 
clinic of the University Hospital Nijmegen, Nijmegen, the Netherlands by a family 
physician or specialist and by self-referral These patients had have to experienced 
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disabling fatigue for at least 6 months for which no somatic explanation could be 
offered and that did not subside with bedrest u Fifty-three healthy subjects were 
selected through a regional newspaper advertisement All patients participating in 
this study underwent a full physical examination and a standard neurologic 
examination at the beginning of the study and, if indicated, further technical 
investigations Patients with MS and healthy subjects were matched to the patients 
with CFS in regard to age, sex, and educational level The study was approved by 
the ethics committee of our hospital and patients gave their informed consent 
INSTRUMENTS 
In a previous study, we developed a multidimensional fatigue assessment method 5 
In the present study, these dimensions were measured by questionnaires and by a 
self-observation list and a Sleep Pattern Observation List over a 2-week period For 
all instruments, high scores indicate nonfavorable functioning 
Subjective fatigue Subjective fatigue was measured by the Subjective Fatigue 
subscale of the Checklist Individual Strength (CIS) 5 On the self-observation list, 
subjective fatigue was measured 4 times a day on a 4-point scale (Daily Observed 
Fatigue score) 
Other complaints Other complaints were assessed by the Complaints Probing 
List, in which specific complaints were rated on a 4-point scale as follows 1, never 
present, 2, several times a month, 3, several times a week, 4, every day 
Psychological well-being The Beck Depression Inventory (BDI)1516 is a 
standardized self-report questionnaire for measuring depression Subjective fatigue 
was excluded as a symptom The Symptom Checklist (SCL)17 is an indicator of 
psychological disturbances 
Impairment in daily life The Sickness Impact Profile (SIP)18 " measures the 
influence of complaints in different areas of daily functioning On the self-
observation list patients indicated 4 times a day whether they had failed to perform 
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activities as a result of fatigue. 
Level of physical activity. The Physical Activities subscale of the CIS and the 
Mobility subscale of the SIP measure the level of physical activity. On the Physical 
Activities Rating Scale, patients indicated if they had engaged in 20 different 
activities ("never", "rarely", "now and then", "often", "very often"). On the self-
observation list, level of physical activity was rated daily on a 7-point Likert scale 
(Daily Observed Activity score). 
Causal attributions. Each patient's opinions concerning the causes of the 
complaints were measured with the Causal Attributions List. Eight possible causes 
of the complaints were presented. Patients could indicate on a 5-point Likert scale if 
they agreed or disagreed with each cause. There are 2 subscales: "Physical" and 
"Psychosocial" (Cronbach's alpha reliability coefficient was .71 and .75 
respectively). 
Sense of control over symptoms. The subjective sense of control over symptoms 
was measured by a specific 5-point scale question ("do you think you can influence 
your complaints?") and selected items of the modified Pain Cognition List.20 The 
modification entails the replacement of the word pain by fatigue. Cronbach's alpha 
reliability coefficient for this scale was .74. 
Neuropsychological functioning. The dimension of neuropsychological 
functioning was measured by the Concentration subscale of the CIS and the SIP. 
Social functioning. For social functioning, general questions were asked 
concerning satisfaction in social life and problems in social relations. The Social 
Interactions subscale of the SIP was also included. 
Sleep disturbances. On the self-observation list, quality of sleep ("slept well", 
"problems falling asleep", "restless sleep", "early awakening in the morning") was 
recorded daily (Daily Observed Quality of Sleep scores). A special Sleep Pattern 
Observation List was completed in combination with the self-observation list. The 
patient recorded daily every 30 minutes if resting or asleep. The following 
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parameters were calculated over the 12-day period: hours asleep at night, hours 
asleep during the day, hours awake before falling asleep, hours awake during the 
night, hours resting after waking up in the morning, and hours resting during the 
day (Daily Observed Sleep Pattern scores). 
Information was collected concerning age, sex, education, premorbid and 
current occupational situation, and duration of complaints. Education level was 
determined by a Dutch standardized scoring system (range, 1-7), which is especially 
applied in research. On the self-observation list, patients reported once a day the 
hours spent on occupational activities. 
DATA ANALYSIS 
Logarithmic transformations were performed on variables with a skewness of more 
than 1. The analysis of differences between groups on nominal variables was carried 
out with the χ2 test and on ordinal variables with the Mann-Whitney test. In these 
tests, Bonferoni correction for multiple comparisons was applied. Because there 
were 3 experimental groups, 3 comparisons were made. Assuming a significance 
level of .05, a difference was considered significant if the Ρ value was less than .02. 
The analysis of differences between groups on ratio variables was performed by 
analysis of variance. Multiple comparisons were made by Duncan multiple range 
tests. Unless stated otherwise, reported significant differences refer to Duncan 
multiple range test with a Ρ value of less than .05. The relationship between 
subjective fatigue and other dimensions was evaluated by χ2 tests in the case of 
nominal and dichotomous variables. For other variables, the Pearson correlation 
coefficient was used. To control the type I error due to multiple correlations, only Ρ 
values of less than .01 were considered significant. 
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17 (34) 
33 (66) 
35 8(19 56) 
3 6 (3 6) 
5 (0 5-22) 
12 (24) 
39 (76) 
36 3(19-54) 
4 2 (3 7) 
5 (1-48) 
13(24) 
40 (76) 
37 1 (19 63) 
4 3 (3 7) 
Table 1: Characteristics of50 patients with multiple sclerosis (MS), 51 patients 
with chronic fatigue syndrome (CFS), and 53 healthy subjects ' 
MS CFS Healthy 
Sex, No (%) 
M 
F 
Mean age (range), y 
Mean education (range) t 
Median duration of 
complaints (range), y 
Ellipses indicate data not applicable 
t Education level was determined according to a Dutch standardized 
scoring system (range, 1-7) 
Results 
DEMOGRAPHICS 
Information on age, sex, education, and duration of complaints are summarized in 
Table 1 There were no significant differences between groups in these variables 
There were also no significant differences in premorbid or current occupational 
situation between patients with MS and patients with CFS (Table 2) Compared with 
healthy subjects, significantly more patients with MS received disablement insurance 
benefits (P< 001) and significantly more CFS were on sick leave (P= 003) or 
received disablement insurance benefits (P= 0001) Results of the self-observation 
list show that the patients with MS who indicated that they had been working 
worked an average of 2 7 d/wk (range, 0 5-4 5 d/wk) for 5 3 h/d (range, 1-10 h/d) 
Patients with CFS who had jobs worked an average of 2 2 d/wk (range, 0 5-5 d/wk) 
for 4 1 h/d (range, 15-11 5 h/d) 
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Table 2: Occupational situation before onset of complaints and current occupational situation 
of patients with multiple sclerosis (MS), patients with chronic fatigue syndrome (CFS), and 
healthy subjects. 
No. (%) 
MS CFS Healthy 
Working 
Housekeeping 
Unemployed 
Retired 
Disablement insurance 
Before 
Onset 
35 (70) 
0(0) 
12 (24) 
0(0) 
0(0) 
Current 
14 (28) 
15 (30) 
3(6) 
1(2) 
11(22) 
Before 
Onset 
37 (72) 
0(0) 
7(14) 
0(0) 
0(0) 
Current 
14 (27) 
9(18) 
3(6) 
0(0) 
13 (25) 
Current 
25 (47) 
14 (26) 
3(6) 
2(4) 
0(0) 
benefits 
Sick leave 0 (0) 5 (10) 0 (0) 10 (20) 1 (2) 
School 3 (6) 1 (2) 7 (14) 2 (4) 8 (15) 
Healthy subjects who had been working worked on average 3.2 d/wk (range, 0.5-6 
d/wk) for 6.2 h/d (range, 2-11 h/d). There was a significant difference between 
patients with CFS and healthy subjects with respect to how many hours they worked 
per day (P = .001). In both patient groups there was no relationship between 
subjective fatigue and any demographic variable. 
DIMENSIONS 
Subjective fatigue and other complaints. 19 (39%) of patients with MS reported 
fatigue to be present several times a week (CFS, 13 [26%]; healthy, 8 [15%]), and 
23 (46%) reported fatigue to be present every day (CFS, 38 [74%]; healthy, 0). 
Results on the Complaints Probing List (Table 3) show that there is a considerable 
overlap in symptoms between patients with MS and patients with CFS. Scores on the 
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Table 3: Prevalence of complaints based on the Complaints Probing List of patients with 
multiple sclerosis (MS), patients with chronic fatigue syndrome (CFS), and healthy subjects' 
MS CFS Healthy P-value (χ2) 
MS/CFS 
Fatigue 
Sleep problems 
post exertional malaise 
Myalgia 
Muscle weakness 
Headache 
Dizziness 
Memory problems 
Concentration problems 
Sore throat 
Tender lymph nodes 
Arthralgia 
Irritability 
Depressed mood 
85t 
34 
34t 
39t 
49t 
39t 
15t 
45t 
46t 
3 
0 
30 
39t 
29| 
loot 
59t 
68Î 
85t 
69Ϊ 
ЗЗф 
41t 
69t 
74t 
18 
21* 
49t 
31t 
18 
13 
15 
0 
6 
2 
6 
0 
4 
6 
4 
2 
9 
4 
6 
01 
03 
003 
001 
06 
60 
008 
03 
01 
02 
002 
04 
44 
23 
* complaints were rated present if they occurred at least several tunes a week 
t Significant difference compared with healthy subjects (P< 001 [χ2 test]) 
t Significant difference compared with healthy subjects (P < 02 [χ2 test]) 
CIS Subjective fatigue subscale and the self-observation list are presented in Table 4 
There were no differences in subjective fatigue scores between patients with chronic 
progressive MS and patients with relapsing-remitttng MS To evaluate whether 
fluctuations in subjective fatigue seventy exist over time, separate subjective fatigue 
severity scores were calculated for week 1 and for week 2 on the self-observation 
list The correlation between the scores for weeks 1 and 2 was r = 0 89 in patients 
with MS and r=0 88 in patients with CFS The mean difference in subjective fatigue 
severity between weeks 1 and 2 was 4% for patients with MS, 3% for patients with 
CFS, and 21% for healthy subjects These results indicate that, in contrast to healthy 
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Table 4: Results on subjective fatigue severity, physical activity, and neuropsychological 
functioning of patients with multiple sclerosis (MS), patients with chronic fatigue syndrome 
(CFS), and healthy subjects* 
Subjective fatigue: 
CIS 
Daily Observed Fatigue 
Physical activity: 
Daily Observed Activity 
Physical Activities 
Rating 
SIP-Mobility 
CIS-Activity 
Neuropsychological : 
CIS Concentration 
SIP Concentration 
MS 
5.4 + 1.3 
5.6 + 3.0 
3.7+1.1 
3.7+0.4 
5.3 + 8.2 
4.6 + 1.7 
4.1±1.9 
21.3±18.9 
CFS 
6.0±1.0 
7.9+2.4 
4.2+1.3 
3.9+0.4 
7.5 + 8.7 
4.8±1.7 
5.2±1.4 
35.0+18.7 
Healthy 
2.2+1.3 
1.6±1.4 
5.4+ 1.0 
2.8+0.5 
0.2±1.5 
17.4+4.5 
1.9+1.0 
1.1+0.3 
Duncan multiple 
MS/ 
CFS 
* 
* 
* 
ns 
ns 
ns 
* 
* 
range test 
MS/ CFS/ 
HS HS 
* * 
* * 
* * 
* * 
* * 
* * 
* * 
* * 
* CIS indicates Checklist Individual Strength (from Vercoulen et al.5); SIP, Sickness Impact 
Profile (from Bergner et α/.19 and Jacobs et al·9); and ellipses P< .05 
t Values are mean ± SD 
subjects, patients with MS and patients with CFS experience little short-term 
fluctuation in subjective fatigue severity over time. EDSS was not related to 
subjective fatigue in MS. 
Psychological well-being. Results on the SCL are displayed in Figure 1. Patients 
with MS had significantly lower scores than patients with CFS on the subscales 
Somatization and Cognitive Difficulties. On all other subscales, both patient groups 
had similar scores. When compared with healthy subjects, patients with MS and 
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35 
Symptom 
• CFS « MS H 
Figure 1: Symptom Checklist scores of patients with chronic fatigue syndrome (CFS), 
patients with multiple sclerosis (MS), and healthy subjects (H). Data were available on 
35 healthy subjects. ANX indicates anxiety; AGO, agoraphobia; DEP, depression; 
SOM, somatisation; COG, cognitive difficulties; SEN, interpersonal sensitivity; HOS, 
hostility, and SLP, sleep disturbances. 
patients with CFS did not have significantly different scores on interpersonal 
sensitivity. On the other subscales, the patients in both groups had higher scores than 
did healthy subjects. 
The mean+SD BDI score for patients with MS was 10.0±6.5 and 10.8±4.7 for 
patients with CFS, which was not significantly different. The mean+SD BDI score 
of healthy subjects was 2.7+3.7, which was significantly lower than the scores in 
the two patient groups. Using a BDI cutoff score of 16 or above, 8 (17%) patients 
with MS, 8 (16%) patients with CFS, but no healthy subjects had current 
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depression Depression is thought to be a result of a prolonged disability or loss of 
sense of control over symptoms However, in both patient groups, the BDI score 
was related only to the SIP Social Interactions subscale (CFS, r=0 41, MS 
r=0 68), not to any other measure of impairment in daily life, duration of 
complaints, or sense of control Depression is also hypothesized to cause subjective 
fatigue directly or through producing low levels of physical activity No evidence 
was found for these associations in MS or in CFS In patients with MS and in 
patients with CFS, subjective fatigue severity was related to the Somatization 
subscale of the SCL (r=0 43 and r=0 48, respectively) 
Impairment in daily life On the self-observation list, patients with MS reported 
less often than patients with CFS that they had failed to perform activities as a result 
of the complaints (Daily Observation Impairment score, 46 0 and 23 9, respectively, 
P= 001) Results on the SIP are displayed in Figure 2 Patients with MS had 
significantly lower scores than patients with CFS on the subscales Activities at 
Home, Social Interactions, Concentration Problems, and Recreation and Pastimes 
On all subscales, patients with MS and patients with CFS had higher scores than 
healthy subjects In patients with MS and in patients with CFS, CIS Subjective 
Fatigue subscale was related to Activities at Home (r=0 51 for both groups) and 
Recreation and Pastimes (r=0 42 and r=0 44, respectively) On the self-observation 
list, the Daily Observed Fatigue score was related to the Daily Observed Impairment 
Score in MS (r=0 40) and in CFS (r=0 63) 
Level of physical activity Results on physical activity are presented in Table 4 
In CFS, evidence was found for the relationship between level of physical activity 
and physical attributions (physical attributions with Mobility, r=0 35) and between 
subjective fatigue and physical activity CIS Subjective Fatigue with Mobility of the 
SIP (r=0 47), Physical Activity of the CIS (r=0 52), the Physical Activities Rating 
List (r=0 35), and the Daily Observed Activity Score (r=0 34) In MS no such 
relations were found 
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SR PC HM MOB SI WLK CON W RP 
Area of Daily Functioning 
• CFS — — — MS · H 
Figure 2: Sickness impact Profile scores of patients with chronic fatigue syndrome 
(CFS), patients with multiple sclerosis (MS), and healthy subjects (H). SR indicates 
sleep/rest; PC, personal caretakjng; HM, activities at home; MOB, mobility; SI, social 
interactions; WLK, walking; CON, concentration; W, work; and RP, recreation and 
pastimes. 
Attributions regarding the causes of the complaints. The patients' opinions 
concerning the causes of the complaints are presented in Table 5. 15 (30%) patients 
withMS named at least one psychosocial cause compared with 7 (14%) patients with 
CFS (χ 2 test, P = . 0 4 ) . 44 (88%) patients with MS and 40 (78%) patients with CFS 
named at least one physical cause, which was not significantly different. There were 
no significant differences between both patient groups in total scores regarding 
physical attributions and psychosocial attributions. To evaluate whether there is a 
resistance to psychosocial interpretations of the complaints, correlations between 
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Table 5: Patients' opinions regarding the causes of the complaints 
(percentage agreed). 
Causes 
Psychosocial: 
Work situation 
Home situation 
Life too busy 
Childhood 
Worry too much 
Physical: 
Virus 
Physical abnormalities 
Physical disease 
MS 
2 
4 
17 
4 
33 
22 
83 
82 
CFS 
4 
0 
6 
8 
4 
43 
75 
49 
P(X2) 
.60 
.14 
.09 
.44 
0.002 
0.03 
.28 
0.001 
psychosocial attributions and measures of psychological well-being (total scores on 
the BDI and the SCL) were calculated. In CFS, there were no significant 
correlations between these variables. In MS, on the other hand, attributing 
complaints to psychosocial causes was related to high total scores on the BDI 
(r = 0.52) and the SCL (r = 0.64). 
Sense of control over symptoms. There were no significant differences in sense 
of control over symptoms between patients with MS and patients with CFS. Based 
on the sense of control question, 19 (38%) patients with MS and 12 (24%) patients 
with CFS were convinced that they could influence their complaints. Sense of 
control was related to subjective fatigue severity in MS and in CFS (r=0.41 and 
r = 0.38, respectively). 
Neuropsychological functioning. In patients with MS, the prevalence of self-
reported concentration problems was significantly lower than in patients with CFS 
(23 [46%] vs 38 [74%]), but there were no significant differences in the prevalence 
of self-reported memory problems (22 [45%] vs 35 [69%]) (Table 3). In both patient 
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groups, these prevalence rates were significantly higher than in healthy subjects 
These findings were confirmed by results on the CIS and SIP Concentration 
subscales (Table 4) There was no relationship between subjective fatigue severity 
and memory and concentration problems on any instrument in MS or CFS 
Social fitnctiomng 11 (21%) patients with MS reported difficulties with social 
relations (CFS, 13 [16%], healthy, 10 [19%]) and 5 (10%) patients reported to be 
dissatisfied with social functioning (CFS, 9 [18%], healthy, 5 [9%]) There were no 
significant differences in these variables between the 3 groups On the Social 
Interactions subscale of the SIP (see "Impairment in Daily Life" section), both 
patient groups had abnormal scores There was no relationship between subjective 
fatigue and any social functioning variable in MS or in CFS 
Sleep problems For self-reported prevalence rates of sleep problems see Table 
3 There was no significant difference between patients with MS and patients with 
CFS in the SCL Sleep Disturbances subscale, but patients in both groups scored 
higher than healthy subjects (Figure 1) Results on the self-observation list on the 
Sleep Pattern Observation List are presented in Table 6 In both patient groups, 
subjective fatigue was not related to any variable measuring aspects of sleep 
Comment 
The main aims of the present study were to better characterize fatigue in patients 
with MS and to investigate the relationships between the subjective experience of 
fatigue and impairment in daily life, depression, level of physical activity, cognitions 
and attributions, sleeping problems, and neuropsychological complaints 
The present study shows that fatigue in MS is a serious problem Almost half of 
the patients reported that they felt fatigued every day, and fatigue was present in 
85% of the patients at least once a week Also, the patients with MS experienced 
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Table 6: Results of patients with multiple sclerosis (MS), patients 
sundrome (CFS), and healthy subjects (HS) on the self-observation list 
Quality scores) and Sleep Pattern Observation list (Daily Observed 
(mean ± SD) 
with chronic fatigue 
(Daily Observed Sleep 
Sleep Pattern scores) 
Daily Observed Quality of Sleep 
Slept well 
Problems falling asleep 
Restless sleep 
Early awakening 
Daily Observed Sleep Pattern 
Hours asleep at night 
Hours awake before sleep 
Hours awake during the night 
Hours staying in bed after 
sleep at night 
Hours asleep during the day 
Hours rest during the day 
MS 
64±26 1 
27±19 3 
26±22 7 
21 ±24 1 
7 6±1 0 
0 6 ± 0 6 
0 4 ± 0 4 
0 4 ± 0 4 
0 4 ± 0 5 
0 5 ± 0 5 
CFS 
56±30 4 
28±23 3 
29±23 9 
16±23 1 
8 0 + 1 7 
0 8 ± 0 7 
0 4 + 0 5 
0 5 ± 0 4 
0 7 ± 0 9 
1 1±1 2 
HS 
77±15 5 
20±20 5 
12±9 9 
16±8 2 
7 5 ± 0 7 
0 4 ± 0 3 
0 1±0 1 
0 3±0 3 
0 2 ± 0 3 
0 2 ± 0 3 
Duncan Multiple 
MS/ 
CFS 
20 
49 
76 
27 
13 
11 
64 
54 
range test 
MS/ 
HS 
27 
09 
99 
13 
27 
CFS/ 
HS 
83 
05 
14 
09 
* Values are mean ± SD 
t Ellipses indicate ρ < 05 
$ Mean percentage of occurrence 
high fatigue seventy levels, almost as high as those of the patients with CFS 
Furthermore, in a 2-week period, subjective fatigue seventy was shown to be stable 
over time and was closely related to impairment in daily life 
Although problems in occupational situation were marked, which was most 
apparent from the substantial number of patients who were on sick leave or received 
disablement insurance benefits, occupational situation was not related to the level of 
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subjective fatigue This finding might suggest that fatigue is not a problem that is 
serious enough to cause a patient with MS to quit his job However, in patients with 
CFS, the key symptom of fatigue caused a similar percentage of patients to be on 
sick leave or to receive disablement insurance benefits, and in this group there was 
also no relationship between the level of subjective fatigue and occupational 
situation 
With respect to the hypothesized role of psychological factors involved in the 
perpetuation of complaints, as outlined in the introduction, it can be concluded that 
patients with MS and patients with CFS have similar profiles of depression, physical 
activity, sense of control over symptoms, and causal attributions Regarding the 
relationships between the relevant dimensions, several findings indicate similarities, 
but also differences, between patients with MS and patients with CFS with respect to 
the processes involved in the experience of fatigue 
First, sense of control appears to play an important role in subjective fatigue in 
CFS as well as in MS In the present study, sense of control was closely related to 
subjective fatigue in both patient groups In a prospective study on the natural course 
in CFS, we found that a low sense of control was the strongest predictor of 
chromcity and a determinant of high subjective fatigue severity " 
Second, present data do not support the hypothesized role of depression in 
fatigue in MS or in CFS No evidence was found in either patient group for the 
hypothesis that depression may develop as a result of prolonged disability or 
perceived helplessness in controlling complaints Also, the BDI score was not 
related to subjective fatigue in MS or in CFS 
Third, results with respect to the Somatization subscale of the SCL are of 
interest It has been shown that, although there is psychological disturbance, this in 
general is of only mild severity and not as severe as in psychiatric patients 5 2122 In 
the present study, patients with MS and patients with CFS showed a similar profile 
on all measures of psychological well-being, with the exception of the SCL 
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Somatization subscale On this scale, patients with MS scored intermediately 
between healthy subjects and patients with CFS In a previous study, we found that 
patients with CFS had somatization scores similar to those of psychiatric 
outpatients 3 These results may indicate the presence of somatization disorder in 
CFS, which represents psychological disturbance expressed in multiple physical 
symptoms Against this hypothesis argue the findings that psychological disturbance 
in patients with CFS, as measured with the other SCL subscales and the BDI, was 
moderate and similar to that in patients with MS In addition, other investigators 
have found the prevalence of somatization disorder in patients with CFS to be quite 
low (15 %)2324 and similar to that in other patient groups2527 Another interpretation 
of high somatization scores on the SCL may be that patients are highly tuned in to 
bodily sensations Considering the close relationship between the SCL Somatization 
subscale and the CIS Subjective Fatigue subscale in CFS ás well as in MS, focusing 
on bodily sensations may play a role in the experience of fatigue in both patient 
groups This process appears to be most pronounced in CFS 
Fourth, patients with CFS and patients with MS showed significantly lower 
levels of physical activity than healthy subjects However, the level of physical 
activity was related to subjective fatigue and causal attributions in CFS but not in 
MS 
Finally, patients with MS and patients with CFS did not differ in total scores in 
regard to causal attributions However, when the context in which such attributions 
are made is considered, it can be seen that there are differences between both 
groups In MS, there is a somatic substrate, which generally is presented to the 
patient as "probably related to a viral infection " In CFS, on the other hand, no 
somatic cause is established Yet, the vast majority of patients with CFS named at 
least one physical cause and significantly more often than patients with MS indicated 
that a virus was responsible for their complaints Furthermore, psychosocial 
attributions were more common m patients with MS than m patients with CFS, and 
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these attributions were related to measures of psychological well-being in patients 
with MS but not in patients with CFS. These findings suggest that patients with MS 
are more open to psychosocial explanations of the complaints than are patients with 
CFS, who show a strong resistance to this type of explanation, as has been 
documented previously.5·810 Causal attributions thus appear to play a different role in 
CFS than in MS. 
In contrast to what was expected, EDSS scores were not related to subjective 
fatigue in MS. This finding would suggests that subjective fatigue in MS is not 
related to the disease activity. 
Two methodological issues need to be addressed. First, in the MS sample, the 
majority of patients were only mildly affected as measured by the EDSS. It is 
unclear whether in more severely affected patients with MS fatigue would be even 
more severe or whether the relationships between subjective fatigue and measures of 
the somatic substrate, physical activity, and attributions would yield different 
results. Second, in the present study, the EDSS was the only parameter reflecting 
somatic disturbance in MS. Future research should incorporate more explicit 
measures of the somatic substrate, notably magnetic resonace imaging. 
Present findings indicate that fatigue is a serious problem in MS and provide a 
basis for future research. A multi-dimensional approach proves to be a valuable 
method for assessing fatigue, not only to characterize fatigue, but also to identify 
processes that may contribute to the subjective experience of fatigue. An important 
finding of the present study is that psychological factors, such as sense of control 
and focusing on bodily sensations, seem to play a role in the subjective experience 
of fatigue in MS. At present, no effective somatic treatment for fatigue exists. The 
recognition that psychological factors may be involved in the experience of fatigue 
opens possibilities for psychotherapeutic interventions. 
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The persistence of fatigue in chronic fatigue syndrome 
Abstract 
Objective The cause of chronic fatigue syndrome (CFS) is unknown With respect 
to factors perpetuating fatigue, on the other hand, a model has been postulated in the 
literature in which behavioral, cognitive, and affective factors play a role in 
perpetuating fatigue In the present study this hypothesized model was tested in 
patients with CFS and in fatigued patients with multiple sclerosis (MS) 
Method 51 patients with chronic fatigue syndrome and 50 patients with multiple 
sclerosis matched for age, sex, and education The hypothesized model was 
formulated in terms of cause and effect relationships and an integral test of this 
model was performed by the statistical technique "structural equation modeling" 
Results Attributing complaints to a somatic cause produced low levels of physical 
activity, which in turn had a causal effect on fatigue severity In contrast, depression 
had to be deleted from the model Two new causal relationships were found sense 
of control over symptoms and focusing on bodily symptoms each had a direct causal 
effect on fatigue The model showed excellent fit for CFS patients, but was rejected 
for MS patients Therefore, a new model for MS patients had to be developed 
Sense of control had a causal effect on fatigue In the MS model no causal 
relationship was found between the somatic substrate as measured by the Expanded 
Disability Status Score and fatigue or functional impairment Causal attributions, 
low level of physical activity, and focusing on bodily symptoms played an important 
role in the persistence of fatigue in CFS, but not in MS 
Conclusions The etiology of CFS is unknown, but the present study shows that 
cognitive and behavioral factors are involved in the persistence of fatigue Treatment 
should be directed at these factors The processes involved in the subjective 
experience of fatigue in CFS were different from the processes related to fatigue in 
MS 
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Introduction 
Doctors dealing with patients with chronic fatigue syndrome (CFS) encounter 
significant problems and uncertainties no somatic cause can be established, no 
scientifically sound diagnostic test is available, and a somatic treatment is lacking 
Considering these uncertainties many doctors are reluctant making the diagnosis 
CFS The patient, on the other hand, is very persistent in obtaining a diagnosis and a 
somatic explanation for his complaints 
The etiology of CFS is unknown With respect to factors perpetuating 
complaints, in the literature a model has been proposed in which behavioral, 
cognitive, and affective factors perpetuate fatigue ' 3 According to this model, 
patients with CFS tend to avoid physical activity because in their view activity 
causes symptoms, such as fatigue and myalgia This avoidant behavior, in fact, leads 
to more symptoms through physical deconditioning In addition, these patients 
attribute complaints to a somatic cause and show strong resistance to psychosocial 
explanations 4 8 Attributing complaints to an organic cause may reinforce the idea 
that physical activity is harmful and thus may cause avoidance of physical activity 
Attributing complaints to a somatic cause may also lead to low sense of control over 
symptoms which in tum may produce mood disorder Since depressed patients are 
known to be inactive, depression may contribute to producing low levels of physical 
activity Depression may also produce fatigue directly 
Support for this model can be found in prospective studies and cognitive-behavioral 
treatment (CBT) programs2 813 These studies, however, can provide only 
circumstantial evidence as the model was not tested integrally and because these 
studies were not specifically concerned with evaluating the causal direction of 
relationships Also, one of the reported CBT treatment programs was uncontrolled 2 
In the present study, an integral test of this model was performed using the 
statistical technique "structural equation modeling", also referred to as "causal 
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modeling" This technique is often used to test a theory about relationships between 
theoretical constructs 14 These analyses improve the ability to make causal inferences 
about these relationships from non-expenmental data " 
In a previous study we found a close relationship between fatigue on the one 
hand and sense of control and focusing on bodily symptoms on the other 16 In 
addition, in a longitudinal study of our research group we found that sense of control 
was a powerful predictor of fatigue severity and chronicity 8 These findings are not 
specified in the initial model Therefore, after the testing of the initial model we 
attempted to extend the model with respect to these findings 
In developing a model for CFS patients with MS are a useful comparison group 
as in MS fatigue is a frequent and prominent symptom 816"19 In a previous study we 
have performed a detailed multi-dimensional assessment of CFS patients and 
fatigued MS patients, measuring cognitive, emotional, behavioral, and social 
functioning 16 We found similar profiles on physical activity, depression, causal 
attributions, and sense of control over symptoms in CFS and MS To evaluate the 
specificity of the final model to CFS, this model also will be tested on the data of 
patients with multiple sclerosis (MS) 
Method 
PATIENTS 
Fifty-one patients with CFS fulfilling criteria for CFS20 and fifty patients with a 
clinically definite diagnosis of MS21 who reported fatigue (chronic progressive 
course N = 19, relapsing remitting course N = 31) participated in this study Mean 
Expanded Disability Status Score (EDSS)22 was 2 8 (range =1-6) Both patient 
groups were similar with respect to age, sex, educational level, and duration of 
complaints (see Table 1) All patients participating in this study received full 
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Table I: Age, education, sex, and duration of complaints of 51 patients with CFS 
and 50 patients with MS There were no significant differences on any variable 
Sex 
Age (yrs ) 
Education* 
Complaints 
duration (yrs ) 
male 
female 
mean 
range 
mean 
range 
median 
range 
CFS 
12 (24%) 
39 (76%) 
36 3 
19-54 
4 2 
3 7 
5 
1 48 
MS 
17 (34%) 
33 (66%) 
35 8 
19-56 
3 6 
3-6 
5 
0 5-22 
* Based on Dutch standardized scoring system for research purposes 
(range 1 'no education' to 7 'university') 
physical examination and standard neurologic examination at the start of the study 
and, if indicated, further clinical and laboratory investigations Educational level 
was determined by a Dutch standardized scoring system which is especially applied 
in research (range 1 'no education' to 7 'university') A detailed description of 
these patients can be found elsewhere 16 
INSTRUMENTS 
A detailed description of the instruments used can be found elsewhere " '6 In short, 
the relevant dimensions are measured by the following instruments 
Subjective fatigue The subjective feeling of fatigue was measured by the 
subjective fatigue subscale of the fatigue questionnaire Checklist Individual Strength 
(CIS) 4 
Depression The Beck Depression Inventory (BDI)2324 is a standardized self-
report questionnaire to measure depression Fatigue was excluded as a symptom 
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Focusing on bodily symptoms Of the Symptom Checklist (SCL-90-R)25 the 
subscale somatization (SCL-SOM) was used 
Functional impairment Of the Sickness Impact Profile26 2? the subscale problems 
with activities at home (SIP-HM) was used to measure impairment in daily life 
Level of physical activity This dimension was measured by SIP subscale 
mobility (SIP-MOB) and the Physical Activities Rating Scale (PARS) On the latter 
scale 20 different activities were rated on a 5-point scale (never - rarely - now and 
then - often - very often) 
Causal attributions The patient's opinions concerning the causes of the 
complaints were measured with the Causal Attributions List In the present study the 
subscales "physical" and "psychosocial" causes were combined into one total score 
High scores indicate physical attributions low scores indicate psychosocial 
attributions 
Sense of control over symptoms Perceived sense of control over symptoms was 
measured by a specific 5-point scale question and selected items of the modified Pain 
Cognition List (mPCL) 28 
SiATisTiCAL ANALYSES 
Logarithmic transformations were performed on variables with a skewness of more 
than 1 To develop a model for the perpetuation of fatigue in CFS, we followed the 
'model generating' approach described by Joreskog & Sorbom 14 In this approach 
the theoretical model that is initially tested is not assumed to hold exactly in the 
population, but may only be tentative When the initial model is rejected, it can be 
modified and the resulting model can be tested again 
The cause and effect relationships of the initial model were defined according to 
the hypothesized model described in the introduction For this model a set of 
structural equations was formulated, with unknown parameters representing the 
regression coefficients between the variables These equations take the form of 
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Y=b1X,+b2X2 +e, in which Y represents a criterion variable, X, and X2 represent 
the predictor variables, b, and b, represent the unknown regression coefficients, and 
e represents the error of prediction The LISREL 8 0 program14 was used for 
estimating the unknown regression parameters based on the correlations between the 
variables under study The Maximum Likelihood method of estimation was used 
The next step is to test the model as a whole (ι e the Goodness of Fit) using two 
criteria The first is the Chi2 statistic which is a measure of whether the residual 
correlations obtained by comparing the observed and predicted values differ from 
zero
 29
 If the Chf is small in reference to the degrees of freedom the statistic is not 
significant and the model is considered to be a plausible representation of the causal 
processes in the underlying data 15 As the Chf statistic depends on the sample size, 
which is relatively small in the present study, the second criterion is the Adjusted 
Goodness of Fit Index 3 0 This is a measure for the relative amount of variances and 
covanances jointly accounted for by the model, adjusted for the degrees of freedom 
This index can assume a value between zero and 1 and is independent of sample size 
and relatively robust against departures from normality As the distribution of this 
index is unknown there is no standard for comparison Taking into account the 
advantages and disadvantages of both parameters, the model was said to fit the data 
if the Chi2 statistic was not significant (p>0 05) and the Adjusted Goodness of Fit 
Index was high (preferably above 90) We also took into account the Population 
Error of Approximation (expressed as the Root Mean Square Error of 
Approximation) which is a measure of the degree to which the model holds in larger 
samples (ι e is a measure of generahsabihty) Values up to 0 05 indicate a close fit 
in larger populations and values up to 0 08 represent reasonable errors of 
approximation in the population 31 
The modification of the initial model was based on the t-values and the 
modification indexes provided by the LISREL-program The t-value indicates 
whether a relationship specified in the model is significant A nonsignificant 
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relationship should be deleted. For each possible relationship a modification index is 
calculated measuring how much the Chi-square is expected to decrease when this 
relationship would be introduced into the model. In this way new causal 
relationships can be identified that improve the model. In addition, the modifications 
must be theoretically meaningful in order to avoid that the model is fitted to the 
data. To evaluate the specificity of the final model to CFS patients, it will also be 
tested on the data of MS patients. 
Results 
DEVELOPMENT OF A MODEL FOR CFS PATIENTS 
In Table 2 the correlation matrix is presented. The testing and modification of the 
model was a multi-stage process. Results for each stage are presented in Table 3. 
Stage 1. Following the hypotheses described in the introduction, the cause and 
effect relationships for the initial model (see Figure 1) were defined as going from: 
causal attributions to low sense of control; low sense of control to depression; causal 
attributions and depression to low level of physical activity; low level of physical 
activity and depression to fatigue. It is hypothesized that functional impairment is 
caused by fatigue, depression, and a low level of physical activity. Testing of the 
model revealed that the following relationships were not significant: depression to 
physical activity and to functional impairment; causal attributions to sense of 
control; sense of control to depression; and fatigue to functional impairment. The 
modification indexes suggested a new causal relationship from sense of control to 
fatigue. 
Stage 2. The model was modified according to stage 1 results and after 
subsequent testing the modification indexes suggested an additional relationship from 
focusing on bodily symptoms to fatigue. 
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Table 2: Correlation coefficients between variables eligible for the structural equation 
modeling of 51 CFS patients 
fatigue 
SOM 
BDI 
HM 
MOB 
PARS 
SCS 
CA 
fatigue 
1 00 
48 
30 
51 
47 
35 
38 
29 
SOM 
1 00 
23 
41 
19 
08 
26 
IO 
BDI 
1 00 
17 
20 
22 
Ol 
-08 
HM 
1 00 
68 
43 
12 
30 
MOB 
1 00 
50 
07 
42 
PARS 
1 00 
15 
19 
ses 
1 00 
12 
CA 
1 00 
Fatigue=CIS Subjective Fatigue, SOM=SCL-Somatization, BDI = Beck Depression 
Inventory, HM = SIP-Problems with Homemaking, MOB = SIP-Mobihty, PARS = Physical 
Activities Rating Scale, SCS = sense of control over symptoms, CA=Causal Attributions 
Table 3: Stages in LISREL analyses for CFS data (Chi2, degrees of freedom, p-value of Chi2 
Adjusted Goodness of Fit Index) 
STAGE Description of the model 
(added or deleted causal relations) 
Chi2 df ρ AGFI 
Stage 1 Testing of the initial model rejected 
Stage 2 Deleted fatigue to functional impairment, 
depression to fatigue, depression to physical 
activity, sense of control to depression, causal 
attributions to sense of control 
Added sense of control to fatigue 
Stage 3 Added focusing on bodily symptoms to 
fatigue 
Stage 4 Added focusing on bodily symptoms to 
functional impairment 
1181 11 0 38 0 85 
19 00 12 0 09 0 78 
12 11 11 0 36 0 85 
3 65 10 0 96 0 94 
168 
The persistence of fatigue in chronic fatigue syndrome 
Stage 3 After modifying the model, the modification indexes suggested to 
include a relationship from focusing on bodily symptoms to functional impairment 
Stage 4 Testing of the modifed model showed a good fit as the Adjusted 
Goodness of Fit Index was well above 90 and the Chi2 statistic was not significant 
The modification indexes did not suggest any new relationships Figure 2 presents 
the final CFS-model and Table 6 the summary statistics The Root Mean Square 
Error of Approximation (RMSEA) was less than 0 05 indicating a close fit for the 
model if tested in a larger sample 
DEVELOPMENT OF A MODEL FOR MS PATIENTS 
The correlation matrix is presented in Table 4 and the results for each stage of the 
modeling process are presented in Table 5 
Stage 1 The final model for CFS patients (Model 1) was tested on the data of 
MS patients This model was rejected as the Chi2 was significant and the Adjusted 
Goodness of Fit Index was low (Table 6 gives the summary statistics) 
Stage 2 For MS patients a new model had to be developed EDSS is an 
indicator of the somatic substrate in MS which can be expected to have a direct 
causal effect on level of physical activity, functional impairment, and fatigue 
Functional impairment is hypothesized to be caused by fatigue, low level of physical 
activity, and EDSS Considering the close relationship between sense of control and 
fatigue this relationship was also included Testing of the new model showed that the 
following relationships had to be deleted EDSS to fatigue, EDSS to functional 
impairment, and physical activity to functional impairment The modification 
indexes suggested a relationship from sense of control to physical activity 
Stage 3 After testing of the modified model, the modification indexes suggested 
an additional relationship going from sense of control to physical activity This 
model showed a good fit and the modification indexes did not suggest any new 
relationships 
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Table 4: Correlation coefficients between variables eligible for the structural equation 
modeling of 50 MS patients 
fatigue 
SOM 
BDI 
HM 
MOB 
PARS 
SCS 
CA 
EDSS 
fatigue 
1 00 
43 
20 
51 
11 
33 
41 
10 
01 
SOM 
1 00 
52 
32 
27 
06 
07 
-45 
-08 
BDI 
1 00 
22 
44 
12 
10 
-39 
07 
HM 
1 00 
27 
32 
19 
08 
05 
MOB 
1 00 
29 
31 
03 
38 
PARS 
1 00 
38 
10 
34 
ses 
1 00 
-02 
21 
CA 
1 00 
28 
EDSS 
1 00 
Fatigue=CIS Subjective Fatigue, SOM = SCL-Somatization, BDI = Beck Depression 
Inventory, HM = SIP-Problems with Homemaking, MOB = SIP-Mobihty, PARS = Physical 
Activities Rating Scale, SCS=sense of control over symptoms, CA=Causal Attributions, 
EDSS = Expanded Disability Status Score 
Stage 4 As depressed patients are fatigued and physically inactive (1), in the 
model, depression was defined as having a causal effect on fatigue and on physical 
activity Testing this model, the fit became weaker than in the stage 4 model and no 
other relationships regarding depression were suggested by the program Thus, 
depression was deleted from the model 
Stage 5 Considering the close relationship between fatigue and focusing on 
bodily symptoms in MS patients we found in a previous study (16), this variable was 
entered into the model and was hypothesized to have a causal effect on fatigue 
When tested, the fit was weaker than the fit of the stage 3 model Reversing the 
causal direction between fatigue and focusing on bodily symptoms would not result 
in a better fit Also, no other relationships including focusing on bodily symptoms 
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Table 5- Stages m LISREL analyses for MS data (Chi2, degrees of freedom, p-value of Chi2 
Adjusted Goodness of Fit Index) 
STAGE Description of the model 
(added or deleted causal relations) 
Chi2 df AGFI 
Stage 1 Testing of the CFS model rejected 
Stage 2 Testing of new MS model 
deleted EDSS to fatigue, EDSS to functional 
impairment, physical activity to functional 
impairment 
Added sense of control to fatigue 
Stage 3 Added sense of control to physical activity 
Stage 4 Added depression to fatigue, depression to 
physical activity 
Stage 5 Deleted depression to fatigue, depression to 
physical activity 
Added focusing on bodily symptoms to 
fatigue 
Stage 6 Deleted focusing on bodily symptoms to 
fatigue 
30 46 10 0 0007 0 62 
16 59 9 0 055 0 79 
8 84 8 0 36 0 86 
12 28 10 0 27 0 83 
18 53 11 0 07 0 76 
8 84 8 0 36 0 86 
Table 6: Summary statistics of Structural Equation Model ¡for CFS patients and Model 2 for 
MS patients 
N Chi2 df P-value RMSEA confidence 
interval of 
RMSEA 
Adjusted 
Goodness of 
Fit Index 
Model 1 
CFS 
MS 
Model 2 
MS 
51 3 65 10 0 96 0 00 
50 30 46 10 0 0007 0 20 
50 8 84 8 0 36 0 046 
0 0-0 0 
0 12-0 29 
0 0-0 18 
0 94 
0 62 
0 86 
RMSEA = Root Mean Square Error of Approximation 
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sense of 
control 
causal 
attributions 
• 
w 
\ 
v 
physical 
activity 
/ 
/ 
impairment 
FATIGUE 
η 
Figure 1: Hypothesized model (initial model) on factors perpetuating fatigue in CFS. 
were suggested by the program. Thus, focusing on bodily symptoms was deleted 
from the model. 
The model tested at stage 3 will be the final model for MS patients (Model 2, 
see Figure 3). This model showed an acceptable fit and the Root Mean Square Error 
of Approximation indicated a close fit when this model would be tested in a larger 
population, although the upper confidence limit was outside the close fit range (see 
Table 6 for summary statistics). 
Discussion 
In the present study a model has been developed on factors involved in the 
perpetuation of fatigue in CFS. This model showed a close fit to the underlying data. 
From this model it is clear that psychological factors are involved in the perpetuation 
of fatigue in CFS. 
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sense of 
control 
γ2,1=25 
causal 
attributions 
γ3.2= 44 
ß3 
physical 
activity 
1= 70 
* 
/ 
FATIGUE 
ik 
/ P2,3= 45 
γ2,3= 34 
γ1,3= 29 focussing on 
symptoms 
Figure 2: Structural equation model 1 for CFS patients including LISREL estimates. 
sense of 
control 
γ2,1 = 41 
impairment 
i 
Ρ 1,2= 5 
rr\ 1 IOVJC 
Figure 3: Structural equation model 2 for MS patients including LISREL estimates (EDSS= 
Expanded Disability Status Score). 
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In accordance with the model outlined in the introduction, in CFS, attributing 
complaints to a somatic cause had a direct causal effect on physical activity level, 
which in turn had a direct causal effect on fatigue. In a longitudinal study of our 
research group on the natural course of complaints in patients with CFS, it was 
shown that attributing complaints to somatic causes was associated with a negative 
course of the complaints.8 Other longitudinal studies have found similar results.910 
In contrast to the initial model, depression had to be excluded from the model 
altogether. This finding confirms results of three longitudinal studies in CFS, in 
which current depression did not predict improvement.81011 Sharpe et al.,9 however, 
did find such an association, but in their study depression was not measured 
prospectively. Also, in a controlled study of our research group fluoxetine - an 
antidepresant- did not have an effect on fatigue in patients with CFS fulfilling DSM-
III-R criteria for major depression.32 Taken together, these findings indicate that 
mood disorder is not an essential factor in the perpetuation of fatigue. In fact, in our 
fluoxetine study we also did not find an effect of fluoxetine on depressive symptoms 
in patients with CFS. This finding suggests that processes underlying depressive 
symptoms in CFS may be different from underlying processes in patients with a 
clinical depression.32 
The present model also contains two new variables, sense of control and 
focusing on bodily symptoms, which each have a direct causal effect on fatigue 
severity. Everybody experiences bodily sensations but usually does not take notice of 
them. CFS patients are highly tuned in to bodily symptoms and interpret these as a 
signal that there is something wrong with their body. The effect of this process is 
that these patients are more likely to experience high levels of fatigue. A more 
detailed account on the focusing on bodily symptoms in CFS can be found 
elsewhere.18 The role of sense of control in the subjective experience of fatigue 
supports results from our prospective study in which we found that sense of control 
predicted fatigue severity and chronicity.8 
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Somewhat to our amazement, the present study also shows that processes 
involved in the subjective experience of fatigue in CFS are clearly different from 
processes related to the subjective experience of fatigue in MS The model for CFS 
patients did not fit to the data of MS patients, for whom a new model had to be 
developed Causal attributions, low level of physical activity, and focusing on bodily 
sensations play an important role in the subjective experience of fatigue in CFS, but 
not in MS The only similarity between the MS model and the CFS model was the 
direct causal effect of sense of control on fatigue 
The MS model shows that in MS sense of control is not the result of 
neurological dysfunction itself as indicated by the EDSS Surprisingly, there also 
was no causal relationship between fatigue and neurological dysfunction Also, 
functional impairment was directly determined by fatigue, but not by EDSS With 
respect to the MS model, two methodological issues should be addressed which may 
have influenced results First, there may have been a selection bias as the present 
MS sample had relatively mild neurological dysfunction Stenager et al " found that 
the relationship between the Kurtzke Disability Status Score (DSS) and impairment 
in social and sparetime activities was most pronounced in patients with moderate 
disease activity Thus, it may be possible that in more severely affected MS patients 
the relationships between EDSS, fatigue, and functional impairment would be 
different Second, EDSS was the only measure reflecting somatic disturbance Our 
future research will include more severely affected MS patients as well as other 
measures of the somatic substrate in addition to EDSS, such as MRI Despite these 
limitations, the present study warrants further study of fatigue in MS as these 
patients experience significant fatigue16 " which affects daily functioning and is 
influenced by psychological factors that are not the result of disease activity itself 
The latter finding opens possibilities for therapeutic interventions, directed at 
increasing sense of control and by that reducing fatigue and functional impairment 
The strength of this study was that the model on the relationships between 
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behavior, affect, cognitions, and fatigue was formulated in terms of cause and effect 
relationships and that an integral test of this model was performed Three general 
remarks have to be made with respect to methodology First, our CFS patients had 
relatively long duration of complaints It is not clear whether the model would apply 
to patients with a short duration of complaints A second and related issue concerns 
the fact that the study was cross-sectional Although the statistical technique we 
used, "structural equation modeling", allows to make causal inferences from such 
data, the dynamics of the processes involved in fatigue may change in time For 
example, it is not known whether in the very early stages of the illness physical 
attributions are as strong as has been documented in patients with long duration of 
complaints, or whether there is avoidance of physical activity This time aspect 
could not be included into the present model Similar analyses based on data from 
longitudinal studies including patients with short duration of complaints are needed 
It is impentive to note that the present study does not claim that CFS is an 
entirely psychological condition The patient experiences genuine symptoms, but the 
fact that no somatic abnormalities can be found in patients with CFS has lead many 
professionals to conclude that the complaints "therefore must have" a psychological 
origin This Carthesian dualism nowadays has been refuted, especially by disciplines 
such as psychoneuroimmunology which have shown that psychological and somatic 
processes may interact in a complex manner What the present study does claim, 
however, is that although etiology of CFS is unknown psychological factors are 
involved in the persistence of fatigue It is these factors that can be influenced by 
specific cognitive-behavioral treatment directed at changing cognitions and 
attributions and increasing physical activity, with promising results 2 '213 
Patients with CFS are primarily seen by doctors (notably general practitioners 
and internists) These professionals can play a key role in whether the patient keeps 
on searching for somatic explanations (with resulting chronicity and high medical 
consumption) or whether the patient tries cognitive-behavior therapy In this context 
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it is essential that, while taking complaints seriously, addressing causal attributions 
should be the first step to take. Unless these attributions have changed, the patient 
will not be inclined to engage in any non-somatic treatment program and most 
certainly will not be willing to increase physical activity level. The patient should 
learn to accept that the original cause of the complaints is unknown and that a 
continuing search for medical explanations is not helpful but rather has a detrimental 
effect on complaints. Instead, it would be more worthwhile to try a treatment 
program which is directed at better coping with complaints which reduces symptoms 
and functional impairment. 
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The measurement of physical activity 
Summary 
This paper describes the assessment of physical activity in chronic fatigue syndrome 
(CFS) and investigated the following questions Do patients with CFS have low 
levels of physical activity, is there a relationship between actual level of physical 
activity and fatigue, can self-report measures adequately assess actual level of 
physical activity, what is the role of cognitions with respect to physical activity, and 
are results with respect to physical activity specific to CFS Three different types of 
activity measures were used self-report questionnaires, a 12-day self-observation 
lisi, and a motion-sensing device (Actometer) which was used as a reference for 
actual activity level Fifty-one patients with CFS, 50 fatigued patients with multiple 
sclerosis (MS), and 53 healthy subjects participated in this study Although none of 
the self-report questionnaires showed high correlations with the Actometer, 
questionnaires that require simple ratings of specified activities were related to the 
Actometer and can be used as acceptable substitutes, in contrast to instruments that 
require general subjective interpretations of activity that had low or non-significant 
correlations with the Actometer Actometer results showed that CFS patients and 
MS patients had similar activity levels and both groups were significantly less active 
than healthy subjects Compared to MS patients, CFS patients were more likely to 
indicate that they had been less active than other persons they knew Activities 
which patients expected to result in higher fatigue levels were less frequently 
performed Patients with CFS had significantly higher scores on this measure than 
MS patients and healthy subjects Low levels of physical activity were related to 
severe fatigue in CFS but not in MS In conclusion, although CFS patients have 
similar low activity levels than MS patients, there are also important differences 
between both groups in CFS cognitive factors are more prominently involved in 
producing the low activity levels than in MS and in CFS patients activity level is 
related to fatigue but not in MS 
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Introduction 
Chronic fatigue syndrome (CFS) is a condition of severe disabling fatigue, lasting 
for at least six months, and for which no somatic explanation can be found ' Many 
accompanying complaints may be present, such as myalgia, headache, sore throat, 
gastrointestinal complaints, and memory and concentration problems 
Analogous to mechanisms described in chronic pain patients,23 Wessely and 
colleagues hypothesized about the role of avoidance of physical activity in the 
perpetuation of fatigue in CFS 5 According to these authors the patient experiences 
genuine symptoms and learns that physical activity aggravates these symptoms, in 
particular fatigue and myalgia, and attributes them to ongoing physical illness The 
patient tries to prevent symptoms by avoiding physical activity Prolonged inactivity 
leads to physical deconditioning such that symptoms emerge at progressively lower 
levels of physical activity Hence, a vicious circle of avoidance and symptoms has 
been established However, there are no empirical data to support this hypothesis in 
CFS 
In many studies a positive relationship between physical activity and 
psychological and physical health has been documented and also the recognition that 
exercise holds promise in the prevention and treatment of illness as a primary or 
adjuvant therapy 6 7 An association between low levels of physical activity and 
fatigue has been reported in several studies 810 Exercise has been shown to have 
beneficial effects on fatigue in subjects enrolled in aerobic classes," l2 in older adults 
following a single bout of physical activity13 and in patients with cardiac failure '4 
At present, a large number of studies has been published on chronic fatigue 
syndrome but there are only three studies, all from our research group, in which the 
relationship between fatigue and physical activity in CFS was assessed empirically 
In these studies we found a positive relationship between low levels of physical 
activity and fatigue15 '6 and in one study we found that the causal direction of this 
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relationship was going from low levels of physical activity to high fatigue seventy 1? 
In all the above-mentioned studies on physical activity in CFS, self-report 
questionnaires were used, reflecting subjective interpretations of physical activity 
level It is not clear whether subjective accounts of physical activity level adequately 
reflect the actual level of physical activity Therefore, the primary aims of the 
present study were to assess actual activity level in patients with CFS to validate 
claims of lower levels of physical activity and to validate the reported relationship 
between fatigue and activity level that was found on self-report questionnaires In 
addition, we evaluated whether physical activity level adequately can be assessed by 
self-report measures An accelerometer was used as a reference for actual level of 
physical activity Accelerometers are motion-sensing devices which yield highly 
reliable data18 and have been reported to be valid instruments in measuring human 
physical activity as close correlations were found with energy expenditure,1921 but 
never have been used in studies on CFS before 
In the hypothesis described above, patients avoid physical activity because in 
their view activity causes symptoms In a previous study we have developed a model 
on factors perpetuating fatigue in CFS The model showed that the patient's opinion 
that complaints had a physical cause contributed to low levels of physical activity '7 
Thus, cognitions appear to play a part in physical activity in CFS In the present 
study we investigated patients' cognitions with respect to activity and their 
relationship with fatigue in more detail 
Finally, to investigate the specificity of physical activity results to CFS, we 
included patients with multiple sclerosis (MS) into the study Patients with MS form 
a useful comparison group as in MS fatigue is a prominent and disabling symptom,16 
and - in contrast to CFS - a somatic substrate (inflammation and demyelination of 
the central nervous system) is established 
Concluding, the present study investigated the following questions Do patients 
with CFS have low levels of physical activity compared to healthy subjects, can self-
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report measures adequately assess actual level of physical activity; what is the role 
of cognitions with respect to physical activity; is there a relationship between level 
of physical activity and fatigue; and are results with respect to physical activity 
specific to CFS. 
Method 
SUBJECTS 
Fifty-one patients with chronic fatigue were randomly selected from our CFS-
database, acquired by referral to the General Internal Medicine outpatient clinic. 
Patients had to experience severe disabling fatigue for at least six months for which 
no somatic explanation could be offered.' Fifty patients with a definite diagnosis of 
MS22 were included by the Department of Neurology (chronic progressive: N = 19; 
relapsing remitting: N = 31). All patients were mobile. Mean Expanded Disability 
Status Scale (EDSS) of Kurtzke23 was 2.8 (range=l-6). Fifty-three healthy subjects 
were included to provide a standard for normality. These subjects were selected 
through a regional newspaper advertisement. All patients participating in this study 
received full physical examination at the beginning of the study and, if indicated, 
further technical investigations. Healthy subjects were matched to the patients with 
CFS on age, sex, and educational level. Educational level was determined by a 
Dutch standardized scoring system which is especially used in research (range: 1 "no 
education" to 7 "university"). 
INSTRUMENTS 
Accelerometer (Actometer). Accelerometers based on a piezo-electric sensor yield 
highly reliable and valid data.18"21 The Actometer will be used as a reference to 
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evaluate the abilities of self-report questionnaires to measure actual activity level 
The Actometer was manufactured by the Department of Electronics and Instrumental 
Services of the Psychological Laboratory of the University of Nijmegen (size 
43*29*16 mm, weight 41 grams) It consists of a piezo-electnc sensor which is 
sensitive in three directions Acceleration of the sensor results in an output-signal 
This signal is amplified and filtered by a bandpass filter with a frequency between 
0,8-10 Hz All signals above a certain threshold are added to a monostable 
multivibrator with a "one-shot" time of 250 ms This pulse-generator triggers a 2-bit 
counter, such that accelerations are added to a maximum of three Each second this 
counter is read and reset by the microcontroller, which adds the value to the 
integration counter The integration counter is set at five minutes In this way every 
five minutes an activity score is produced To allow for inter-instrument 
comparability all Actometers were calibrated at equal thresholds This was done in a 
standardized way A speaker connected to a frequency oscillator with variable 
amplitude settings was used to produce standard movements All Actometer 
thresholds were set at the same amplitude The Actometer was attached to the ankle 
and was worn by the patient for a period of 12 days, day and night, unless taking a 
bath or when swimming 
Self-report measures In the same period of 12 days the Actometer is worn, the 
patient completes a self-observation list Level of physical activity was rated daily on 
a 7-point Likert scale Mean score for the two-week period was used in analyses 
(Daily Observed Activity score) Also, once a day patients reported the number of 
hours spent on occupational activities and on housekeeping activities 
The Activity subscale of the Checklist Individual Strength (CIS)24 and the 
subscales mobility (SIP-MOB) and walking (SIP-WLK) of the Sickness Impact 
Profile2526 measure the level of physical activity 
On the specially designed Physical Activities Rating Scale (PARS) 20 different 
activities were presented For each activity, patients were asked to indicate how 
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frequently they had performed the specified activity (never - rarely - now and then -
often - very often). Scores were summed into a total score (PARS-Activity score). 
With respect to self-perceived activity level, patients were asked to rate activity 
during the past month (very inactive - rather inactive - neutral - rather active - very 
active) and activity compared with other persons they knew (much less active - less 
active - equally active - more active - much more active). 
Cognitions related to physical activity. For each of the 20 activities of the PARS 
patients indicated on a 5-point scale how fatigued they expected they would become 
if they would perform the specified activity. These items were summed into the 
PARS-Expected Fatigue score. In addition, patients indicated on a 5-point scale how 
fatigued they expected other persons they knew would become if these persons 
would perform the specified activity. These items also were summed into a total 
score (PARS-Expected Fatigue Others score). 
Subjective feeling of fatigue. The subjective feeling of fatigue was measured by 
the Subjective Fatigue subscale of the fatigue questionnaire Checklist Individual 
Strength (CIS).24 The CIS is a sensitive measure with good discriminating power and 
reliability. 
Additionally, data concerning age, sex, education, duration of complaints, 
occupational status, and type of work (predominantly sitting - sitting and 
standing/walking - predominantly standing/walking) was collected. 
STATISTICAL ANALYSES 
Variables with a skewness of more than 1 were logtransformed to produce 
approximately normal distributions. Testing differences between groups on 
dichotomous variables was done by χ2 test and on ordinal variables with the Mann-
Whitney test. For these tests, Bonferoni-correction for multiple comparisons was 
applied. Considering three experimental groups, three comparisons were made. 
Assuming a significance level of 0.05, a difference was considered significant if the 
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p-value was less than 0.017. Testing differences between groups on ratio variables 
was performed by analysis of variance. Multiple comparisons were made by Duncan 
multiple ranges tests. Pearson correlation coefficients were computed to evaluate the 
relationships between variables. To control type I error due to calculating multiple 
correlations, p-value for a correlation was set at 0.01. To evaluate homogeneity of 
activity measures principal components analyses were performed. 
Results 
DEMOGRAPHIC 
Results on age, sex, education, duration of complaints, and occupational situation 
are presented in Table 1. There were no significant differences among the three 
groups in age, sex, education, duration of complaints, or hours spent on 
housekeeping activities. Compared with healthy subjects, in the CFS and MS 
samples a significantly greater proportion of subjects received invalidity benefits or 
were on sick leave (Chi2: ρ <0.001), and both patient groups spent fewer hours on 
occupational activities (p<0.05). There was a non-significant trend for a smaller 
proportion of subjects to have jobs in the CFS and MS groups than in healthy 
subjects (p=0.04 and p=0.07 respectively). 
LEVEL OF PHYSICAL A crrvm 
Data on the instruments measuring level of physical activity are presented in Table 
2. There were no differences between CFS patients and MS patients in any 
instrument measuring level of physical activity. Compared with healthy subjects, 
both patient groups had significantly lower scores on all instruments. The CFS 
patients were more likely to indicate that they had been less active than other 
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Table 1: Age, sex, and education of 50 patients with MS, 51 patients with CFS, and 53 
healthy subjects. 
Sex: 
male 
female 
Mean age (range) 
Mean education mean (range) 
Median duration of complaints (range) 
Occupational situation: 
working 
housekeeping 
unemployed 
invalidity benefits/sick leave 
retired 
school 
Self-observation list (2 weeks) 
total hours working 
total hours housekeeping 
CFS 
12 (24%) 
39 (76%) 
36.3 (19-54) 
4.2 (3-7) 
5 (1-48) 
14 (27%) 
9(18%) 
3 (6%) 
23 (45%) 
0 (0%) 
2 (4%) 
10.4(19.7) 
12.7(12.3) 
MS 
17 (34%) 
33 (66%) 
35.8 (19-56) 
3.6 (3-6) 
5 (0.5-22) 
14 (28%) 
15 (30%) 
3 (6%) 
16 (32%) 
1 (2%) 
1 (2%) 
13.3(21.5) 
12.8(15.3) 
Healthy 
13 (24%) 
40 (76%) 
37.1 (19-63) 
4.3 (3-7) 
-- (--) 
25 (47%) 
14 (26%) 
3 (6%) 
1 (2%) 
2 (4%) 
8(15%) 
35.7 (29.3) 
17.1 (17.6) 
persons they knew than the MS patients and the healthy subjects. MS patients 
significantly were more likely to indicate that they had been less active than others 
than healthy subjects. 
Detailed analyses on self-perceived activity ratings showed that of the CFS 
patients and the MS patients who gave the response "neutral" or "active" on the self-
perceived activity question (74% and 69%, respectively), 90% of these CFS patients 
and 70% of these MS patients indicated that they had been less active than others. In 
contrast, 96% of healthy subjects gave the response "neutral" or "active" but only 
33% rated themselves as less active than others (difference with patient groups": 
Chi2: ρ<0.001). There were no significant differences between CFS patients and 
MS patients in any of these comparisons. 
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Table 2: Mean scores (standard deviations) on activity instruments of CFS patients, MS 
patients, and healthy subjects (HS) 
signif differences 
CFS MS Healthy CFS/ CFS/ MS/ 
MS HS HS 
Activity Level 
Actometer' 
SIP-MOB' 
SIP-WLK' 
PARS-Activity' 
CIS-Activity' 
Daily Observed Activity' 
Self-perceived Activity2 
Activity Compared Others 
Self-perceived2 
Activity-cognitions 
PARS-Expected Fatigue2 
1
 Duncan multiple range test ρ < 0 05 
2
 Mann-Whitney test p<0 017 
ns= non-significant 
Possible confounders (age, sex, education, duration of complaints, number of 
hours working, type of work, and number of hours spent on housekeeping activities) 
were identified per activity instrument by means of stepwise multiple regression 
analyses Age, sex, education, and duration of complaints were not related to any 
activity measure Number of hours working, type of work, and number of hours 
spent on housekeeping activities, on the other hand, were related to the instruments 
Including these variables as covanates in analyses of variance, the differences 
between both patient groups and healthy subjects remained significant for all 
instruments (p<0 01) 
23 3 (10 7) 26 1 (13 6) 
26 2 ( 8 7) 28 4 ( 8 2) 
31 6 ( 8 3) 31 1 (95) 
2 1(04) 2 3 ( 0 4 ) 
3 2 ( 1 7 ) 3 4 ( 1 7 ) 
3 8 ( 1 3 ) 4 3(11) 
2 9(1 1) 3 1 (1 1) 
1 5 (0 6) 2 0 (0 9) 
4 0 (0 6) 3 6 (0 8) 
35 5 (10 8) 
33 5 ( 1 5) 
40 8 ( 1 3) 
2 7 ( 0 5 ) 
5 8 ( 1 5 ) 
5 4 ( 1 0 ) 
3 9 (0 8) 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
* 
* 
* 
* 
* 
* 
* 
2 7(10) 
2 2 (0 6) 
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Table 3: ¡ntercorrelations between instruments measuring level of physical activity based on 
data of CFS patients and MS patients 
Acto 
SIP WLK 
PAR 
SIP MOB 
DOA 
CIS-Act 
Self-perc 
Acto 
1 00 
J9 
J6 
J5 
JO 
24 
17 
SIP WLK 
1 00 
23 
JQ 
20 
17 
22 
PAR 
1 00 
J2 
_42 
_32 
Л 
SIP-MOB 
1 00 
¿fi 
J2 
M 
DOA 
1 00 
_53 
Л 
CIS ACT 
1 00 
J2 
Self-perc 
1 00 
Acto = Actometer, SIP- WLK = SIP- Walking, SIP-MOB = SIP-Mobihty, PARS = Physical 
Activities Rating Scale, CIS-ACT=CIS-Activities, Self-perc=self-perceived current activity 
level, DOA= Daily Observed Activity (self-observation list) Correlations underlined 
p < 0 0 1 
A CTOMETER VERSUS SELF REPORT QUESTIONNAIRES MEASURING LEVEL OF PHYSICAL A CTIVITY 
Because CFS patients and MS patients had different scores than healthy subjects on 
all activity measures, the intercorrelations between the variables measuring physical 
activity presented in Table 3 are based on the combined data of CFS patients and 
MS patients only In the table, all variables were ordered according to the degree of 
correlation with the Actometer Although in general correlations between the 
Actometer and self-report measures were moderate or low, it can be observed that 
with decreasing correlations with the Actometer, instruments increasingly reflect 
more subjective and general interpretations of physical activity level The self-
perceived activity question can be considered as the instrument requiring the most 
general and subjective interpretation of activity level as it requires a subjective 
interpretation of general activity level during the last month This instrument had the 
lowest (non-significant) correlation with the Actometer 
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Table 4: Results of principal components analyses (factor loadings) of variables 
measuring physical activity based on data of CFS patients and MS patients. 
CIS-Activity 
Self-perceived activity 
Daily Observed Activity 
SIP-Walking 
SIP-Mobility 
Actometer 
Physical Activities Rating Scale 
factor 1 
.862 
.767 
.763 
.232 
.478 
.317 
.555 
factor 2 
.299 
365 
.340 
.822 
.770 
.723 
.566 
To further test effects of type of method principal components analyses were 
performed on the activity measures. These analyses yielded a two-factor solution 
(Table 4). As activity variables were interrelated (see Table 3) it is not reasonable to 
assume orthogonality of the factor solution. Therefore, oblique rotation was applied. 
After rotation the factors were easily interpreted and were named "General 
Subjective" and "Behavioural". 
In further analyses, the number of activity measures was reduced by calculating 
a summary scores for the two types of self-report questionnaires that emerged from 
the factor solution. For each factor, the weighted scores of the questionnaires 
belonging to that factor were summed. The weighting was performed to achieve 
approximately equal standard deviations of variables per factor, which improves 
reliability. The Actometer was excluded from the "Behavioural" score and will be 
treated as a separate variable because the Actometer is a criterion for actual activity 
and considering the poor relationship with the self-report questionnaires. Thus, in 
further analyses the following activity variables will be used: the Actometer, the 
summary score for the "Behavioural" questionnaires, and the summary score for the 
"General Subjective" questionnaires. 
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ACTIVITY RELATED COGNITIONS 
In Table 2 data are presented on the PARS-Expected Fatigue score Patients with 
CFS had significantly higher PARS-Expected Fatigue scores than MS patients and 
both patient groups had significantly higher PARS-Expected Fatigue scores than 
healthy subjects In both patient groups there was a negative correlation between 
PARS-Expected Fatigue score and how often activities actually had been performed 
(PARS-Activity score) (CFS r= -37 , MS r= - 42), but there was no correlation 
between both variables in healthy subjects In both patient groups this relationship 
extended to other activity questionnaires High PARS-Expected Fatigue scores 
corresponded with low activity levels on the "Behavioural" questionnaires (CFS r= 
- 56, MS r= - 52) and to a lesser degree with the "General Subjective" 
questionnaires (CFS r= - 37, MS r= - 38) Considering the relationship with the 
Actometer, however, in CFS patients a correlation was found (r= - 28) but in MS 
patients no significant relationship was found 
RELATIONSHIPS BETWEEN ACTIVITY AND FATIGUE 
Table 5 contains correlations between fatigue severity as measured by the CIS 
subscale Subjective Fatigue and the activity measures In patients with CFS, we 
found a relationship between actual activity level and fatigue seventy as expressed 
by the correlation between the Actometer and the CIS subscale Subjective Fatigue 
In MS patients and healthy subjects this correlation was not significant The same 
picture was found with respect to the "Behavioural" self-report questionnaires a 
relationship was found in CFS patients but not in MS patients and healthy subjects 
The "General Subjective" score was related to fatigue in all groups 
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Table 5: Correlations of the Actometer and the "General Subjective" and 
"Behavioural " factor scores with fatigue severity as measured with the CIS for CFS 
patients, MS patients, and healthy subjects. 
Actometer Behavioural General Subjective 
activity measures activity measures 
CIS-Fatigue: 
CFS patients -.24 -.52 -.¿S 
MS patients -.16 -.29 -.49 
Healthy subjects ^20 -^ 29 -J2 
Correlations underlined: p<0.01 
Discussion 
LEVEL OF PHYSICAL ACTIVITY 
The present study shows that patients with CFS have significantly lower levels of 
physical activity on different types of instruments than healthy subjects. 
Occupational situation and housekeeping activities significantly influenced activity 
level The number of hours working, having a job predominantly requiring standing 
or walking, and the number of hours spent on housekeeping activities resulted in 
higher activity levels. Nevertheless, after correcting for the effects of these 
variables, CFS patients still were less active than healthy subjects. This means that 
patients who had jobs still were less active than healthy subjects. From this study it 
is not clear whether patients with jobs did more easy during work than healthy 
subjects or whether they took more rest when not working. 
ACTOMETER VERSUS SELF-REPORT QUESTIONNAIRES 
Accelerometers, such as the Actometer used in the present study, are reliable and 
valid measures of human physical activity. A clear disadvantage of the Actometer is 
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that it is a rather costly and time-consuming method This particularly is a setback in 
clinical settings The present study showed that one has to be very careful with using 
self-report questionnaires as measures for actual activity level none of the self-
report questionnaires had strong correlations with the Actometer Thus, self-report 
questionnaires are no parallel tests for the Actometer 
However, some self-report questionnaires can be used as acceptable substitutes 
for the Actometer in contrast to other questionnaires The less an instrument 
required general subjective interpretations, the more this instrument was related to 
the Actometer These typically were questionnaires that required only simple 
responses to specified activities Also, in principal components analyses these 
instruments were included into the same factor as the Actometer In contrast, self-
report questionnaires requiring subjective interpretations of general activity level 
over a prolonged period had low or non-significant correlations with the Actometer 
and were included into a different factor than the Actometer Moreover, we found 
that on self-perceived activity ratings CFS patients and MS patients show a response 
pattern different from healthy subjects 
The subjective instruments do not measure actual behaviour Responses on these 
instruments appear to be an expression of the patients' views about activity and may 
be biased by cognitions concerning illness and disability In healthy subjects such 
cognitions do not exist and therefore their responses were not biased by these 
cognitions 
ACTIVITY RELATED COGNITIONS 
Cognitions are prominently involved in producing low levels of physical activity in 
CFS but not in MS. We found that specific activities which patients expected to 
result in high fatigue levels were less frequently performed than activities which 
were expected to produce less fatigue This was confirmed by the finding that high 
fatigue expectations also were related to low Actometer readings Patients with CFS 
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had significantly higher scores on activity-related fatigue expectations than patients 
with MS These findings fit into the model on factors perpetuating fatigue we 
developed in a previous study 17 In that model it was demonstrated that attributing 
complaints to a physical disease contributes to low activity levels In contrast, for 
MS a different model had to be developed in which low levels of activity were not 
caused by attributions, but by the disease process (measured with EDSS) Thus, 
patients with CFS believe that complaints have a physical cause16 24 27 28 and in their 
view physical activity is harmful Consequently, these patients try to prevent 
symptoms by avoiding physical activity 
PHYSICAL ACTIVITY AND FATIGUE 
The relationship between low levels of physical activity and high levels of fatigue in 
CFS we found in previous studies15 '6 was confirmed in the present study in which 
fatigue severity was related to measures of actual activity level This study also 
showed that in studying the relationship between two concepts one has to realise that 
the strength of this relationship is also dependent on whether the same types of 
methods were used to measure each concept We found that the strength of the 
correlation between fatigue severity and activity measures increased as the activity 
measures reflected more subjective interpretation The CIS also is a self-report 
questionnaire requiring a general subjective interpretation Thus, responses on these 
instruments are susceptible to the same biases It is then not surprising that, although 
no relationship was found between fatigue severity and actual activity level in MS 
patients and healthy subjects, there was a correlation between the CIS and the 
"General Subjective" score m both groups This finding also is in line with Eifert & 
Wilson29 who cautioned that the strength of a relationship between two concepts is 
also dependent on whether the same type of method is used 
Although we found that CFS patients and MS patients had similar (low) levels 
of physical activity, the actual level of physical activity was related to fatigue 
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severity in CFS but not in MS. The question is: how can low levels of physical 
activity produce fatigue in one patient group but not in another patient group with 
similar low activity levels? A possible explanation may be distilled from our clinical 
observations and observations made by others30 that in CFS periods of rest are 
interrupted by short periods of marked activity during which patients perform at 
"normal" levels. These short periods of high activity may be due to trying to live up 
to high standards,30 social demands, or because on such days the patient feels less 
fatigued. It can be hypothesized that in patients with a low overall activity level 
short periods of high activity especially may have detrimental effects. We currently 
are analysing the Actometer data to evaluate whether patients with CFS exhibit more 
pronounced oscillations in activity level than patients with MS. 
SPECIFICITY OF ACTIVITY RESULTS TO CFS 
There were several similarities between patients with CFS and patients with MS with 
respect to activity results. Both groups had similar levels of physical activity, which 
were lower than activity levels of healthy subjects, and in both patient groups 
responses on questionnaires requiring subjective interpretations may be biased by 
cognitions concerning illness and disability. 
There were, however, also important differences between CFS and MS. First, 
in CFS cognitions appeared to play a more prominent role in causing low activity 
levels than in MS. Patients with CFS had stronger expectations that activity would 
produce fatigue and such expectations were related to low activity. Secondly, low 
levels of physical activity were related to fatigue in CFS but not in MS. Thirdly, 
although both patient groups had similar activity levels, CFS patients were more 
likely to indicate that they had been less active than other persons they knew. CFS 
patients generally feel that their illness is not taken seriously and feel that they have 
to defend themselves. Such cognitions may reinforce the tendency to report that had 
not been active. For MS patients this bias is not as prominent as for CFS patients: a 
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somatic explanation for their complaints is established These findings support the 
notion presented in the section "Actometer versus self-report questionnaires" that in 
patients subjective ratings concerning physical activity may be biased by illness and 
disability related cognitions 
Successful treatment of fatigue in CFS should not be directed only at 
encouraging patients to increase activity level but in addition particular attention 
should be paid to the cognitive processes that lie at the root of their physical 
inactivity attributing complaints to a physical cause and believing that activity is 
harmful and leads to fatigue 
Acknowledgements 
This study has in part been supported by Stichting Vrienden MS Research (grant 91-
89 MS) 
We are indebted to EHW Damhuis, JCJM Walk, and STFM Frequm for their 
support in the data collection 
References 
1 Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David к et al A 
report chronic fatigue syndrome guidelines for research J Royal Soc Med 
1991,84 118 121 
2 Keefe F, Gil К Behavioural concepts in the analyses of chronic pain J Consulting Clin 
Psychology 1986,54 776-783 
3 Philips H Avoidance behaviour and its role in sustaining chronic pain Behav Res Ther 
1983 25 273 279 
199 
Chapter 10 
4 Weisenberg M Psychological intervention for the control of pain Behav Res Ther 
1987,25 301-312 
5 Wessely S, Butler S, Chalder T, David A The cognitive behavioural management of 
the post-viral fatigue syndrome In R Jenkins and J Mowbray, eds Post-viral fatigue 
syndrome Chichester John Wiley & Sons, 1991, 305-334 
6 Clearing-Sky M Exercise issues for prescribing psychologists Psychol Health, 
1988,2 189-207 
7 Dubbert PM Exercise in behavioural medicine J Consultmg Clin Psychology 
1992,60 613-618 
8 Hughes J, Crow R, Jacobs D, Mittelmark M, Leon A Physical activity, smoking, and 
exercise-induced fatigue J Behav Med 1984,7 217-230 
9 Chen MK The epidemiology of self-perceived fatigue among adults Preventive Med 
1986,15 74 81 
10 Kroenke K, Wood DR, Mangelsdorf AD, Meier NJ, Powell JB Chronic fatigue in 
primary care Prevalence, patient characteristics, and outcome J Am Med Assoc 
1988,260 929-934 
11 Choi PY, van Horn JD, Picker DE, Roberts HI Mood changes in women after an 
aerobic dance class a preliminary study Health Care Women Intern 1993,14 167 177 
12 Lox CL, Rudolph DL The subjective Exercise Experience Scale (SEES) factorial 
validity and effects of acute exercise J Soc Behav Personality 1994,9 837-844 
13 Pierce EF, Pate DW Mood alterations in older adults following acute exercise 
Perceptual Motor Skills 1994,79 191-194 
14 Mayou R, Blackwood R, Bryant B, Garnham J Cardiac failure symptoms and 
functional status J Psychosom Res 1991,35 399-407 
15 Vercoulen JHMM, Swanink CMA, Galama JMD, Fennis JFM, van der Meer JWM, 
Bleijenberg G Prognosis in chronic fatigue syndrome (CFS) a prospective study on the 
natural course J Neurol Neurosurg Psychiatry 1996,60 489-494 
16 Vercoulen JHMM, Hommes OR, Swanink CMA, Jongen PJH, Fennis JFM, Galama 
JMD, van der Meer JWM, Bleijenberg G The measurement of fatigue in patients with 
multiple sclerosis a multi-dimensional comparison with patients with chronic fatigue 
syndrome and healthy subjects Arch Neurol 1996,53 642-649 
200 
The measurement of physical activity 
17 Vercoulen JHMM, Swanink CMA, Galama JMD, Fennis JFM, Jongen PJH, Hommes 
OR, van der Meer JWM, Blerjenberg G The persistence of fatigue in chronic fatigue 
syndrome and multiple sclerosis the development of a model Submitted 
18 Try on WW Activity measurent in psychology and medicine Plenum Press, New York, 
1991,47-49 
19 Montoye HJ, Washburn R, Servais S, Erti A, Webster JG, Nagle FJ Estimating 
energy expenditure by a portable accelerometer Med Sci Sports Exercise 1983,15 403-
407 
20 Servais SB, Webster JG Estimating human energy expenditure using an accelerometer 
device J Clin Engineering 1984,9 159-171 
21 Meijer GA, Westerterp KR, Koper H, ten Hoor F Assessment of energy expenditure 
by recording heart rate and body acceleration Med Sci Sports Exercise 1989,21 343-
347 
22 Poser CM, Paty DW, Scheinberg L, McDonald I, Davis D, Ebers GC, et al New 
diagnostic criteria for multiple sclerosis guidelines for research protocols Ann Neurol 
1983,13 227 231 
23 Kurtzke J Rating neurologic impairment in multiple sclerosis an Epanded Disability 
Status Scale (EDSS) Neurology 1983,33 1444-1452 
24 Vercoulen JHMM, Swanink CMA, Galama JMD, Fennis JFM, van der Meer JWM, 
Blerjenberg G Dimensional assessment m chronic fatigue syndrome J Psychosom Res 
1994,38 383-392 
25 Bergner M Bobbit RA, Carter WB, Gilson BS The Sickness Impact Profile 
development and final revision of a health status measure Med Care 1981,19 787-805 
26 Jacobs HM, Luttik A, Touw-Otten FWMM, Melker RA De "sickness impact profile", 
resultaten van een vahderingsonderzoek van de Nederlandse versie Ned Tijdschr 
Geneeskd 1990,134 1950-4 
27 Wessely S, Powell R Fatigue syndromes a comparison of chronic "postviral" fatigue 
with neuromuscular and affective disorders J Neurol Neurosurg Psychiatry 
1989,52 940-948 
28 Hickie I, Lloyd A, Wakefield D, Parker G The psychiatric status of patients with the 
chronic fatigue syndrome Br J Psychiatry 1990,156 534-540 
201 
Chapter 10 
29 Eiffert GH, Wilson PH. The triple response approach to assessment: a conceptual and 
methodological reappraisal. Behav Res Ther 1991; 29: 283-292. 
30 Surawy C, Hackmann A, Hawton K, Sharpe M. Chronic fatigue syndrome: a cognitive 
approach. Behav Res Ther 1995;5:535-544. 
202 
Chapter 11 
The Prevalence of Neuropsychological Impairment in 
Chronic Fatigue Syndrome 
JHMM Vercoulen,1 E Bazelmans,1 CMA Swanink,2 JMD Galama,2 JFM Fennis,3 
PJH Jongen,4 O Hommes," JWM van der Meer,3 G Bleijenberg1 
1
 Department of Medical Psychology,2 Department of Medical Microbiology,3 Department of 
General Internal Medicine,A Department of Neurology All· University Hospital Nijmegen, 
The Netherlands. 
Submitted for publication 

The prevalence of neuropsychological impairment 
Summary 
The present study was designed to provide an estimate of the prevalence of 
neuropsychological impairment in CFS; to evaluate the concordance between 
impairment found on standardized tests and self-reported neuropsychological 
problems; and to study the relationship between neuropsychological functioning and 
fatigue severity and psychological processes. In this study we adopted an individual 
approach with respect to the determination of neuropsychological impairment as 
contrasted with the group comparisons approach used in previous studies. Also, 
correction for premorbid functioning and confounders was done on an individual 
basis. The results of this study showed that only a minority of subjects were 
impaired in neuropsychological functioning. There was no relationship between 
neuropsychological impairment found on standardized tests and self-reported 
memory and concentration problems. Neuropsychological functioning was not 
related to fatigue or depression. Slowed speed of information processing and motor 
speed were related to low levels of physical activity. 
Introduction 
Chronic fatigue syndrome (CFS) is characterized by debilitating fatigue for which no 
somatic explanation can be offered. Various accompanying symptoms may be 
present, such as myalgia, neuropsychological complaints, headache, sore throat, and 
multiple joint pains. Neuropsychological complaints are among the most frequently 
reported complaints, in particular memory and concentration problems. 
Studies that evaluated neuropsychological functioning in CFS by standardized 
neuropsychological tests have yielded conflicting results. Of the studies that included 
controls some studies reported impairment in verbal memory,13 visual memory,4 
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concentration,35 attention span,4 reaction times,67 or speed of information,28 
whereas other studies did not find abnormalities m verbal memory,310 visual 
memory,15 concentration,21C attention span,12 4 ' or reaction times ' 
There may be methodological explanations for these conflicting results In all 
these studies conclusions were based on comparisons of group means Such analyses 
do not appreciate the heterogeneity of CFS It may be that a subgroup of patients is 
impaired in specific neuropsychological functions, whereas other patients are not 
This would result in increased variability in the CFS group compared to a matched 
healthy control group The group mean of CFS patients would be different from the 
group mean of the healthy subjects, but the magnitude of this difference may vary in 
a specific study due to chance selection of subjects " This effect may be more 
prominent in studies using relatively small sample sizes 
In addition, impaired neuropsychological functioning is not necessarily 
expressed by poor test performance per se, but by test performance poorer than 
expected given the individual's premorbid cognitive ability When a particular 
patient has a low score on a test this does not necessarily mean that this patient has 
become impaired due to illness It is conceivable that premorbidly he would have 
performed similarly In this case the patient would incorrectly be considered as 
impaired due to illness Similarly, another patient with a test score similar to the 
mean of healthy controls premorbidly might have had scores higher than the mean of 
healthy controls This particular patient would incorrectly be considered as 
unaffected in neuropsychological functioning Thus, in order to determine whether 
patients are impaired due to their illness, it is important that individual correction for 
premorbid ability takes place Premorbid cognitive ability is usually estimated by 
age, sex, and educational level In all studies reporting on standardized 
neuropsychological testing, however, correction for premorbid ability was done by 
matching for these variables on a group basis This especially is a setback when a 
subgroup of patients is impaired and the other patients are not 
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Another issue with respect to neuropsychological functioning in CFS is the 
relationship between self-reported neuropsychological problems and impairment 
found on neuropsychological tests. At present this relationship has been poorly 
studied. One study did not find a correlation between neuropsychological tests and 
self-report questionnaires.5 Another study found higher scores on self-report 
questionnaires measuring subjective neuropsychological problems in CFS than in 
healthy controls, depressed patients and patients with multiple sclerosis, but few 
differences between CFS patients and control groups on neuropsychological testing.2 
This discrepancy led the authors to conclude that in CFS there is overreporting of 
neuropsychological problems. In both studies, however, results were based on a 
group approach and in the latter study this relationship was studied indirectly. What 
is needed is an evaluation of the concordance between self-reported 
neuropsychological impairment and neuropsychological impairment found on formal 
testing; does an individual patient who complains of neuropsychological problems 
also show impairment on standardized tests? 
In a previous study we have developed and tested a model with respect to 
factors perpetuating fatigue. We found that a low level of physical activity, low 
sense of control over symptoms, and focusing on bodily symptoms each had a direct 
causal effect on fatigue severity. Low levels of physical activity were caused by 
attributing complaints to physical abnormalities.12 The relationship between 
neuropsychological functioning and these processes is unclear. In addition, in one 
study it has been suggested that some neuropsychological impairment in CFS is 
caused by depression,5 although this could not be substantiated in another study.2 
Therefore, in the present study this relationship also will be investigated. 
The present study investigated the following questions: what is the prevalence of 
neuropsychological impairment in CFS; what is the concordance between self-
reported neuropsychological problems and neuropsychological impairment found by 
standardized tests; and what is the relationship between neuropsychological 
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Table 1: Age, education, ' and sex of 51 patients with CFS and 53 healthy subjects 
CFS Healthy 
Sex 
Age (yrs ) 
Education* 
Complaints duration (yrs ) 
male 
female 
mean 
range 
mean 
range 
median 
range 
12(24%) 
39 (76%) 
36 3 
19-54 
4 2 
3-7 
5 
1-48 
13 (24%) 
40 (76%) 
37 1 
19-63 
4 3 
3-7 
-
-
Based on Dutch standardized scoring system for research purposes 
(range 1 'no education' to 7 'university') 
functioning on the one hand and fatigue seventy, depression, and the processes 
involved in the perpetuation of fatigue (causal attributions, physical activity, sense of 
control, and focusing on bodily symptoms) on the other9 In this study we will adopt 
an individual approach with respect to the determination of neuropsychological 
impairment and this approach will be contrasted with a group comparison approach, 
as was used in previous studies 
Methods 
SUBJECTS 
Fifty-one patients with chronic fatigue syndrome were randomly selected from our 
CFS-database These patients had to experience severe disabling fatigue for at least 
six months and for which no somatic explanation could be '3 Fifty-three healthy 
subjects were selected through a regional newspaper advertisement All patients 
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received full physical examination at the beginning of the study and, if indicated, 
further clinical and laboratory investigations Healthy subjects were matched to the 
patients with CFS on age, sex, and educational level Educational level was 
determined by a Dutch standardized scoring system that is especially applied in 
research (range l="no education" to 7 = "university") There were no significant 
differences between groups on these variables (see Table 1) 
INSTRUMENTS 
In this study self-report questionnaires, a 12-day self-observation list, and 
standardized neuropsychological tests were used The self-report questionnaires have 
been described in more detail elsewhere 141516 
Self-reported complaints of memory and concentration On the Complaints 
Probing List specific complaints were rated on a 4-point scale (never present -
several times a month - several times a week - every day) During a period of 12 
days patients completed a self-observation list The presence or absence of memory 
and of concentration problems was rated four times a day The mean percentage of 
occurrence over the whole two-week period was calculated (Daily Observed 
Memory score and Daily Observed Concentration score) The Concentration 
subscales of the Checklist Individual Strength (CIS)14 and the Sickness Impact 
Profile (SIP)1718 were also included 
Standardized neuropsychological tests The following neuropsychological 
functions were evaluated (used instruments in parenthesis) speed of information 
processing (Complex Reaction Time Task), motor speed (Complex Reaction Time 
task), concentration (computerized cancellation test, Symbol Digit subtest of the 
WAIS, Trail Making test), attention span (Digit Span subtest of the WAIS), verbal 
memory (California Verbal Learning Test), and visual memory (Figure of Rey) On 
the Digit Span the maximum number of digits recalled were scored 
On the computerized cancellation task 33 lines of 12 groups of dots are 
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presented on a computer screen Each group consists of 3, 4, or 5 dots presented in 
random order and random position With a special response board the 4-dot groups 
have to be indicated as quickly as possible The following parameters are 
automatically produced by the program number of omissions, number of mistakes, 
number of corrections, total time, mean time per line, and dispersion width 
(difference between slowest and fastest line) 
The Complex Reaction Time task (CRT) consists of three consecutive tasks On 
a response board five target buttons are situated in an arch around a start button The 
target buttons are placed at equal distances from the start button Each target button 
contains a stimulus light In all tasks the subject keeps the start button pressed, until 
a stimulus lights up In the first task, only one stimulus button (the middle) can light 
up In the second task, three different stimulus buttons (the middle three) can light 
up in random order In the third task, three different stimulus buttons (the three 
buttons most to the left) can light up in random order In this task subjects are asked 
not to press the button in which the stimulus lights up (considering the first two tasks 
the obvious response), but the button to the right of the stimulus Each task consists 
of 30 trials and is preceded by a practice session of four trials to avoid practice-
effects To prevent anticipation-effects, the time elapsing between pushing the start 
button and the lighting of the stimulus varies between 0 5 and 2 5 seconds (in 
random order) In the CRT, reaction time (speed of information processing) and 
movement time (motor speed) are separately registered by the computer Reaction 
time is defined as the time elapsed between the moment the stimulus lights up and 
the moment the start button is released Motor speed is defined as the time elapsed 
between the moment the start button is released and the moment the target button is 
pressed As the motor component is the same for each task (due to equal distances 
between the start button and the target buttons), motor speed is expected to be 
approximately equal across the three tasks As the CRT was used for the first time in 
the present study, this assumption has to be tested With respect to speed of 
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information processing three reaction time based parameters were used in analyses: 
baseline reaction time as measured by task 1 (stimulus detection and response 
initiation), the difference between task 1 and task 2 (processing of choice selection), 
and the difference between task 2 and task 3 (suppression of obvious response). The 
CRT is a measure of motor-related speed of information processing. 
Depression. The Beck Depression Inventory (BDI)19,20 is a standardized self-
report questionnaire to measure depression. Fatigue was excluded as a symptom. 
Fatigue. The subjective feeling of fatigue was measured by the Subjective 
Fatigue subscale of the (CIS).14 
Causal attributions. The patient's opinions concerning the causes of the 
complaints were measured with the Causal Attributions List.15 One total score is 
computed: high scores indicate physical attributions low scores indicate psychosocial 
attributions. 
Sense of control over symptoms. Perceived sense of control over symptoms was 
measured by a specific 5-point scale question and selected items of the modified Pain 
Cognition List (mPCL).15 
Level of physical activity. In the same period of 12 days the self-observation list 
is completed, the patients wore a motion-sensing device based on a three-directional 
piezoelectric sensor (the Actometer).16 The Actometer is at the size of a matchbox 
and was attached to the ankle. Patients wore the Actometer day and night. It 
measures the number of movements each five-minute period. Physical activity level 
was also measured by the SIP subscale mobility (SIP-MOB)1718 and the Physical 
Activities Rating Scale (PARS). On the latter scale 20 different activities were rated 
on a 5-point scale (never - rarely - now and then - often - very often). 
Focusing on bodily symptoms. This variable is measured by the somatisation 
subscale of the Symptom Checklist (SCL-90-R).21 
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DETERMINATION OF NEUROPSYCHOLOGICAL IMPAIRMENT 
For each subject neuropsychological impairment scores were computed for motor 
speed (CRT baseline movement time), concentration (Trail Making A and B, 
Symbol Digit total score, and mean time and dispersion width of the cancellation 
task), attention span (Digit Span total score), verbal memory (California Verbal 
Learning Test trial 1, trial 5, total words recalled, list B, and the long term recall 
conditions), visual memory (Rey Figure recall score), and speed of information 
processing (CRT baseline reaction time and the difference score between reaction 
time task 1 versus task 2) For each neuropsychological function the test parameters 
listed in parenthesis were summed into a raw total score Each raw total score was 
converted to standardized residual scores by regressing age, sex, and education with 
each score The regression coefficients for these conversions were calculated on the 
data of healthy subjects only For each subject the obtained standardized residual 
score represents the difference between the individual's predicted and actual score 
and thus is a measure for neuropsychological impairment due to illness for that 
particular neuropsychological function (the neuropsychological impairment score) 
With this technique individual differences in premorbid cognitive ability are 
corrected for For each neuropsychological impairment score the fifth percentile of 
healthy controls was used as a cutoff to decide whether a patient was impaired in 
that area of cognitive functioning (the neuropsychological impairment index) 22 
Finally, an overall neuropsychological impairment score was calculated by counting 
the number of tests failed Again, the fifth percentile of healthy subjects was used to 
determine the cutoff for the overall neuropsychological impairment index Note that 
the neuropsychological impairment score is a dimensional variable and the 
neuropsychological impairment index is a dichotomous variable 
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STATISTICAL ANALYSES 
Skewed variables have been transformed by logarithmic or square root 
transformations to produce approximately normal distributions Testing differences 
between groups on nominal variables was done by Chi2 test and on ordinal variables 
by the Mann-Whitney test Testing differences between groups on ratio variables 
was performed by analysis of variance Alpha was set at 0 01 to control for Type I 
error due to multiple testing Evaluating the relationship between ratio variables was 
done by computing Pearson's correlation coefficient Concordance between self-
reported neuropsychological impairment (Complaints Probing List) and 
neuropsychological impairment based on standardized tests (neuropsychological 
impairment indexes) was evaluated by Cohen's Kappa, which is a measure of 
concordance between two dichotomous variables corrected for chance Logistic 
regression analyses were used to determine which neuropsychological function most 
contributed to the overall neuropsychological impairment index 
Results 
SELF REPORTED MEMORY AND CONCENTRATION PROBLEMS 
Data on self-reported memory and concentration problems are presented in Table 2 
On the Complaints Probing List, 69% of CFS patients reported memory problems 
and 74% reported concentration problems These prevalence rates were higher than 
in healthy subjects On the self-report questionnaires CIS-Concentration, SIP-
Concentration, and on the Daily Observed Memory score and Daily Observed 
Concentration score of the self-observation list patients had significantly higher 
scores than healthy subjects 
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69% 
74% 
5 2 (0 2) 
5 0 (2 6) 
4% 
6% 
1 9 (0 1) 
2 2 (0 3) 
0 0001 
0 0001 
0 0001 
0 0001 
Table 2: Self-reported memory and concentration scores on the Checklist Individual Strength 
(CIS), Sickness Impact Profile (SIP), and self-observation list of CFS patients and healthy 
subjects (Mean (SEM)) 
CFS Healthy p-value 
Complaints Probmg List 
memory' 
concentration" 
CIS Concentration 
SIP Concentration 
Self-observation list 
Daily Observed Memory* 23 0 (3 9) 0 2 (0 1) 0 0001 
Daily Observed Concentration* 36 8 (4 3) 1 2 (0 5) 0 0001 
" percentage of patients indicating the compiami present at least a few times per week 
# mean percentage of occurence 
MOTOR SPEED 
The CRT was designed to separate the motor component and the information 
processing component of the response To test the assumption that motor speed is 
approximately equal across the three tasks (because of equal distances between the 
start button and the target buttons), multivariate analyses of variance with repeated 
measures on the motor speed parameters of the three CRT tasks were performed In 
these analyses it was shown that there were significant differences between groups in 
motor speed (GROUP-effect p < 0 001) With each subsequent task there was an 
increase in motor speed (TASK-effect p < 0 001) The increase in motor speed over 
subsequent tasks (TASK*GROUP-effect) was not significantly different between 
groups Thus, in both groups motor speed slows down with increasing complexity of 
the task This finding suggests that information processing also takes place during 
the movement phase and not only during the reaction time phase Therefore, the 
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Table 3: Results (in seconds) with respect to motor speed and information processing speed 
as measured with the Complex Reaction Time Task (Mean (SEM)) in CFS patients and 
healthy subjects 
Motor speed 
Information Processing 
Baseline reaction time (Task 1) 
Difference task 1 - task 2 
Difference task 2 - task 3 
CFS 
0 25 (0 02) 
0 35 (0 01) 
0 07 (0 02) 
0 13 (0 02) 
Healthy 
0 19(0 01) 
0 29(0 01) 
0 01 (0 01) 
0 09 (0 01) 
p-value 
0 002 
0 001 
0 003 
ns 
speed of information processing parameters described in the methods section will be 
corrected for these effects, by adding the differences between motor speed of task 2 
and task 3 with baseline motor speed to the reaction times of task 2 and task 3 
respectively Baseline motor speed data are presented in Table 3 Analyses of 
variance showed that patients with CFS had significantly slower baseline motor 
speed than healthy subjects 
SPEED OF INFORMATION PROCESSING 
Data on information processing speed are presented in Table 3 Analyses of variance 
showed that baseline reaction time (stimulus detection and response initiation) in 
CFS patients was significantly slower than in healthy subjects The processing of the 
response selection (difference task 1 - task 2) also was significantly slower in CFS 
patients There were no differences between patients and healthy subjects with 
respect to suppression of an obvious response (difference task 2 - task 3) 
CONCENTRATION 
Group results on standardized neuropsychological tasks measuring concentration are 
presented in Table 4 There were no differences between patients with CFS and 
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Table 4: Mean (uncorrected) scores of CFS patients and healthy subjects on concentration 
tasks (Mean (SEM)) 
Trail Making 
A (sec ) 
В (sec ) 
Interference 
Digit Span 
Forward 
Backward 
Total 
Symbol Digit 
Cancellation task 
omissions 
mistakes 
corrections 
total time (sec ) 
mean time per line (sec ) 
dispersion width 
CFS 
36 3 (1 8) 
67 2 (3 9) 
30 9 (2 9) 
5 9 (0 2) 
5 1 (0 2) 
11 0 (0 3) 
57 1 (1 8) 
6 2(1 1) 
3 4(1 3) 
8 6 ( 1 4 ) 
381 5 (21 0) 
14 4 (1 0) 
7 5 (0 8) 
Healthy 
29 3 (1 2) 
57 2 (2 8) 
27 9 (2 4) 
6 3 (0 3) 
5 6 (0 3) 
11 9 (0 5) 
64 2 (1 7) 
7 0(1 2) 
1 7 (0 5) 
11 4(1 6) 
322 4 (9 6) 
11 9(0 4) 
5 7 (0 3) 
p-value 
0 002 
ns 
ns 
ns 
ns 
ns 
0 004 
ns 
ns 
ns 
0006 
0 007 
ns 
healthy subjects on the Digit Span The patients were significantly slower than 
healthy subjects on the Trail Making Task A, the Symbol Digit task, and the total 
time and mean time per line of the cancellation task They also had higher dispersion 
width scores on the cancellation task, which means greater variability in 
performance in CFS patients 
Performance on the Trail Making, Symbol Digit, and cancellation tasks not only 
depends on concentration skills, but also on motor speed and attention span After 
correction for the effect of motor speed by including baseline CRT motor speed as a 
covanate into the analyses, the differences on the cancellation task disappeared, but 
not on the Trail Making A and the Symbol Digit task However, the group 
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34 8 (0 3) 
22 1 (0 9) 
7 8 (0 3) 
13 8 (0 3) 
58 9 (1 4) 
7 9 (0 3) 
12 5 (0 4) 
13 1 (0 4) 
12 8 (0 4) 
13 2(0 4) 
15 0 (0 2) 
35 7 (1 0) 
22 5 (0 9) 
8 6 (0 3) 
14 5 (0 3) 
62 8 (1 3) 
8 2 (0 3) 
13 0(0 4) 
13 8(0 3) 
13 7 (0 3) 
14 1 (0 3) 
15 3 (0 2) 
0 002 
ns 
ns 
0 009 
0 010 
ns 
ns 
ns 
ns 
ns 
ns 
Table 5: Mean scores of visual (Rey figure) and verbal memory (California verbal Learning 
Test CVLT) tasks of CFS patients and healthy subjects (Mean (SEM)) 
Test CFS Healthy p-value 
Rey figure 
Copy 
Recall 
CVLT 
List A trial 1 
List A trial 5 
List A trial 1 5 
List В 
Short delay free recall 
Short delay cued recall 
Long delay free recall 
Long delay cued recall 
Recognition 
differences on these measures disappeared after additional correction for attention 
span effects (Digit Span total score) 
MEMORY 
Results on standardized neuropsychological tasks measuring memory functioning are 
presented in Table 5 On the Rey figure, CFS patients made less accurate copies 
than healthy subjects, but there were no significant differences in the visual recall 
condition 
On the California Verbal Learning Task, CFS patients significantly recalled 
fewer words across the five trials (immediate recall) than healthy subjects, 
suggesting impaired acquisition of verbal stimuli, but there were no differences 
between both groups in any long-term recall condition and the recognition condition 
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Table 6: Prevalence rates of cognitive impairment m CFS patients 
with respect to motor speed, information processing speed, 
concentration, attention span, verbal memory, visual memory, and a 
total impairment score, adjusted for premorbid ability, confounders, 
and the prevalence rate in healthy subjects (5 %) 
CFS 
Motor speed 25 % 
Information processing speed 36% 
Concentration 17 % 
Attention span 3% 
Verbal memory 13 % 
Visual memory 0 % 
Overal neuropsychological impairment 29 % 
There were no significant differences between both groups in list В or the 
recognition condition 
NEUROPSYCHOLOGICAL IMPAIRMENT INDEXES 
Data on the neuropsychological impairment indexes are presented in Table 6 The 
percentages were corrected for the proportion of helthy subjects with impaired 
functioning (5%) Results show that a subgroup of patients is impaired in 
neuropsychological functioning We demonstrated that the concentration tasks used 
in the present study also depend on motor speed and attention span (see section 
"Concentration") Therefore, the concentration impairment index also has been 
computed after individual correction for the effects of these variables This resulted 
in a reduction of the proportion of patients with impaired concentration from 27 % to 
17% 
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Stepwise logistic regression analyses showed that the information processing 
speed index resulted in 80% of cases correctly classified on the overall 
neuropsychological impairment index On subsequent steps the other impairment 
indexes were included into the model in the following order (percentages indicate the 
percentage correctly classified by the model at that particular step) motor speed 
(80%), concentration (92%), verbal memory (98%), and working memory (100%) 
Considering the relative high predictive power of information processing speed, this 
function appears to be the most important predictor of overall neuropsychological 
impairment 
Information processing impairment score was associated with the concentration 
impairment score (r= 40) The concentration impairment score was related to the 
verbal memory impairment score (r= 36) 
SELF REPORT VERSUS NEUROPSYCHOLOGICAL IMPAIRMENT INDEXES 
In Table 7 self-reported memory and concentration problems as measured with the 
Complaints Probing List are contrasted with the respective neuropsychological 
impairment indexes for patients with CFS There was no concordance between self-
reports of concentration problems or memory problems and formal tests measuring 
these functions, as expressed by nonsignificant Chi2's and very low Kappa's We 
also did not find correlations between the neuropsychological impairment scores and 
the other self-report measures of neuropsychological problems (the concentration 
subscales of the SIP and CIS, the Daily Observed Memory score, and the Daily 
Observed Concentration score) Considering the total group of patients with CFS, 
51% reported concentration problems and 53% reported memory problems that 
could not be confirmed by standardized testing Considering only patients who 
reported neuropsychological problems, in 70% of the patients with CFS who 
reported concentration problems and 77% of the patients with CFS who reported 
memory problems these complaints could not be confirmed by formal testing Taken 
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Table 7: Concordance between self-reported concentration and memory problems and the 
concentration and memory impairment indexes for CFS patients. 
self-reported n o 
problem yes 
Kappa 
Chi2 
Concentration 
Concentration impairment index 
no yes 
21% 5%* 
51%" 23% 
0.06 
0.558 (ns) 
Memory 
Verbal Memory impairment index 
no yes 
31% 0%* 
53%" 16% 
0.16 
0.070 (ns) 
underreporting 
overreporting 
together, this means that in CFS there is substantial overreporting of 
neuropsychological complaints. 
THE RELATIONSHIP OF NEUROPSYCHOLOGICAL IMPAIRMENT WITH FATIGUE SEVERITY, 
DEPRESSION, AND THE PROCESSES PERPETUATING FATIGUE 
None of the neuropsychological impairment scores showed a relationship with 
fatigue severity or depression severity. Overall impairment score was related to the 
physical activity measures SIP-Mobility, PARS, and the Actometer (-.38, -.42, and -
.48, respectively). Similar associations with these activity measures were found for 
the speed of information processing score (r= -.38, -.34, and -30, respectively) and 
the motor speed impairment score (r= -34, -.33, and -.47, respectively). None of 
the impairment scores was associated with focusing on bodily symptoms, sense of 
control, or causal attributions. Considering the large number of self-report measures 
of neuropsychological problems, we combined them into one variable. This variable 
was related to SCL-Somatisation (r= .36), CIS subjective fatigue (r= .40), and BDI 
(r=.46). 
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Self-reported memory or concentration complaints were associated with higher 
scores on SCL-Somatisation (p<0 01 for both complaints) and CIS Subjective 
Fatigue (p<0 03 and p < 0 01, respectively) 
Discussion 
The analyses based on the group comparisons would lead to the conclusion that CFS 
patients show impairment in concentration skills, verbal memory, speed of 
information processing, and motor speed Results with respect to neuropsychological 
impairment indexes, on the other hand, showed that only a minority of patients is 
impaired 
The fact that only a minority of patients showed neuropsychological impairment 
may explain why some studies did find neuropsychological problems whereas other 
studies did not As indicated in the introduction, when a subgroup of patients is 
impaired whereas the other patients are not, this leads to increased variability in the 
patient group compared to healthy subjects Chance selection then may be 
responsible for one study to find a significant difference between CFS and healthy 
subjects in, for example, verbal memory but not in another study Similarly, this 
phenomenon also may explain why in some studies not on all test parameters of 
verbal memory significant differences were found between patients and controls In 
most of these studies the authors interpreted these findings as evidence that 
neuropsychological impairment in CFS is subtle In the present study such findings 
also occurred On the California Verbal Learning test we found significant 
differences in immediate free recall conditions but not in long-term free recall 
conditions Considering the small number of patients who were impaired in verbal 
memory, these contradicting findings more likely are due to the above mentioned 
chance selection effect than that they have to be interpreted as evidence for subtle 
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verbal memory impairment in patients with CFS 
Additionally, there are other methodological setbacks of previous studies First, 
most neuropsychological tests tap different cognitive functions Frequently used tests 
to measure concentration such as the Trail Making and the Symbol Digit test tap 
motor speed, visual search processes, attention span, and concentration skills 
Abnormal performance on these tests does not give information on which particular 
function is impaired A patient with an abnormal score on the Trail Making actually 
may not be impaired in concentration skills, but this low score may merely be the 
result of slowed motor performance In this particular patient a low test score would 
falsely lead to the conclusion that the patient has concentration problems In the 
present study, 27% of patients would be considered impaired in concentration based 
on the Trail Making, Symbol Digit test, and cancellation task After controlling for 
motor speed and attention span effects, however, only 17% could be considered 
impaired in concentration Second, as described in the introduction, when no 
individual correction for premorbid functioning has been performed this may lead to 
confounding, especially when a subgroup of the patients is impaired 
Two other studies have calculated a neuropsychological impairment parameter 
based on neuropsychological tests In one study, for all tests the number of standard 
deviations below the mean of healthy controls was calculated into a total score as an 
indication for neuropsychological impairment2 Patients with CFS had significantly 
higher scores on this overall neuropsychological impairment rating than healthy 
controls However, in this study correction for premorbid functioning had been 
performed by matching for age, sex, and education on a group basis and no attempt 
had been made to determine the prevalence of neuropsychological impairment in 
CFS In a study by Krupp et al5 seventy of neuropsychological impairment was 
defined as the number of tests that fell one standard deviation below estimated 
premorbid functioning Although, the percentage of patients they rated to be 
impaired (35%) is not very different from the prevalence of overall 
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neuropsychological impairment in the present study (29%) the reliability of their 
method is questionable Correction for premorbid functioning consisted of a 
subjective estimation by one of the authors given the performance on three other 
neuropsychological tests (Information and Vocabulary subtests of the WAIS and the 
Reading portion of the Wide range Achievement test-Revised) This approach 
provides only an indirect and subjective correction for premorbid functioning Also, 
the authors did not use data of healthy subjects as a reference for normal 
functioning, as was done in the present study, but CFS patients themselves and by 
that they are risking circular evidence An additional disadvantage of both studies is 
that indexes based on the number of standard deviations below a given mean only 
reflect functioning of patients relative to that mean, rather than providing an absolute 
estimate of neuropsychological impairment When a subject scores one standard 
deviation below the mean of healthy subjects, this does not necessarily imply that 
functioning is abnormal, one standard deviation below the mean of healthy subjects 
may well be in the normal range 
In the present study the methodological problems described above have been 
avoided by determining neuropsychological impairment on an individual basis In 
addition, individual corrections for premorbid abilities and for confounders were 
done In this way, for each patient, we obtained a pure measure of 
neuropsychological impairment due to illness for different neuropsychological 
functions (the neuropsychological impairment scores) Neuropsychological 
functioning probably best can be considered as dimensional (as expressed by the 
neuropsychological impairment score) rather than categorical Therefore, using a 
cutoff of 5% of healthy subjects to distinguish between unaffected and disturbed 
functioning (neuropsychological impairment index) by definition is rather arbitrary 
The prevalence rates of neuropsychological dysfunctioning based on the 
neuropsychological impairment indexes as used in the present study therefore should 
be viewed as estimates 
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Most patients reported memory and concentration problems However, of the 
patients reporting memory or concentration problems, in the majority of cases these 
complaints could not be confirmed by standardized tests Considering the total group 
of CFS patients, half of the patients reported unsubstantiated memory or 
concentration problems Thus, in CFS there is considerable overreporting of 
memory and concentration complaints Self-reported neuropsychological problems 
were related to fatigue seventy and depression, but neuropsychological impairment 
based on standardized tests was not 
We found that speed of information processing was the strongest predictor of 
overall neuropsychological impairment, correctly classifying 86% of patients Speed 
of information processing is most consistently reported to be slowed in CFS 
DeLuca et al used the Paced Auditory Serial Addition Test (PASAT), which is a 
measure of speed of information processing for verbal material They found 
significant slower performance m CFS patients compared to healthy subjects 2 8 In 
one of their studies they measured visual information processing efficiency with the 
Trail Making test 2 As they found significant differences between patients with CFS 
and healthy controls on the PASAT but not on the Trail Making test, they concluded 
that in CFS there is specific impairment in information processing efficiency for 
verbal material only The authors cautioned, however, that the PASAT and the Trail 
Making may not have been equally difficult In addition, the present study showed 
that the Trail Making is not a suitable test for measuring visual information 
processing speed because performance on this tests heavily relied on motor speed 
and attention span Moreover, the present study showed that patients with CFS also 
show impairment in motor-related information processing speed, although only in a 
subgroup of patients Taken together, in a subgroup of patients with CFS there may 
be slowing of information processing speed that is not restricted to a specific 
modality but rather appears to be generalized 
Although the present study showed that neuropsychological functioning is 
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normal in the majority of CFS patients, the proportion of patients who showed 
neuropsychological impairment (about one-third) are too large to be ignored 
Impairment based on neuropsychological tests could not be attributed to fatigue 
or depression Several neuroimaging studies of the brain using MRI reported white 
matter lesions, but quantitative summary analyses of these studies by Cope & 
David23 showed no significant increase in white matter lesions Reviewing studies on 
functional neuroimaging (most using WmTc-HMPAO SPECT) the same authors 
concluded that no pattern of abnormalities in regional cerebral blood flow 
characteristics of CFS was found Thus, to date no cerebral abnormalities have been 
established that are characteristic of CFS This in part may be attributed to 
methodological problems, in particular technical problems and confounding 
factors " 
Others have suggested that patients with CFS may have a bias for processing 
somatic or fatigue-related information and that overconcem about this information 
may affect attentional processes24 We have shown that in patients with CFS there is 
strong focusing on bodily symptoms15 and present data indeed show a relationship 
between focusing on bodily symptoms and self-reported neuropsychological 
problems However, present data do not lend support for their hypothesis that 
somatic overconcem leads to impaired neuropsychological functioning as we did not 
find a relationship between focusing on bodily symptoms and neuropsychological 
test performance 
Another explanation for poor neuropsychological test performance can be 
derived from our finding that speed of information processing and motor speed were 
related to level of physical activity Moreover, these neuropsychological functions 
were most frequently impaired In a previous study we found significantly lower 
activity levels in CFS patients than in healthy subjects 16 Thus, it can be 
hypothesized that prolonged inactivity may result in mental slowing, perhaps due to 
lack of stimulation However, evidence for this hypothesis as yet is circumstantial 
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The causal direction of the relationships between activity level and 
neuropsychological dysfunctioning is not clear It is also possible that there is no 
causal relation both may be consequences from another underlying process 
Future studies are needed to clarify the origin of the poor neuropsychological 
test performance that can be found in a subgroup of CFS patients Such studies 
should link neuroimaging results with neuropsychological test performance on an 
individual basis and should evaluate the influence of physical activity on 
neuropsychological test performance 
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12.1 Introduction 
The etiology of chronic fatigue syndrome as yet is unknown The diagnosis 
Chronic Fatigue Syndrome by definition is established when patients already have 
complaints for quite a while (at least six months) In these patients no somatic 
abnormalities have been found ' However, this does not rule out the possibility that 
in patients already diagnosed as having CFS the complaints had a somatic starting 
point The studies presented in the present thesis primarily were focused on 
processes that cause complaints to perpetuate In this chapter we will try to 
synthesize the results found in these studies, evaluate them on their merits and 
shortcomings, and to derive directions for future research from them 
12.2 Assessment and diagnosis 
12 2 1 MULTI DIMENSIONAL ASSESSMENT 
The multi-dimensional assessment method we have developed (chapter 4) has proven 
to be useful in filling the void that existed in assessment methods The set of 
dimensions we have identified in chapter 4 should not be considered as definite or as 
exhaustive m describing CFS The development of the multi-dimensional assessment 
is a dynamic process which should exceed the present studies Future research 
should indicate whether a new dimension should be added, whether a dimension 
should be deleted, or whether it should be further specified 
In our studies we used self-report questionnaires, self-observation lists, 
standardized neuropsychological tests, and a motion-sensing device (the Actometer) 
In general, we found that using different methods to measure the same concept 
yielded different results (chapter 5, 10, 11) and that the strength of the relationship 
between two different concepts may be attenuated by using different types of 
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assessment methods (chapter 10) Thus, each type of assessment method can add 
useful information to the description of the patient Comprehensive assessment of 
CFS thus not only entails measuring along different dimensions, but also that 
different types of methods should be employed However, when studying 
relationships between different concepts, preferably the same type of method should 
be used to avoid confounding 
12 2 2 IMPLICA TIONS OF PRESENT STUDIES FOR CURRENT CASE DEFINITIONS 
The most frequently used case definitions are the original CDC-1988 case definition2 
and the British case definition 3 In both case definitions fatigue should last for at 
least 6 months and no somatic explanation should be present The major difference 
between both case definitions is the additional use of symptom criteria in the CDC 
case definition According to these symptom criteria a patient has to fulfill a 
minimum number of specified symptoms (at least 6 out of a list of 11 symptoms) In 
1994, the CDC definition has been revised 4 The symptom criteria were made less 
strict (at least 4 out of 8) and when the patient does not meet the symptom criteria, 
but has unexplained fatigue for more than 6 months, he is classified as idiopathic 
chronic fatigue 
The requirement of a minimum number of specified symptoms, however, is 
questionable First, fatigue and other symptoms commonly reported m CFS are 
nonspecific as there is considerable overlap in symptoms between patients with CFS 
and patients with a clinical depression and neuromuscular diseases,5 chronic pain,6 
and multiple sclerosis (chapter 8) Second, Wessely and colleagues observed that 
there is a linear relationship between the number of symptoms included into the 
CDC symptom entena and the number of other somatic symptoms reported by 
patients 7 This means that there is no evidence that the symptoms included in the 
CDC symptom criteria are characteristic of CFS Third, when controlling for effects 
of the number of symptoms, we found no differences in fatigue seventy or other 
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dimensions between patients fulfilling CDC-1988 symptom criteria and those 
patients who did not (chapter 5) We were able to replicate these findings with 
respect to CDC-1994 entena in another sample of CFS patients, described in 
chapter 8 (data not shown) Finally, whether or not a specific symptom is scored as 
present in a particular patient (and consequently the number of patients fulfilling 
CDC symptom criteria) depends to a large extent on how the data are collected (see 
previous section) When CDC-1994 criteria for Chronic Fatigue Syndrome are 
applied on the CFS sample presented in chapter 11, specific probing would result in 
43% of the patients fulfilling the criteria versus 18% of patients when spontaneously 
reported complaints were scored and standardized neuropsychological tests were 
used to establish memory or concentration problems 
Thus, symptoms appear to have little diagnostic value A minimum symptom 
requirement as in the CDC case definitions does not appear to create a patient group 
distinct from patients who do not fulfill symptom criteria, except for distinguishing 
between patients having many symptoms and patients having few symptoms In 
addition, prevalence rates of such diagnoses largely depend on how symptoms were 
assessed Consequently, there is no evidence that justifies the distinction made in the 
CDC-1994 case definition between chronic fatigue syndrome and idiopathic chronic 
fatigue 
12.3 Chronic fatigue syndrome: a psychological condition? 
The fact that in CFS no physical abnormalities can be found has led many 
professionals to conclude that complaints "therefore must have" a psychological 
origin In chapter 3, however, it was argued that CFS is not an atypical 
manifestation of depression, or psychopathology in general This conclusion was 
further supported by studies in this thesis Not all CFS patients suffer from a clinical 
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depression (chapter 4, 5, 7, 8) and in patients with CFS the degree of neurosis and 
the severity of depression is considerably lower than in psychiatric outpatients 
(chapter 4). In chapter 8 it was shown that on measures of psychological well-being 
patients with CFS had similar profiles on the SCL-90-R than patients with MS and 
there was no difference in the proportion of patients that could be considered as 
having a depression. 
What originally caused the complaints is unknown, but we have found that 
psychological processes are involved in the perpetuation of complaints. These 
processes in particular concern attributions and cognitions (idea's a patient has 
concerning his complaints, the verbal content of thinking processes) and behaviour. 
In the following paragraphs the role of psychological processes in CFS will be 
discussed. 
12.3.1 SENSE OF CONTROL OVER SYMPTOMS (SELF-EFFICACYEXPECTATIONS) 
Cognitions have been rather neglected in studies on CFS. The concept of sense of 
control over symptoms (self-efficacy expectations) even never has been studied in 
CFS before. However, studies in the present thesis show that sense of control over 
symptoms is prominently involved in the perpetuation of fatigue. In the longitudinal 
study on the natural course it was shown that a lack of perceived control was a 
potent factor in predicting fatigue severity and was the strongest factor predicting 
chronicity (chapter 6). In chapter 9 these results were confirmed in a different 
sample and with a different method ("structural equation analyses"). From the model 
developed in that study it was clear that sense of control had a direct causal effect on 
fatigue. 
In chapter 4 and chapter 8 it was found that approximately one-third of patients 
experienced positive sense of control. From the present studies it is not clear what 
determined sense of control to be positive or negative in patients with CFS. In 
chapter 3 it has been suggested that attributing complaints to physical abnormalities 
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would induce the idea of personal uncontrollabihty, because there are physical 
disturbances the doctor is the one to offer the solution In the model no such 
relationship was found One has to bear in mind, however, that patients participating 
in the studies described in the present thesis had a relatively long duration of 
complaints (about 4-5 years) Present data therefore cannot provide information on 
the origins of beliefs concerning sense of control It may be that in some patients the 
view of personal uncontrollabihty in the case of somatic disturbance already was 
present before the onset of complaints On the other hand, it is also conceivable that 
in other patients such beliefs have developed during the course of the disease 
12 3 2 CAUSAI ATTRIBUTIONS 
Attributing complaints to a physical cause is one of the most distinctive features of 
CFS (chapters 4 and 8) and these attributions have been shown to be associated with 
chronicity (chapter 6) This effect appeared to be mediated by causing the patient to 
avoid physical activity (chapter 9) CFS patients not only attribute their complaints 
to physical abnormalities, but these attributions also are very persistent In our 
longitudinal study (chapter 6) we found that of patients who at initial assessment had 
a median duration of complaints of 4 5 years, during a follow-up period of 18 
months 75% still used medication and 59% had visited a specialist or alternative 
practitioner Thus, patients continue to search for a somatic cause for their 
complaints, apparently even for many years 
The fact that these patients are so persistent in attributing complaints to a 
physical cause is quite surprising, as abnormalities never have been found on 
physical examinations In MS a somatic cause is established and is presented to the 
patient as "probably caused by a viral infection" It is therefore remarkable that 
patients with CFS had similar scores as patients with MS with respect to attributing 
complaints to a physical cause and significantly more often than MS patients 
indicated that their complaints were caused by a viral infection (chapter 8) In 
235 
Chapter 12 
addition, patients with MS are more open to psychosocial interpretations of their 
complaints than CFS patients 
Where do these persistent and change-resistant attributions come from9 In the 
present thesis we were not able to demonstrate the origins of the somatic 
attributions As described in the previous paragraph on sense of control, the long 
duration of complaints of the samples under study may have obscured the 
mechanisms that he at the root of specific cognitions and attributions In a primary 
care study it was shown that within the first six months of the illness the majority of 
patients attributed fatigue to psychosocial rather than to physical causes 8 This 
finding suggests that these attributions develop during the course of the illness It 
can be speculated that several factors may contribute to the genesis of strong somatic 
attributions As no somatic cause can be established but complaints continue to 
persevere, a patient often is told that there is nothing wrong or thai their complaints 
must be psychological A psychological explanation does not seem to be as hgitimate 
as a somatic abnormality, it may indicate weakness or even malingering The patient 
feels not to have been taken seriously, especially by doctors, but also by his social 
system (family, friends, neighbours) This may motivate the patient to search for a 
(legitimate) somatic abnormality to "prove his right" 
12 3 3 LEVEL OF PHYSICAL ACTIVITY 
We found that patients with CFS have significantly lower levels of physical activity 
and that low activity levels were associated with high fatigue severity (chapter 8, 9, 
10) It has been suggested that low levels of physical activity and fatigue both result 
from abnormalities of the muscular system Abnormalities in muscle 
electrophysiology9 and muscle histology have been reported,1011 although others did 
not find such abnormalities 12 Moreover, normal contractile function of skeletal 
muscle has been reported13 '5 and a study on recovery following exercise also found 
normal muscle physiology '6 Thus, muscle abnormalities are unlikely to cause low 
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physical activity levels and fatigue. 
We found that cognitions and attributions do play an important part in the 
establishment of low activity levels. In the model on cognitive and behavioural 
factors involved in the perpetuation of fatigue in CFS (chapter 9) we found that low 
levels of physical activity were (in part) caused by attributing complaints to a 
physical cause. In chapter 10 we found that activities which patients expected to 
result in high fatigue levels were less frequently performed than activities which 
were expected to produce less fatigue. Also, in that study we found that expecting 
excercise to produce fatigue was related to low overall actual activity levels as 
measured with a motion-sensing device (the Actometer) during 12-day periods. 
Taken together, patients with CFS are convinced that complaints have a physical 
cause and in their view physical activity is harmful. Consequently, these patients try 
to prevent symptoms by avoiding physical activity. 
Our model can explain results of studies using a symptom limited incremental 
cycle exercise test.'7'9 Montague et al. reported lower than predicted heart rates at 
the end of exercise compared to controls18 and Gibson et al.17 found a lower peak 
heart rate and reduced lactate levels five minutes after exercise compared to 
controls. In addition, in the study by Gibson et al. patients had greater perception of 
exertion than controls at similar physiological effort.17 Riley et al. also reported 
higher perceived exertion scores in CFS patients than in controls.19 These results 
suggest that CFS patients have lowered thresholds for sensations during exercise and 
that they did not exercise to their full physiological capacity. These results can be 
predicted from our model. Patients believe that exercise is harmful and they are very 
sensitive to bodily sensations, which in their view signal damage. As these patients 
are inclined to prevent symptoms by avoiding exercise, they were not exercising to 
their limit. 
Avoidance of physical activity has major consequences. The model on factors 
perpetuating fatigue also showed that low levels of physical activity had a direct 
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causal effect on fatigue seventy (chapter 9), although the mechanism by which this 
effect takes place is as yet not clear A possible mechanism may be physical 
deconditioning, which is reported in one study 1β Other studies, however, did not 
find evidence of physical deconditioning in CFS 1 6 1 7 The different outcomes of these 
studies on deconditioning may be due to differences in fitness in the general 
population 16 
Within this context, a rather surprising finding was that low levels of physical 
activity produced fatigue in CFS, but not in MS patients who had similar low activity 
levels9 In chapter 10 it was suggested that a possible explanation may be that in CFS 
periods of rest are interrupted by short periods of marked activity during which 
patients perform at "normal" levels It may be that in patients with a low overall 
activity level short periods of high activity especially may have detrimental effects, 
possibly because of physical deconditioning This hypothesis is currently being tested 
12 3 4 DEPRESSION 
Although we argued that CFS cannot be relabeled as a depression (paragraph 12 3), 
some authors have suggested that in patients with CFS depression - when present -
may contribute to the perpetuation of complaints '9 21 The studies presented in this 
thesis, however, present strong evidence that this is not the case In the longitudinal 
study, depression was not a predictor of the natural course of the illness (chapter 6) 
Others have found similar results 22 23 In addition, structural equation analyses 
showed that depression had to be excluded from the final model on perpetuating 
factors altogether, suggesting that depression is of no value in predicting fatigue 
seventy or any of the processes that did have a causal effect on fatigue (chapter 9) 
Fluoxetine is a potent antidepressant in patients diagnosed as having major 
depressive disorder according to DSM-III-R,24 but we found that it was not effective 
on depressive symptomatology in CFS patients who additionally had the same 
diagnosis (chapter 7) This suggests that mechanisms underlying the presentation of 
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depressive symptoms in CFS patients are different from those in patients with major 
depressive disorder Other studies lend support for this hypothesis Cleare et al2i 
found that prolactine responses to the selective serotonine releasing agent d-
fenfluramine in CFS patients were higher than in healthy subjects and in patients 
with major depressive disorder they were lower This may suggest that in CFS there 
is serotonine hypersensitivity as contrasted to patients with major depressive disorder 
where there appears to be serotonine hyposensitivity " Moreover, the adminstration 
of a serotonine re-uptake inhibitor (paroxetine) in healthy subjects resulted in a 
reduced capacitity to perform prolonged exercise 26 Fluoxetine, being a selective 
serotonine re-uptake inhibitor, therefore may have a detrimental effect in CFS This 
may explain the lack of placebo-effect in our fluoxetine-treated patients (chapter 7) 
fluoxetine made symptoms worse, thereby suppressing the expected placebo-effect 
The absence of placebo-effect in our study was found in the depressed and in the 
non-depressed patients This suggests that hypersensitivity is independent of whether 
or not patients presented depressive symptomatology Two other studies, on the 
other hand, did not find a difference in d-fenfluramine-induced prolactine responses 
between CFS patients and healthy subjects 27 28 
Thus, the presentation of depressive symptoms in CFS does not indicate the 
same condition as in depressed patients and this does not contribute to the 
persistence of fatigue It seems to be worthwhile to further investigate 
neuroendocrine function in CFS 
12 3 5 FOCUSING ON BODILY SYMPOMS 
Scores on measures of psychological well-being of CFS patients usually are 
intermediate between healthy subjects and psychiatric patients, and are similar to 
patients with MS (see paragraph 12 3) The somatisation subscale of the SCL-90, 
however, is an exception to this rule On this subscale patients with CFS had higher 
scores, similar to psychiatric patients In chapter 8 it was concluded that the high 
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scores on this measure more likely reflect strong focusing on bodily sensations, 
rather than that these are evidence for the fact that patients with CFS are cases of 
somatisation disorder in the sense of psychological disturbance expressed in physical 
symptoms In addition, the diagnosis of somatisation disorder is of very limited use 
in CFS as the prevalence of somatisation disorder in CFS was shown to vary from 0 
to 98% in the same sample depending on whether a symptom was coded as being 
due to a physical or to a psychiatric disease 29 
In the model on factors perpetuating fatigue it was found that SCL-Somatisation 
had a causal effect on fatigue and in chapter 10 we found that high scores on this 
measure were related to a high degree of expecting activity to produce fatigue Thus, 
the somatisation subscale of the SCL-90 appears to be an important variable and 
therefore further validation of the concept it measures is warranted 
12 3 6 NEUROPSYCHOLOGICAL FUNCTIONING 
Complaints of memory and concentration problems are among the most 
frequently reported complaints by CFS patients Studies using standardized 
neuropsychological tests, however, have generated conflicting results In chapter 11 
it was shown that this resulted from methodological setbacks, especially those 
related to inadequate correction for premobid abilities and ignoring the confounding 
effects of the heterogeneity of CFS In that study we showed that in CFS a subgroup 
of patients is impaired in neuropsychological functioning, whereas other patients are 
not 
The proportion of patients who were impaired (about one-third) is too high to be 
ignored, but at present there is no definite explanation for the poor tests performance 
in some patients Information processing, the most frequently impaired function in 
CFS, is reported to be impaired in depressed patients,30 but we did not find such a 
relationship in CFS (chapter 11) This finding may form further evidence that 
depressive symptomatology in CFS is an expression of other processes than in major 
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depressive disorder. 
To date, no pattern of cerebral abnormalities has been found that is 
characteristic of CFS, but this may have methodological causes. In addition, 
neuroendocrine function may be impaired in CFS (see section 12.3.4) and this may 
be related to neuropsychological impairment. Also, we found that the most 
frequently impaired functions (speed of information processing and slowed motor 
speed) were related to low levels of physical activity. As in chapters 9 and 10 we 
showed that low levels of physical activity were caused by cognitive processes 
(attributing complaints to somatic causes and expecting exercise to produce fatigue) 
and considering the fact that no physical cause is known for these low activity 
levels, slowed speed of information processing may not be the result of damaged 
cerebral structures or processes, but rather be a consequence of prolonged lack of 
stimulation. In that case poor test performance can be viewed as a behavioural 
problem. On the other hand, high levels of serotonine have been reported to reduce 
exercise capacity in healthy subjects. As serotonine supersensitivity has been 
reported in CFS (see section 12.3.4), impaired neuropsychological functioning and 
low activity levels may both be consequences of impaired serotonine function. 
12.6 Conclusions and future directions 
The main conclusion of the present thesis is that, although etiology of CFS is 
unknown, psychological factors are involved in the persistence of fatigue. These 
processes were clearly different from the processes related to the experience of 
fatigue in another patient group experiencing marked fatigue (MS). 
These conclusions were derived from different studies, performed in different 
samples, and using different designs. The longitudinal study was of importance as 
predictors of the natural course represent factors that are associated with chronicity. In 
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chapter 9 a model on cognitive and behavioural factors involved in the perpetuation 
of fatigue in CFS was developed and tested, using the statistical technique 
"structural equation modeling" One of the most appealing properties of the model 
that resulted from these analyses is, that it provided information about the direction 
of causation between variables In addition, the model was tested integrally These 
analyses enabled us to evaluate the unique effects of each of these processes and 
their interrelations The comparisons with healthy subject provided a standard for 
normality and the comparison with fatigued MS patients in particular were of 
importance to evaluate the specificity of the results we found in CFS 
From these studies it became clear that sense of control over symptoms and 
causal attributions are very important processes in CFS Focusing on bodily 
symptoms also appeared to play a prominent role in CFS, but further research is 
needed to validate this concept and to further investigate its consequences Similarly, 
physical activity also plays an important role in CFS, but the comparison with MS 
patients showed that overall activity level was not the key deficit It was suggested 
that overall activity level should be related to overall activity patterns Depression 
does not play a crucial role in CFS It is even questionable whether the presentation 
of depressive symptoms in CFS represents major depressive disorder 
The major setback of the studies presented in this thesis is that the patients who 
were studied had a relatively long duration of complaints In previous paragraphs it 
was suggested that the processes related to the persistence of fatigue become 
established during the course of the illness or may change in time Getting insight 
into the origins of what determines sense of control to be negative, or what causes 
oversensitivity to bodily sensations or physical attributions is of major importance 
To prevent these processes to become established as such and to prevent their 
interplay as we have demonstrated in our studies may prevent fatigue to become 
chronic Similar analyses (structural equation analyses) based on data from 
longitudinal studies including patients with short duration of complaints therefore are 
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needed As hypothesized above social processes may be of importance in this 
respect The influence of the social environment has been rather neglected in this 
thesis It seems to be most worthwhile to investigate the influence of the interactions 
of the patient with the doctor, partner, family, friends, colleagues (or the work 
situation in general), and to evaluate the influence of invalidity benefits-related 
procedures 
Future research should be directed at discovering yet unknow etiological 
mechanisms in CFS An interesting line of investigation would be studying the 
relationships between neuroimaging results, neuroendocrine functioning, 
neuropsychological functioning (information processing speed), and physical activity 
level The measurement of physical activity preferably should be done by a motion-
sensing device or questionnaires which require simple responses to specified 
activities (chapter 10) In addition, the effects of activity patterns should be studied 
In any future study the heterogeneity of CFS should be appreciated Traditional 
(clinical) criteria, such as specific symptoms (and related criteria such as CDC-
critena and DSM-IV) are not fruitful in order to achieve homogeneous groups As 
has been done in chapter 11 investigations should be located more at an individual 
level 
The results of the present study have significant therapeutic implications At 
present two major studies reported on cognitive-behavioural treatment in CFS and 
claimed beneficai effects 33 35 These interventions, however, were primarily 
concerned with increasing activity level Results of the present studies, however, 
point to the importance of addressing cognitions and attributions Changing physical 
attributions would be the first step to take Unless these attributions have changed, 
the patient will not be inclined to engage in any non-somatic treatment program and 
most certainly will not be willing to increase physical activity level In addition, 
treatment should be specifically directed at improving sense of control and reducing 
focusing on bodily sensations As patients are primarily seen by doctors (notably 
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general practitioners and internists), these professionals play an important role in 
whether a patient keeps on searching for somatic explanations (with resulting 
chronicity and high medical consumption) or whether he tries cognitive-behaviour 
therapy We currently are carrying out a controlled trial in which the value of a 
cognitive-behavioural intervention which is directed at these processes is evaluated 
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Summary 
Chronic fatigue syndrome (CFS) is characterised by severe disabling fatigue, 
lasting for more than 6 months, and for which no somatic explanation can be 
offered Chronic fatigue is a major problem, to the patient who experiences severe 
disabling complaints, to the doctor who finds himself confronted with a patient with 
multiple nonspecific symptoms, for which he cannot provide a solution, and chronic 
fatigue is a problem to society, considering the repeated diagnostic evaluations and 
juridical procedures regarding the awarding of invalidity benefits The main subjects 
of this thesis were how to assess CFS and what factors are associated with the 
persistence of the complaints 
At the start of our studies we reviewed the literature concerning the somatic and 
psychological hypotheses on etiology, presented in Chapter 2 and Chapter 3, 
respectively 
Chapter 4 describes the development of a multi-dimensional assessment method 
to fill the void in methods to provide a comprehensive assessment of CFS Two-
hundred and ninety-eight patients with CFS completed questionnaires that assessed 
behavioural, emotional, cognitive, and social functioning By means of statistical 
techniques nine dimensions were identified subjective experience, psychological 
well-being, functional impairment in daily life, sleep disturbances, avoidance of 
physical activity, neuropsychological functioning, attributions related to the cause of 
the complaints, sense of control over symptoms (self-efficacy expectations), and 
social functioning These dimensions were shown to be relatively independent 
Thus, each dimension provides a unique contribution to the description of a patient 
In Chapter 5 we evaluated the usefulness of laboratory tests and psychological 
questionnaires for the assessment of CFS Laboratory tests were not found to be 
useful as no significant differences were found between patients and matched healthy 
controls With respect to psychological tests, on the other hand, measures of fatigue 
severity, depression severity, and functional impairment discriminated between 
patients and controls and therefore are helpful tools in the assessment of CFS 
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In Chapter 6 a study is presented in which the patients described in chapter 5 
were followed up after 18 months in order to determine spontaneous improvement 
and to identify factors that predict improvement Three percent of these patients 
reported complete recovery and 17% reported improvement At follow-up the 
significant problems in occupational situation and the high medical consumption 
found at initial assessment remained unchanged Sociodemographic characteristics or 
receiving treatment by a specialist or alternative practicioner did not predict 
improvement Predictors for improvement were sense of control over symptoms, 
less fatigue, shorter duration of complaints, and a relative absence of attributing 
complaints to a physical cause It was concluded that the improvement rate in 
patients with a relatively long duration of complaints is small and that psychological 
factors are related to chromcity, especially cognitive factors 
The first randomised, double-blind, placebo-controlled study of anti-depressant 
therapy in CFS is described in Chapter 7 In this study the effect of a 20 mg daily 
dose of fluoxetine (ProzacR) on the dimensions of CFS was evaluated in depressed 
and in nondepressed CFS patients We did not find any significant difference in 
improvement between the fluoxetine-treated patients and the patients from the 
placebo-group in any dimension of CFS The absence of an effect on depressive 
symptomatology suggests that the processes underlying the presentation of 
depressive symptoms in CFS may differ from those in patients with major depressive 
disorder We concluded that the prescription of a 20 mg daily dose of fluoxetine is 
not warranted in CFS, whether these patients are depressed or not 
In Chapter 8 a multi-dimensional characterisation of fatigue was performed in 
patients with multiple sclerosis (MS) MS patients experienced significant fatigue, 
which had a marked impact on daily functioning and was not related to depression or 
to the somatic substrate as measured by Kurtzke's Expanded Disability Status score 
(EDSS) MS patients and CFS patients showed similar low levels of physical activity 
and had similar scores on psychological well-being than CFS patients, except that 
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patients with CFS had significantly higher somatization scores These scores were 
interpreted as strong focusing on bodily sensations In both patient groups fatigue 
severity was related to low sense of control over symptoms and strong focusing on 
bodily sensations However, in CFS relationships were found between low levels of 
physical activity and attributing symptoms to a physical cause and between 
subjective fatigue severity and physical activity, but not in MS 
In the literature a model has been postulated in which behavioural, cognitive, 
and affective factors play a part in perpetuating fatigue In Chapter 9 this model 
was formulated in terms of cause and effect relationships and an integral test of this 
model was performed by the statistical technique "structural equation modeling" 
Attributing complaints to a somatic cause produced low levels of physical activity, 
which in turn had a causal effect on fatigue seventy In contrast to the hypothesized 
model, depression had to be deleted from the model Two new causal relationships 
were found sense of control over symptoms and focusing on bodily symptoms each 
had a direct causal effect on fatigue The model showed excellent fit for CFS 
patients, but was rejected for MS patients Therefore, a new model for MS patients 
had to be developed In this model, sense of control had a causal effect on fatigue, 
which in turn had a causal effect on functional impairment Attributions, physical 
activity, and focusing on bodily symptoms had to be deleted from the MS model 
Also, EDSS was not related to fatigue or functional impairment This study showed 
that cognitive and behavioral factors are involved in the persistence of fatigue and 
that the processes involved in the subjective experience of fatigue in CFS were 
different from the processes related to fatigue in MS 
The study presented in Chapter 10 set out to measure actual activity level by a 
motion-sensing device (Actometer) to validate claims of low activity levels in CFS, 
to evaluate whether self-report measures can adequately assess actual level of 
physical activity, and to evaluate the relationships between physical activity level, 
fatigue, and cognitions we found in chapter 4, 8, and 9 in more detail None of the 
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self-report questionnaires showed close correlations with the Actometer However, 
questionnaires that required simple ratings of specified activities were related to the 
Actometer and can be used as acceptable substitutes, in contrast to instruments that 
require general subjective interpretations of activity that had low or non-significant 
correlations with the Actometer Although CFS patients and MS patients had similar 
low activity levels, activity level was associated with fatigue in CFS only In 
addition, cognitive factors appear to be more prominently involved in producing the 
low activity levels in CFS than in MS We found that activities which patients 
expected to result in higher fatigue levels were less frequently performed Patients 
with CFS had significantly higher scores on this measure than MS patients and 
healthy subjects 
Neuropsychological complaints, notably memory and concentration problems, 
are frequently reported by patients with CFS Studies using standardized 
neuropsychological tests, however, have yielded conflicting results Chapter 11 was 
designed to provide an estimate of the prevalence of neuropsychological impairment, 
to evaluate the concordance between impairment found on standardized tests and 
self-reported neuropsychological problems, and to evaluate the relationship between 
neuropsychological functioning and fatigue severity and the processes involved in 
the perpetuation of fatigue To overcome the methodological setbacks of previous 
studies, neuropsychological impairment was determined on an individudal basis after 
individual correction for premorbid abilities and confounders Seventeen percent of 
patients showed impairment in concentration, 13% were impaired in verbal memory, 
25% had slowed motor speed and 27% had slowed speed of information processing 
Overall, 29% of patients could be considered as impaired in neuropsychological 
functioning There was no relationship between neuropsychological impairment 
found on standardized tests and self-reported memory and concentration problems 
In fact, in the majority of patients these complaints could not be substantiated by 
formal testing The most frequently impaired functions (speed of information 
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processing and motor speed) were related to measures of physical activity, but not to 
fatigue seventy, depression, sense of control over symptoms, or attributions 
regarding the cause of the complaints Poor test performance may be caused by 
prologned lack of stimulation 
Finally, in Chapter 12 the results of the studies presented in this thesis were 
placed into one perspective, the strong point and weak points were evaluated, and 
directions for future research were formulated It was concluded that, although 
etiology of CFS is unknown, psychological factors play a part in the perpetuation of 
complaints These factors particularly concern cognitions and behaviour, on which 
treatment should be directed Comprehensive assessment of CFS should consist of a 
multi-dimensional assessment using different types of assessment methods to 
measure each dimension Future research should be directed at further validation of 
the concept focusing on bodily symptoms, and the influence of the social 
environment In addition, cerebral functioning, neuroendocrine functioning should 
be investigated and these results should be linked to neuropsychological test 
performance and physical activity Patients with short duration of complaints should 
be included and more attention should be paid to forming homogeneous subgroups 
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Samenvatting 
Het chronische vermoeidheidssyndroom (CVS) wordt gekenmerkt door ernstige 
invaliderende vermoeidheid, die langer duurt dan zes maanden en waarvoor geen 
lichamelijke verklaring gevonden kan worden Chronische vermoeidheid is een groot 
probleem voor de patient die ernstige invaliderende klachten ervaart, voor de arts 
die zich geconfronteerd ziet met een patient met meervoudige non-specifieke 
klachten waarvoor hij geen oplossing voorhanden heeft, en chronische vermoeidheid 
is een probleem voor de maatschappij met het oog op de veelvuldige, vaak kostbare 
diagnostische onderzoekingen en juridische procedures De centrale onderwerpen in 
dit proefschrift hebben betrekking op het meten van vermoeidheid en de factoren die 
een bijdrage leveren aan het in stand houden van de klachten 
Bij aanvang van onze studies hebben we overzichten gemaakt van de 
internationale literatuur met betrekking tot somatische en psychologische hypothesen 
over de enologie Deze overzichten worden gepresenteerd in respectievelijk 
Hoofdstuk 2 en Hoofdstuk 3 
Hoofdstuk 4 beschrijft de ontwikkeling van een multi-dimensionele 
meetmethode die voorziet in een uitgebreide meting van CVS 298 patiënten met 
CVS vulden vragenlijsten in gericht op gedragsaspecten en het emotionele, 
cognitieve en sociale functioneren Met behulp van statistische technieken werden 
negen dimensies geïdentificeerd het subjectief gevoel van moeheid, psychologisch 
welbevinden, beperkingen in het dagelijks leven, slaapstoornissen, vermijden van 
lichamelijke activiteit, neuropsychologische functioneren, attributies met betrekking 
tot de door de patient veronderstelde oorzaken van de klachten, de mate van ervaren 
controle over de klachten (self-efficacy verwachtingen) en sociaal functioneren 
Deze dimensies bleken relatief onafhankelijk Dit betekent dat elke dimensie een 
unieke bijdrage levert aan het beschrijven van de patient 
In Hoofdstuk 5 wordt een onderzoek beschreven naar het nut van laboratorium 
testen en psychologische vragenlijsten voor het meten van CVS Laboratorium testen 
werden niet als nuttig bevonden, aangezien er geen significante verschillen met 
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gematchte gezonde controles gevonden werden. Met betrekking tot psychologische 
testen echter, bleken de vragenlijsten gericht op de mate van moeheid, depressie en 
beperkingen in het dagelijks leven goed onderscheid te kunnen maken tussen 
patiënten en controles en zijn derhalve nuttige hulpmiddelen bij het meten van CVS. 
In Hoofdstuk 6 wordt een studie gepresenteerd waarin de patiënten die eerder 
beschreven in hoofdstuk 5 na 18 maanden opnieuw onderzocht werden. Het doel van 
deze studie was na te gaan in hoeverre spontaan herstel mogelijk is bij CVS en te 
onderzoeken welke factoren dit herstel kunnen voorspellen. Drie procent van de 
patiënten rapporteerden volledig herstel en 17% meldde verbetering van de klachten 
maar geen volledig herstel. Tijdens de follow-up metingen bleek dat de in het eerste 
onderzoek geconstateerde grote problemen in de werksituatie en de hoge medische 
consumptie onveranderd problematisch waren. Sociodemografische kenmerken noch 
het ontvangen van behandeling door een specialist of alternatief genezer bleken van 
invloed op herstel. Voorspellers van herstel waren: mate van ervaren controle over 
de klachten, minder ernstige vermoeidheid, relatief korte klachtenduur en een 
relatieve afwezigheid van het toeschrijven van de klachten aan lichamelijke 
oorzaken. Geconcludeerd werd dat spontaan herstel bij patiënten met een relatieve 
lange klachtenduur gering is en dat psychologische factoren gerelateerd zijn aan het 
in stand houden van de klachten, met name cognitieve factoren. 
De eerste gerandomiseerde, dubbel-blind, placebo-gecontroleerde studie naar 
het effect van anti-depressieve therapie bij CVS wordt beschreven in Hoofdstuk 7. 
In dit onderzoek werd het effect van een dagelijkse dosis van 20 mg fluoxetine 
(Prozac") op de dimensies van CVS geëvalueerd bij depressieve en niet-depressieve 
CVS patiënten. We vonden geen significant verschil in verbetering ten aanzien van 
geen enkele dimensie van CVS tussen de met fluoxetine behandelde patiënten en de 
patiënten die een placebo toegediend kregen. Het uitblijven van een effect op de 
depressieve symptomen suggereert dat de processen die ten grondslag liggen aan 
depressieve symptomen bij CVS verschillen van die bij depressieve patiënten. We 
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concludeerden dat het voorschrijven van een dagelijkse dosis van 20 mg fluoxetine 
aan patiënten met CVS niet geïndiceerd is, ongeacht of een patient depressieve 
symptomen kent of niet 
In Hoofdstuk 8 wordt een multi-dimensionele beschrijving van vermoeidheid 
bij patiënten met multiple sclerose (MS) gepresenteerd Patienten met MS ervoeren 
ernstige vermoeidheid, die een sterke relatie vertoonde met beperkingen m het 
dagelijks leven, maar die niet gerelateerd was aan depressie of het somatisch 
substraat zoals gemeten met de Kurtzke's Expanded Disability Status Score (EDSS) 
Patienten met MS en patiënten met CVS vertoonden vergelijkbare lage niveau's van 
lichamelijke activiteit en hadden vergelijkbare scores op maten voor het 
psychologisch welbevinden, met uitzondering van het feit dat CVS-patienten hogere 
somatisatie scores kenden Deze laatste scores werden geïnterpreteerd als een sterke 
gerichtheid op lichamelijke gewaarwordingen In beide patiënt-groepen bleek sterke 
vermoeidheid gerelateerd aan een lage mate van ervaren controle over de klachten 
en sterke gerichtheid op lichamelijke gewaarwordingen Voorts werden bij CVS 
relaties gevonden tussen het toeschrijven van de klachten aan lichamelijke oorzaken 
en een laag niveau van lichamelijke activiteit en tussen een laag niveau van 
lichamelijke activiteit en ernstige vermoeidheid Bij patiënten met MS werden deze 
relaties niet gevonden 
In de literatuur is een model gepostuleerd waarin gedragsmatige, cognitieve en 
affectieve factoren een rol spelen bij het in stand houden van de vermoeidheid In 
Hoofdstuk 9 werd dit model geformuleerd in termen van oorzaak en gevolg relaties 
en werd een integrale test van dit model uitgevoerd met behulp van de statistische 
techniek "structural equation modeling" Uit deze analyses bleek dat het toeschrijven 
van de klachten aan lichamelijke factoren leidde tot lage niveau's van lichamelijke 
activiteit, die op hun beurt weer aanleiding gaven tot hoge vermoeidheidsniveau's 
Depressie moest uit het model verwijderd worden, hetgeen betekent dat depressie 
geen rol van betekenis speeltn in het verklaren van vermoeidheid Er werden ook 
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twee nieuwe relaties gevonden een lage mate van ervaren controle over de klachten 
en een sterke gerichtheid op lichamelijke gewaarwordingen bleken elk tot sterke 
vermoeidheid te leiden In de analyses bleek dit model uitstekend te passen bij 
patiënten met CVS, maar moest verworpen worden bij patiënten met MS Daarom 
moest voor MS patiënten een nieuw model ontworpen worden In dit model had de 
ervaren mate van controle over de klachten een causaal effect op de vermoeidheid 
Vermoeidheid op zijn beurt had een effect op de beperkingen in het dagelijks leven 
Attributies, niveau van lichamelijke activiteit en gerichtheid op lichamelijke 
gewaarwordingen speelden in het MS-model geen rol Daarnaast bleek EDSS niet 
gerelateerd aan vermoeidheid of beperkingen in het dagelijks leven Deze studie 
toonde aan dat cognitieve en gedragsfactoren een rol spelen bij het in stand houden 
van moeheid bij CVS en dat de processen die een rol spelen bij de ervaren moeheid 
bij CVS verschillen van die bij MS 
Het onderzoek dat gepresenteerd wordt in Hoofdstuk 10 had tot doel het 
werkelijk niveau van lichamelijke activiteit te meten door middel van een apparaatje 
dat bewegingen registreert, de Actometer, teneinde vast te stellen of patiënten met 
CVS ook daadwerkelijk lage niveau's van lichamelijke activiteit hebben, of 
vragenlijsten het werkelijk niveau van activiteit op een adequate wijze kunnen meten 
en het bestuderen van de relaties die we in eerdere studies vonden tussen 
lichamelijke activiteit, vermoeidheid en cognities (zie hoofdstuk 4, 8, en 9) Geen 
van de vragenlijsten vertoonde een sterke relatie met de Actometer Echter, 
vragenlijsten die slechts een eenvoudige respons vereisten op duidelijk 
gespecificeerde activiteiten bleken gerelateerd aan de Actometer en kunnen als 
acceptabele substituten dienen voor de Actometer, in tegenstelling tot vragenlijsten 
die algemene subjectieve interpretaties vereisen die lage of non-significante relaties 
met de Actometer vertoonden Alhoewel patiënten met CVS en patiënten met MS 
ongeveer gelijke niveau's van lichamelijke activiteit vertoonden, was het niveau van 
lichamelijke activiteit gerelateerd aan moeheid bij CVS maar niet bij MS Ook bleek 
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dat cognitieve factoren bij CVS een grotere rol spelen bij het veroorzaken van lage 
activiteitsniveau's dan bij MS. Bij beide patient groepen vonden we dat activiteiten 
waarvan de patiënt verwachtte dat hij daar vermoeid van zou worden minder vaak 
uitgevoerd werden, maar patiënten met CVS hadden sterkere verwachtingen dat 
activiteit tot vermoeidheid leidde dan patiënten met MS en gezonde controles. 
Neuropsychologische klachten, met name geheugen- en concentratiestoomissen, 
worden vaak gerapporteerd door patiënten met CVS. Studies die met behulp van 
gestandaardiseerde tests poogden deze klachten te onderbouwen leverden echter 
tegenstrijdige resultaten op. De studie beschreven in Hoofdstuk 11 was opgezet om 
een schatting te kunnen maken van de prevalentie van neuropsychologisch 
dysfunctioneren bij CVS. Tevens werd de mate van overeenstemming bepaald tussen 
zelf-gerapporteerde neuropsychologische klachten en neuropsychologisch 
dysfunctioneren gevonden met gestandaardiseerde testen, en werden de relaties 
onderzocht tussen neuropsychologisch dysfunctioneren en moeheid en de 
psychologische factoren die een bijdrage leveren aan het in stand houden van de 
klachten zoals beschreven in eerdere hoofdstukken. Teneinde de methodologische 
problemen te vermijden die andere studies parten hebben gespeeld, werd 
neuropsychologisch dysfunctioneren individueel bepaald na correctie voor 
premorbide functioneren en verstorende factoren. 17% van de patiënten vertoonden 
stoornissen in concentratie, 13% hadden problemen met verbaal geheugen, 25% 
hadden een vertraagde motoriek, en bij 27% van de patiënten werd een vertraagde 
informatie-verwerkingssnelheid geconstateerd. Er werd geen relatie gevonden tussen 
neuropsychologisch dysfunctioneren gebaseerd op gestandaardiseerde testen en zelf-
gerapporteerde geheugen- en concentratieproblemen. Bij de meerderheid van de 
patiënten die deze klachten rapporteerden konden deze niet bevestigd worden met 
behulp van de gestandaardiseerde testen. De meest frequent aangedane 
neuropsychologische functies (snelheid van informatieverwerking en motorische 
snelheid) vertoonden een relatie met maten van lichamelijke activiteit, maar niet met 
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de mate van vermoeidheid, depressie, ervaren controle over de klachten of 
attributies met betrekking tot de oorzaak van de klachten. Neuropsychologisch 
dysfunctioneren wordt mogelijk veroorzaakt door een gebrek aan stimulatie. 
Tenslotte worden in Hoofdstuk 12 de resultaten die in dit proefschrift 
gepresenteerd zijn in één perspectief geplaatst, worden de sterke en zwakke punten 
geëvalueerd en wordt de richting voor toekomstig onderzoek aangegeven. 
Kemconclusie is dat, ondanks dat de oorspronkelijke aanleiding van de klachten 
onbekend is, psychologische factoren een bijdrage leveren aan het in stand houden 
van de klachten. Deze factoren hebben met name betrekking op gedrag en cognities. 
Behandeling moet zich op deze factoren richten. Het meten van CVS dient op multi-
dimensionele wijze plaats te vinden waarbij gebruikt dient te worden gemaakt van 
verschillende methoden om de dimensies te meten. Toekomstig onderzoek naar een 
verdere validatie van het concept gerichtheid op lichamelijke gewaarwordingen bij 
CVS en de invloed van de sociale omgeving zou vruchtbaar kunnen zijn. Tevens 
lijkt het zinvol het cerebraal en neuroendocriene functioneren te bestuderen, waarbij 
deze onderzoekingen gerelateerd dienen te worden aan neuropsychologische testen 
en lichamelijke activiteit. Onderzoek naar patiënten met een relatieve klachtenduur is 
gewenst en het verdient aanbeveling meer homogene subgroepen te indentificeren. 
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ActiLog V3.0 
The ActiLog is a motion-sensing device and is used for registration and 
quantification of human physical activity. The ActiLog is normally wom at the ankle 
and gives little inconvenience. This makes the ActiLog especially suitable for long-
term continuous registrations. Accelerations larger than a predefined treshold are 
treated as activity and are stored into an internal memory. In this way every 5 
minutes an activity score is produced. 
.. Activity 
-day 
10 11 12 13 14 
The ActiLog is easy to program with the included software. No special equipment is 
required, simply connect the ActiLog to the serial port of a standard computer. With 
the software the data can be graphically visualized and a number of quantitative 
parameters are automatically calculated (e.g. mean activity score, sleep-wake pattern, 
etc.). Both the raw data and the calculated parameters can be simply exported to 
most commonly used programs (e.g. Excel, SPSS). 
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24 hour recording with automatic wake/sleep detection 
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Integration-time 
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Max. Record period 
Battery Lifetime 
Dimensions (l*w*h) 
Weight (incl.batt.) 
5 minutes 
600 
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55*25*15 mm 
26 g 
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Stellingen 
behorend bij het proefschrift 
Chronic Fatigue Syndrome: 
Assessment and Psychological Processes as Perpetuating Factors 
Nijmegen, 16 juni 1997 
J.H.M.M. Vercoulen 
Stellingen 
1. Als voor lichamelijke klachten geen lichamelijke oorzaak kan worden aangetoond, 
betekent dit niet dat de klachten op psychopathie duiden, en zeker niet op 
aanstellerij. 
2. Stellen dat het chronisch vermoeidheidssyndroom (CVS) een onzin-ziekte is, is 
gelijk aan het zich bevinden in een stevige plensbui, de ogen sluiten en dan 
concluderen dat het heerlijk droog is. 
3. De klinische waarde van categorale diagnostische systemen, zoals de Diagnostic 
and Statistical Manual of Mental Disorders, wordt overschat. 
4. De stelling dat CVS een manifestatie is van een psychiatrische aandoening dient te 
worden herzien. 
5. Om verwarring te voorkomen bij patiënt én hulpverlener dient een strikt 
onderscheid gemaakt te worden tussen de factoren ten aanzien van de oorzaak van 
de klachten en factoren die de klachten in stand houden. 
6. Depressie speelt geen rol bij het blijven voortbestaan van CVS. 
7. Depressieve symptomen bij CVS duiden niet op een depressieve stoornis in 
psychiatrische zin. 
8. Bij het in stand houden van de klachten bij CVS spelen cognities en attributies 
evenals het niveau van lichamelijke activiteit een belangrijke rol. 
9. Cognities en attributies spelen een belangrijke rol bij het bestaan van een laag 
niveau van lichamelijke activiteit in CVS. 
Stellingen 
10 De processen die een rol spelen bij moeheid bij Multiple Sclerose zijn van andere 
aard dan bij CVS 
11 Bij de behandeling van CVS dient een selectieve serotonine-heropname remmer 
achterwege gelaten te worden Dit geldt ook voor de overige anti-depressiva 
12 Sinds de overlangs doorgezaagde ingemetselde gres-buizen zijn vervangen door 
echte urinoirs, heeft café 't Haantje een deel van zijn charme verloren 



